DDI-MedLine.d180.s0|31-35|DZNep|brand
DDI-MedLine.d180.s1|40-61|S-adenosylhomocysteine|drug
DDI-MedLine.d180.s1|82-91|inhibitors|group
DDI-MedLine.d180.s1|104-112|antitumor|group
DDI-MedLine.d180.s2|9-16|examined|drug
DDI-MedLine.d180.s2|149-150|MM|brand
DDI-MedLine.d180.s2|157-161|lines|group
DDI-MedLine.d180.s3|24-28|DZNep|brand
DDI-MedLine.d180.s3|71-82|HG-U133 Plus|brand
DDI-MedLine.d180.s3|159-168|determined|drug
DDI-MedLine.d180.s4|53-61|sensitive|drug
DDI-MedLine.d180.s5|33-44|quantitative|group
DDI-MedLine.d180.s5|46-51|RT-PCR|brand
DDI-MedLine.d180.s6|32-36|ALOX5|brand
DDI-MedLine.d180.s6|67-75|sensitive|drug
DDI-MedLine.d180.s6|82-85|line|drug
DDI-MedLine.d180.s6|87-90|H929|brand
DDI-MedLine.d180.s6|119-123|DZNep|brand
DDI-MedLine.d180.s7|22-26|ALOX5|brand
DDI-MedLine.d180.s7|51-55|DZNep|brand
DDI-MedLine.d180.s7|60-63|H929|brand
DDI-MedLine.d180.s8|32-36|ALOX5|brand
DDI-MedLine.d180.s8|41-43|RNA|brand
DDI-MedLine.d180.s8|89-92|H929|brand
DDI-MedLine.d180.s9|28-29|MM|brand
DDI-MedLine.d180.s9|57-61|ALOX5|brand
DDI-MedLine.d180.s9|102-103|MM|brand
DDI-MedLine.d180.s10|19-23|Bcl-2|brand
DDI-MedLine.d180.s10|46-50|DZNep|brand
DDI-MedLine.d180.s10|52-62|insensitive|drug
DDI-MedLine.d180.s10|92-96|DZNep|brand
DDI-MedLine.d180.s10|102-108|ABT-737|brand
DDI-MedLine.d180.s10|113-117|Bcl-2|brand
DDI-MedLine.d180.s10|137-151|synergistically|drug
DDI-MedLine.d180.s10|195-199|DZNep|brand
DDI-MedLine.d180.s10|201-211|insensitive|drug
DDI-MedLine.d180.s10|213-214|MM|brand
DDI-MedLine.d180.s11|58-62|DZNep|brand
DDI-MedLine.d180.s11|76-77|MM|brand
DDI-MedLine.d180.s11|128-132|ALOX5|brand
DDI-MedLine.d180.s12|13-17|DZNep|brand
DDI-MedLine.d180.s12|76-80|Bcl-2|brand
DDI-MedLine.d180.s12|106-112|ABT-737|brand
DDI-MedLine.d180.s12|118-122|DZNep|brand
DDI-MedLine.d180.s12|130-144|synergistically|drug
DDI-MedLine.d180.s13|27-31|DZNep|brand
DDI-MedLine.d180.s13|50-64|therapeutically|drug
DDI-MedLine.d180.s13|82-83|MM|brand
DDI-MedLine.d227.s0|0-8|Ephedrine|drug
DDI-MedLine.d227.s0|23-37|antinociceptive|group
DDI-MedLine.d227.s0|49-63|dexmedetomidine|drug
DDI-MedLine.d227.s1|0-14|Dexmedetomidine|drug
DDI-MedLine.d227.s1|26-55|selective alpha-2-adrenoceptor|group
DDI-MedLine.d227.s1|104-111|practice|drug
DDI-MedLine.d227.s1|121-128|sedative|drug
DDI-MedLine.d227.s2|75-83|ephedrine|drug
DDI-MedLine.d227.s2|103-141|dexmedetomidine-induced antinociception|group
DDI-MedLine.d227.s4|0-14|antinociception|group
DDI-MedLine.d227.s5|17-24|received|drug
DDI-MedLine.d227.s6|0-5|saline|drug
DDI-MedLine.d227.s6|9-14|saline|drug
DDI-MedLine.d227.s6|17-25|ephedrine|drug
DDI-MedLine.d227.s6|42-47|saline|drug
DDI-MedLine.d227.s6|50-55|saline|drug
DDI-MedLine.d227.s6|59-73|dexmedetomidine|drug
DDI-MedLine.d227.s6|93-101|ephedrine|drug
DDI-MedLine.d227.s6|118-132|dexmedetomidine|drug
DDI-MedLine.d227.s7|64-78|dexmedetomidine|drug
DDI-MedLine.d227.s7|96-104|ephedrine|drug
DDI-MedLine.d227.s7|178-192|antinociception|group
DDI-MedLine.d227.s7|205-219|dexmedetomidine|drug
DDI-MedLine.d227.s8|53-67|dexmedetomidine|drug
DDI-MedLine.d227.s8|89-97|ephedrine|drug
DDI-MedLine.d227.s9|22-29|combined|drug
DDI-MedLine.d227.s9|49-63|dexmedetomidine|drug
DDI-MedLine.d227.s9|70-78|ephedrine|drug
DDI-MedLine.d227.s9|183-197|dexmedetomidine|drug
DDI-DrugBank.d765.s0|7-16|Inhibitors|group
DDI-DrugBank.d765.s0|19-30|Ketoconazole|drug
DDI-DrugBank.d765.s0|135-145|tolterodine|drug
DDI-DrugBank.d765.s0|211-231|CLINICAL PHARMACOLOGY|brand
DDI-DrugBank.d765.s0|234-244|Variability|brand
DDI-DrugBank.d765.s0|249-258|Metabolism|brand
DDI-DrugBank.d765.s0|264-285|Drug-Drug Interactions|brand
DDI-DrugBank.d765.s1|23-34|ketoconazole|drug
DDI-DrugBank.d765.s1|59-68|inhibitors|group
DDI-DrugBank.d765.s1|90-100|antifungals|group
DDI-DrugBank.d765.s1|107-118|itraconazole|drug
DDI-DrugBank.d765.s1|121-130|miconazole|drug
DDI-DrugBank.d765.s1|136-156|macrolide antibiotics|group
DDI-DrugBank.d765.s1|163-174|erythromycin|drug
DDI-DrugBank.d765.s1|177-190|clarithromycin|drug
DDI-DrugBank.d765.s1|196-207|cyclosporine|drug
DDI-DrugBank.d765.s1|212-222|vinblastine|drug
DDI-DrugBank.d765.s1|249-257|DETROL LA|brand
DDI-DrugBank.d765.s2|21-45|Interactions Interactions|brand
DDI-DrugBank.d765.s2|55-65|tolterodine|drug
DDI-DrugBank.d670.s0|14-19|INVEGA|brand
DDI-DrugBank.d670.s0|34-44|Other Drugs|brand
DDI-DrugBank.d670.s0|46-57|Paliperidone|drug
DDI-DrugBank.d670.s0|105-119|pharmacokinetic|drug
DDI-DrugBank.d670.s1|26-30|liver|drug
DDI-DrugBank.d670.s1|55-66|paliperidone|drug
DDI-DrugBank.d670.s1|77-89|substantially|group
DDI-DrugBank.d670.s1|174-179|CYP1A2|brand
DDI-DrugBank.d670.s1|182-187|CYP2A6|brand
DDI-DrugBank.d670.s1|190-200|CYP2C8/9/10|brand
DDI-DrugBank.d670.s1|203-208|CYP2D6|drug
DDI-DrugBank.d670.s1|211-216|CYP2E1|brand
DDI-DrugBank.d670.s2|11-22|paliperidone|drug
DDI-DrugBank.d670.s3|0-11|Paliperidone|drug
DDI-DrugBank.d670.s4|3-13|therapeutic|drug
DDI-DrugBank.d670.s4|31-42|paliperidone|drug
DDI-DrugBank.d670.s4|60-73|P-glycoprotein|brand
DDI-DrugBank.d670.s5|0-11|Paliperidone|drug
DDI-DrugBank.d670.s5|50-72|P-glycoprotein-mediated|brand
DDI-DrugBank.d670.s6|0-4|Given|drug
DDI-DrugBank.d670.s6|18-20|CNS|brand
DDI-DrugBank.d670.s6|33-44|paliperidone|drug
DDI-DrugBank.d670.s6|47-52|INVEGA|brand
DDI-DrugBank.d670.s7|0-11|Paliperidone|drug
DDI-DrugBank.d670.s7|61-68|dopamine|drug
DDI-DrugBank.d670.s8|38-48|orthostatic|drug
DDI-DrugBank.d670.s8|66-73|additive|drug
DDI-DrugBank.d670.s8|103-108|INVEGA|brand
DDI-DrugBank.d670.s8|140-157|therapeutic agents|group
DDI-DrugBank.d670.s9|14-24|Other Drugs|brand
DDI-DrugBank.d670.s9|29-41|Affect INVEGA|brand
DDI-DrugBank.d670.s9|46-57|Paliperidone|drug
DDI-DrugBank.d670.s9|81-86|CYP1A2|brand
DDI-DrugBank.d670.s9|89-94|CYP2A6|brand
DDI-DrugBank.d670.s9|97-102|CYP2C9|drug
DDI-DrugBank.d670.s9|109-115|CYP2C19|brand
DDI-DrugBank.d670.s9|146-155|inhibitors|group
DDI-DrugBank.d670.s10|37-42|CYP2D6|drug
DDI-DrugBank.d670.s10|84-95|paliperidone|drug
DDI-DrugBank.d784.s0|45-59|anticholinergic|group
DDI-DrugBank.d784.s0|81-86|agents|group
DDI-DrugBank.d784.s0|138-148|(drowsiness|group
DDI-DrugBank.d784.s0|165-184|anticholinergic-like|group
DDI-DrugBank.d784.s1|0-21|Anticholinergic agents|group
DDI-DrugBank.d784.s1|108-122|anticholinergic|group
DDI-DrugBank.d784.s2|47-57|therapeutic|drug
DDI-DrugBank.d784.s3|16-23|chloride|drug
DDI-DrugBank.d784.s3|85-95|DITROPAN XL|brand
DDI-DrugBank.d784.s3|119-130|ketoconazole|drug
DDI-DrugBank.d784.s4|6-15|inhibitors|group
DDI-DrugBank.d784.s4|67-84|antimycotic agents|group
DDI-DrugBank.d784.s4|93-104|itraconazole|drug
DDI-DrugBank.d784.s4|110-119|miconazole|drug
DDI-DrugBank.d784.s4|125-145|macrolide antibiotics|group
DDI-DrugBank.d784.s4|154-165|erythromycin|drug
DDI-DrugBank.d784.s4|171-184|clarithromycin|drug
DDI-DrugBank.d784.s4|214-228|pharmacokinetic|drug
DDI-DrugBank.d784.s4|248-251|Cmax|brand
DDI-DrugBank.d784.s4|257-259|AUC|brand
DDI-DrugBank.d784.s7|24-30|antacid|drug
DDI-DrugBank.d784.s7|42-48|antacid|drug
DDI-DrugBank.d784.s7|70-78|hydroxide|drug
DDI-DrugBank.d784.s7|91-99|hydroxide|drug
DDI-DrugBank.d717.s0|59-66|warfarin|drug
DDI-DrugBank.d717.s0|88-94|hepatic|drug
DDI-DrugBank.d717.s0|175-182|warfarin|drug
DDI-DrugBank.d717.s1|70-82|anticoagulant|group
DDI-DrugBank.d717.s1|123-130|Mitotane|brand
DDI-DrugBank.d717.s1|147-174|coumarin-type anticoagulants|group
DDI-DrugBank.d717.s2|13-20|Mitotane|brand
DDI-DrugBank.d717.s2|32-36|given|drug
DDI-DrugBank.d717.s2|117-123|hepatic|drug
DDI-DrugBank.d669.s0|30-39|vancomycin|drug
DDI-DrugBank.d669.s0|45-61|anesthetic agents|group
DDI-DrugBank.d669.s0|101-114|histamine-like|drug
DDI-DrugBank.d669.s1|29-36|systemic|group
DDI-DrugBank.d669.s1|119-130|amphotericin|drug
DDI-DrugBank.d669.s1|135-149|aminoglycosides|group
DDI-DrugBank.d669.s1|187-194|viomycin|drug
DDI-MedLine.d159.s0|0-9|Protective|drug
DDI-MedLine.d159.s0|21-38|acetyl-l-carnitine|drug
DDI-MedLine.d159.s0|45-49|alpha|group
DDI-MedLine.d159.s1|26-34|oxidative|drug
DDI-MedLine.d159.s1|130-143|Fanconi Anemia|brand
DDI-MedLine.d159.s2|28-46|putative inhibitors|group
DDI-MedLine.d159.s2|102-111|protective|drug
DDI-MedLine.d159.s2|142-152|DEB-induced|brand
DDI-MedLine.d159.s2|206-207|FA|brand
DDI-MedLine.d159.s3|84-94|DEB-induced|brand
DDI-MedLine.d159.s3|153-162|inhibitors|group
DDI-MedLine.d159.s3|167-173|epoxide|drug
DDI-MedLine.d159.s3|187-196|inhibitors|group
DDI-MedLine.d159.s3|201-210|protective|drug
DDI-MedLine.d159.s3|235-247|S-transferase|brand
DDI-MedLine.d159.s4|17-35|putative protective|drug
DDI-MedLine.d159.s4|58-69|antioxidants|group
DDI-MedLine.d159.s4|90-106|protective agents|group
DDI-MedLine.d159.s5|65-73|evidenced|drug
DDI-MedLine.d159.s5|161-163|DEB|brand
DDI-MedLine.d159.s5|183-185|GSH|brand
DDI-MedLine.d159.s5|209-211|ATP|brand
DDI-MedLine.d159.s6|5-22|acetyl-l-carnitine|drug
DDI-MedLine.d159.s6|46-55|protective|drug
DDI-MedLine.d159.s6|67-69|DEB|brand
DDI-MedLine.d159.s6|115-131|alpha-lipoic acid|group
DDI-MedLine.d159.s7|0-11|Collectively|drug
DDI-MedLine.d159.s7|69-78|DEB-induce|brand
DDI-MedLine.d159.s7|159-160|FA|brand
DDI-MedLine.d159.s7|195-204|protective|drug
DDI-MedLine.d159.s7|236-246|DEB-induced|brand
DDI-DrugBank.d590.s0|20-25|TRITEC|brand
DDI-DrugBank.d590.s0|32-45|clarithromycin|drug
DDI-DrugBank.d590.s0|76-85|ranitidine|drug
DDI-DrugBank.d590.s0|190-203|clarithromycin|drug
DDI-DrugBank.d590.s2|37-43|antacid|drug
DDI-DrugBank.d590.s2|109-118|ranitidine|drug
DDI-DrugBank.d590.s2|175-180|TRITEC|brand
DDI-DrugBank.d590.s4|53-62|ranitidine|drug
DDI-DrugBank.d590.s4|78-83|ZANTAC|brand
DDI-DrugBank.d702.s0|70-73|COPD|brand
DDI-DrugBank.d702.s1|14-44|sympathomimetic bronchodilators|group
DDI-DrugBank.d702.s1|47-61|methylxanthines|group
DDI-DrugBank.d702.s2|36-42|SPIRIVA|brand
DDI-DrugBank.d702.s2|55-69|anticholinergic|group
DDI-DrugBank.d642.s0|35-49|anticoagulation|group
DDI-DrugBank.d642.s0|79-89|tigecycline|drug
DDI-DrugBank.d642.s0|112-119|warfarin|drug
DDI-DrugBank.d642.s1|18-30|antibacterial|group
DDI-DrugBank.d642.s1|48-61|contraceptives|group
DDI-DrugBank.d642.s1|79-92|contraceptives|group
DDI-DrugBank.d642.s1|99-107|effective|drug
DDI-DrugBank.d642.s2|21-39|Interactions There|brand
DDI-MedLine.d194.s0|25-42|dasatinib-enhanced|drug
DDI-MedLine.d194.s2|0-8|Effective|drug
DDI-MedLine.d194.s3|23-26|RNAs|brand
DDI-MedLine.d194.s3|49-56|identify|drug
DDI-MedLine.d194.s3|127-131|SKOv3|brand
DDI-MedLine.d194.s4|14-22|dasatinib|drug
DDI-MedLine.d194.s4|41-43|Src|brand
DDI-MedLine.d194.s4|49-51|Abl|brand
DDI-MedLine.d194.s4|129-131|HEY|brand
DDI-MedLine.d194.s5|24-28|Bcl-2|brand
DDI-MedLine.d194.s5|35-38|Cdk1|brand
DDI-MedLine.d194.s5|64-72|dasatinib|drug
DDI-MedLine.d194.s5|250-254|Bcl-2|brand
DDI-MedLine.d194.s5|260-263|Cdk1|brand
DDI-MedLine.d194.s6|4-14|statistical|drug
DDI-MedLine.d194.s6|27-35|two-sided|drug
DDI-MedLine.d194.s7|15-17|Abl|brand
DDI-MedLine.d194.s7|32-41|identified|drug
DDI-MedLine.d194.s7|86-90|SKOv3|brand
DDI-MedLine.d194.s8|23-25|Src|brand
DDI-MedLine.d194.s8|28-30|Fyn|brand
DDI-MedLine.d194.s8|36-39|Abl1|brand
DDI-MedLine.d194.s9|23-31|dasatinib|drug
DDI-MedLine.d194.s10|13-15|HEY|brand
DDI-MedLine.d194.s10|17-33|xenograft-bearing|drug
DDI-MedLine.d194.s10|45-53|dasatinib|drug
DDI-MedLine.d194.s10|171-179|dasatinib|drug
DDI-MedLine.d194.s10|255-264|confidence|drug
DDI-MedLine.d194.s11|0-8|dasatinib|drug
DDI-MedLine.d194.s12|0-8|dasatinib|drug
DDI-MedLine.d194.s13|37-38|CI|brand
DDI-MedLine.d194.s14|0-7|Combined|drug
DDI-MedLine.d194.s14|32-55|TUNEL-positive apoptotic|drug
DDI-MedLine.d194.s15|43-52|dasatinib-|drug
DDI-MedLine.d194.s15|103-110|negative|drug
DDI-MedLine.d194.s15|220-221|CI|brand
DDI-MedLine.d194.s16|54-58|Bcl-2|brand
DDI-MedLine.d194.s16|64-67|Cdk1|brand
DDI-MedLine.d194.s16|82-99|dasatinib-mediated|drug
DDI-MedLine.d194.s16|165-174|negatively|drug
DDI-MedLine.d194.s16|187-191|Bcl-2|brand
DDI-MedLine.d194.s16|197-200|Cdk1|brand
DDI-MedLine.d194.s17|14-16|Src|brand
DDI-MedLine.d194.s17|29-31|Abl|brand
DDI-MedLine.d194.s17|63-71|dasatinib|drug
DDI-MedLine.d194.s17|171-175|Bcl-2|brand
DDI-MedLine.d194.s17|181-184|Cdk1|brand
DDI-DrugBank.d615.s0|0-11|Triprolidine|drug
DDI-DrugBank.d615.s0|29-36|sedative|drug
DDI-DrugBank.d615.s0|103-114|barbiturates|group
DDI-DrugBank.d615.s0|117-125|hypnotics|group
DDI-DrugBank.d615.s0|128-135|narcotic|drug
DDI-DrugBank.d615.s0|149-157|sedatives|drug_n
DDI-DrugBank.d615.s1|15-29|anticholinergic|group
DDI-DrugBank.d615.s1|46-53|atropine|drug
DDI-DrugBank.d615.s1|59-83|tricyclic antidepressants|group
DDI-DrugBank.d615.s1|138-149|triprolidine|drug
DDI-DrugBank.d615.s2|0-11|Triprolidine|drug
DDI-DrugBank.d615.s2|55-59|liver|drug
DDI-MedLine.d217.s0|40-50|anti-cancer|group
DDI-MedLine.d217.s0|61-72|antagonistic|drug
DDI-MedLine.d217.s1|27-42|cyclooxygenase-2|drug
DDI-MedLine.d217.s2|39-65|cyclooxygenase-2 inhibitors|group
DDI-MedLine.d217.s2|120-142|chemotherapeutic agents|group
DDI-MedLine.d217.s4|22-26|cycle|drug
DDI-MedLine.d217.s4|43-45|DNA|brand
DDI-MedLine.d217.s4|57-60|five|drug
DDI-MedLine.d217.s4|84-88|lines|group
DDI-MedLine.d217.s4|97-102|HCT116|brand
DDI-MedLine.d217.s4|105-109|HepG2|brand
DDI-MedLine.d217.s4|112-115|MCF7|brand
DDI-MedLine.d217.s4|121-124|U251|brand
DDI-MedLine.d217.s4|130-133|5-FU|drug_n
DDI-MedLine.d217.s4|147-157|doxorubicin|drug
DDI-MedLine.d217.s4|163-171|etoposide|drug
DDI-MedLine.d217.s5|84-87|MCF7|brand
DDI-MedLine.d217.s5|150-160|doxorubicin|drug
DDI-MedLine.d217.s5|174-178|lines|group
DDI-MedLine.d217.s5|211-216|HCT116|brand
DDI-MedLine.d217.s6|64-68|lines|group
DDI-MedLine.d217.s7|0-10|Mechanistic|drug
DDI-MedLine.d217.s8|8-12|lines|group
DDI-MedLine.d217.s8|45-48|G2/M|brand
DDI-MedLine.d217.s8|110-112|DNA|brand
DDI-MedLine.d217.s9|41-44|G2/M|brand
DDI-MedLine.d217.s9|90-92|DNA|brand
DDI-MedLine.d217.s10|8-18|synergistic|drug
DDI-MedLine.d217.s10|66-69|G2/M|brand
DDI-MedLine.d217.s10|136-137|G1|brand
DDI-MedLine.d217.s11|121-131|doxorubicin|drug
DDI-DrugBank.d675.s0|8-17|Inhibitors|group
DDI-DrugBank.d675.s0|25-45|Macrolide Antibiotics|group
DDI-DrugBank.d675.s0|51-69|Protease Inhibitors|group
DDI-DrugBank.d675.s0|72-76|There|brand
DDI-DrugBank.d675.s0|130-139|connection|drug_n
DDI-DrugBank.d675.s0|205-221|dihydroergotamine|drug
DDI-DrugBank.d675.s0|227-236|ergotamine|drug
DDI-DrugBank.d675.s0|250-252|CYP|brand
DDI-DrugBank.d675.s0|258-267|inhibitors|group
DDI-DrugBank.d675.s1|62-77|methylergonovine|drug
DDI-DrugBank.d675.s1|93-95|CYP|brand
DDI-DrugBank.d675.s1|101-110|inhibitors|group
DDI-DrugBank.d675.s1|146-161|methylergonovine|drug
DDI-DrugBank.d675.s2|36-38|CYP|brand
DDI-DrugBank.d675.s2|44-53|inhibitors|group
DDI-DrugBank.d675.s2|63-83|macrolide antibiotics|group
DDI-DrugBank.d675.s2|92-103|erythromycin|drug
DDI-DrugBank.d675.s2|106-119|troleandomycin|drug
DDI-DrugBank.d675.s2|122-135|clarithromycin|drug
DDI-DrugBank.d675.s2|139-141|HIV|brand
DDI-DrugBank.d675.s2|177-186|inhibitors|group
DDI-DrugBank.d675.s2|195-203|ritonavir|drug
DDI-DrugBank.d675.s2|206-214|indinavir|drug
DDI-DrugBank.d675.s2|217-226|nelfinavir|drug
DDI-DrugBank.d675.s2|229-239|delavirdine|drug
DDI-DrugBank.d675.s2|251-261|antifungals|group
DDI-DrugBank.d675.s2|270-281|ketoconazole|drug
DDI-DrugBank.d675.s2|284-295|itraconazole|drug
DDI-DrugBank.d675.s2|298-309|voriconazole|drug
DDI-DrugBank.d675.s3|12-14|CYP|brand
DDI-DrugBank.d675.s3|20-29|inhibitors|group
DDI-DrugBank.d675.s4|12-21|inhibitors|group
DDI-DrugBank.d675.s4|31-40|saquinavir|drug
DDI-DrugBank.d675.s4|43-52|nefazodone|drug
DDI-DrugBank.d675.s4|55-65|fluconazole|drug
DDI-DrugBank.d675.s4|86-95|fluoxetine|drug
DDI-DrugBank.d675.s4|98-108|fluvoxamine|drug
DDI-DrugBank.d675.s5|20-29|exhaustive|drug
DDI-DrugBank.d675.s5|58-65|consider|drug
DDI-DrugBank.d675.s5|82-84|CYP|brand
DDI-DrugBank.d675.s5|99-104|agents|group
DDI-DrugBank.d675.s5|112-121|considered|drug
DDI-DrugBank.d675.s5|148-163|methylergonovine|drug
DDI-DrugBank.d675.s6|3-17|pharmacokinetic|drug
DDI-DrugBank.d675.s7|33-63|Methergine (methylergonovine|drug
DDI-DrugBank.d766.s1|0-5|Agents|group
DDI-DrugBank.d766.s1|57-60|AIDS|brand
DDI-DrugBank.d766.s1|133-144|erythromycin|drug
DDI-DrugBank.d766.s1|157-165|rifabutin|drug
DDI-DrugBank.d766.s1|168-179|ketoconazole|drug
DDI-DrugBank.d766.s1|186-196|fluconazole|drug
DDI-DrugBank.d766.s2|35-39|liver|drug
DDI-DrugBank.d766.s2|56-65|cimetidine|drug
DDI-DrugBank.d766.s2|134-146|acetaminophen|drug
DDI-DrugBank.d766.s2|160-167|relative|drug
DDI-DrugBank.d766.s2|237-243|sulfate|drug
DDI-DrugBank.d766.s3|25-29|liver|drug
DDI-DrugBank.d766.s3|59-67|imidazole|drug
DDI-DrugBank.d766.s3|90-101|ketoconazole|drug
DDI-DrugBank.d766.s3|104-113|miconazole|drug
DDI-DrugBank.d766.s3|129-154|non-competitive inhibitors|group
DDI-DrugBank.d751.s0|58-64|heparin|drug
DDI-DrugBank.d751.s1|11-19|AGGRASTAT|brand
DDI-DrugBank.d751.s1|42-48|heparin|drug
DDI-DrugBank.d751.s1|124-130|heparin|drug
DDI-DrugBank.d676.s0|12-14|CNS|brand
DDI-DrugBank.d676.s0|54-65|barbiturates|group
DDI-DrugBank.d676.s0|68-81|antihistamines|group
DDI-DrugBank.d676.s0|84-92|narcotics|group
DDI-DrugBank.d676.s0|95-112|hypotensive agents|group
DDI-DrugBank.d676.s0|117-130|phenothiazines|group
DDI-DrugBank.d676.s1|55-62|Antabuse|brand
DDI-DrugBank.d676.s2|8-15|Matulane|brand
DDI-DrugBank.d676.s2|31-39|monoamine|drug
DDI-DrugBank.d676.s2|70-84|sympathomimetic|drug
DDI-DrugBank.d676.s2|93-116|tricyclic antidepressant|group
DDI-DrugBank.d676.s2|131-143|amitriptyline|drug
DDI-DrugBank.d676.s2|145-147|HCl|brand
DDI-DrugBank.d676.s2|150-159|imipramine|drug
DDI-DrugBank.d676.s2|161-163|HCl|brand
DDI-DrugBank.d676.s2|208-215|tyramine|drug
DDI-DrugBank.d676.s2|234-237|wine|drug
DDI-DrugBank.d676.s2|283-289|avoided|drug
DDI-DrugBank.d676.s3|48-56|hydrazine|drug
DDI-DrugBank.d676.s3|58-68|derivatives|group
DDI-DrugBank.d676.s3|105-117|Heinz-Ehrlich|brand
DDI-DrugBank.d676.s4|31-53|chemotherapeutic agents|group
DDI-DrugBank.d581.s0|43-50|Neulasta|brand
DDI-DrugBank.d581.s2|31-38|Neulasta|brand
DDI-DrugBank.d735.s0|140-147|MYCAMINE|brand
DDI-DrugBank.d735.s0|176-187|cyclosporine|drug
DDI-DrugBank.d735.s0|202-213|prednisolone|drug
DDI-DrugBank.d735.s0|227-236|nifedipine|drug
DDI-DrugBank.d735.s0|239-249|fluconazole|drug
DDI-DrugBank.d735.s0|252-260|ritonavir|drug
DDI-DrugBank.d735.s1|50-65|pharmacokinetics|group
DDI-DrugBank.d735.s2|58-65|MYCAMINE|brand
DDI-DrugBank.d735.s2|93-104|cyclosporine|drug
DDI-DrugBank.d735.s2|119-130|prednisolone|drug
DDI-DrugBank.d735.s2|137-147|fluconazole|drug
DDI-DrugBank.d735.s2|149-164|pharmacokinetics|group
DDI-DrugBank.d735.s3|10-12|AUC|brand
DDI-DrugBank.d735.s3|53-56|Cmax|brand
DDI-DrugBank.d735.s3|90-97|MYCAMINE|brand
DDI-DrugBank.d735.s4|0-9|Nifedipine|drug
DDI-DrugBank.d735.s4|11-13|AUC|brand
DDI-DrugBank.d735.s4|19-22|Cmax|brand
DDI-DrugBank.d735.s4|55-66|respectively|drug
DDI-DrugBank.d735.s4|101-108|MYCAMINE|brand
DDI-DrugBank.d735.s4|124-133|nifedipine|drug
DDI-DrugBank.d735.s5|32-41|nifedipine|drug
DDI-DrugBank.d735.s5|63-70|MYCAMINE|brand
DDI-DrugBank.d735.s5|109-118|nifedipine|drug
DDI-DrugBank.d735.s5|146-155|nifedipine|drug
DDI-DrugBank.d735.s6|34-47|P-glycoprotein|brand
DDI-DrugBank.d735.s6|96-118|P-glycoprotein-mediated|brand
DDI-DrugBank.d756.s0|95-109|levomepromazine|drug
DDI-DrugBank.d756.s0|125-135|therapeutic|drug
DDI-DrugBank.d756.s0|149-160|side-effects|drug
DDI-DrugBank.d756.s2|0-16|Additive sedative|drug
DDI-DrugBank.d756.s2|63-77|levomepromazine|drug
DDI-DrugBank.d756.s2|82-86|given|drug
DDI-DrugBank.d756.s2|93-107|benzodiazepines|group
DDI-DrugBank.d756.s2|112-123|barbiturates|group
DDI-DrugBank.d756.s3|12-18|avoided|drug
DDI-DrugBank.d756.s4|6-15|particular|drug
DDI-DrugBank.d756.s4|38-52|levomepromazine|drug
DDI-DrugBank.d756.s4|65-79|anticholinergic|group
DDI-DrugBank.d756.s4|87-112|(tricyclic antidepressants|group
DDI-DrugBank.d756.s4|118-140|antiparkinsonian-agents|group
DDI-DrugBank.d756.s4|144-155|Particularly|drug
DDI-DrugBank.d756.s5|24-38|levomepromazine|drug
DDI-DrugBank.d756.s7|0-7|Caffeine|drug
DDI-DrugBank.d756.s7|35-55|ephedrine/amphetamine|drug
DDI-DrugBank.d756.s7|101-115|levomepromazine|drug
DDI-DrugBank.d756.s8|46-52|avoided|drug
DDI-DrugBank.d756.s9|31-37|avoided|drug
DDI-DrugBank.d756.s9|79-106|levomepromazine considerably|drug
DDI-DrugBank.d756.s10|21-28|antacids|group
DDI-DrugBank.d756.s11|16-20|given|drug
DDI-DrugBank.d756.s11|74-89|leveomepromazine|drug
DDI-DrugBank.d775.s0|9-16|MIVACRON|brand
DDI-DrugBank.d775.s0|92-118|succinylcholine-facilitated|drug
DDI-DrugBank.d775.s0|165-172|MIVACRON|brand
DDI-DrugBank.d775.s0|178-192|succinylcholine|drug
DDI-DrugBank.d775.s0|207-220|systematically|drug
DDI-DrugBank.d775.s1|24-38|succinylcholine|drug
DDI-DrugBank.d775.s1|109-114|agents|group
DDI-DrugBank.d775.s2|0-7|Evidence|drug
DDI-DrugBank.d775.s2|38-52|succinylcholine|drug
DDI-DrugBank.d775.s2|102-109|MIVACRON|brand
DDI-DrugBank.d775.s3|11-18|MIVACRON|brand
DDI-DrugBank.d775.s3|27-41|succinylcholine|drug
DDI-DrugBank.d775.s3|68-71|side|drug
DDI-DrugBank.d775.s3|84-98|succinylcholine|drug
DDI-DrugBank.d775.s4|41-48|MIVACRON|brand
DDI-DrugBank.d775.s4|100-105|agents|group
DDI-DrugBank.d775.s5|52-63|oxide/oxygen|drug
DDI-DrugBank.d775.s5|81-83|M.C|brand
DDI-DrugBank.d775.s6|13-16|ED50|brand
DDI-DrugBank.d775.s6|21-28|MIVACRON|brand
DDI-DrugBank.d775.s6|53-73|CLINICAL PHARMACOLOGY|brand
DDI-DrugBank.d775.s6|76-91|Pharmacodynamics|brand
DDI-DrugBank.d775.s6|97-113|Individualization|brand
DDI-DrugBank.d775.s6|118-124|Dosages|brand
DDI-DrugBank.d775.s7|6-11|agents|group
DDI-DrugBank.d775.s7|45-53|effective|drug
DDI-DrugBank.d775.s7|123-130|MIVACRON|brand
DDI-DrugBank.d775.s8|64-71|MIVACRON|brand
DDI-DrugBank.d775.s9|41-44|ED50|brand
DDI-DrugBank.d775.s10|83-88|agents|group
DDI-DrugBank.d775.s10|98-105|MIVACRON|brand
DDI-DrugBank.d775.s10|123-133|antibiotics|group
DDI-DrugBank.d775.s10|142-156|aminoglycosides|group
DDI-DrugBank.d775.s10|159-171|tetracyclines|group
DDI-DrugBank.d775.s10|186-195|polymyxins|group
DDI-DrugBank.d775.s10|198-207|lincomycin|drug
DDI-DrugBank.d775.s10|210-220|clindamycin|drug
DDI-DrugBank.d775.s10|293-303|anesthetics|group
DDI-DrugBank.d775.s10|306-317|procainamide|drug
DDI-DrugBank.d775.s10|324-332|quinidine|drug
DDI-DrugBank.d775.s11|37-44|MIVACRON|brand
DDI-DrugBank.d775.s11|90-103|cholinesterase|group
DDI-DrugBank.d775.s11|151-164|contraceptives|group
DDI-DrugBank.d775.s11|167-181|glucocorticoids|drug
DDI-DrugBank.d775.s11|195-203|monoamine|drug
DDI-DrugBank.d775.s11|213-222|inhibitors|group
DDI-DrugBank.d775.s11|270-283|cholinesterase|group
DDI-DrugBank.d775.s11|287-296|Resistance|brand
DDI-DrugBank.d775.s11|377-382|agents|group
DDI-DrugBank.d775.s11|456-468|carbamazepine|drug
DDI-DrugBank.d775.s12|42-54|carbamazepine|drug
DDI-DrugBank.d775.s12|81-88|MIVACRON|brand
DDI-DrugBank.d775.s12|160-170|anticipated|group
DDI-DrugBank.d775.s13|53-67|corticosteroids|drug
DDI-DrugBank.d775.s13|71-79|medicines|group
DDI-DrugBank.d775.s13|117-125|medicines|group
DDI-DrugBank.d775.s13|138-146|medicines|group
DDI-DrugBank.d775.s13|189-201|carbamazepine|drug
DDI-DrugBank.d775.s13|213-223|antibiotics|group
DDI-DrugBank.d775.s13|225-229|given|drug
DDI-DrugBank.d775.s13|272-282|neostigmine|drug
DDI-DrugBank.d775.s13|320-330|anesthetics|group
DDI-DrugBank.d775.s13|340-347|procaine|drug
DDI-DrugBank.d775.s13|359-369|anesthetics|group
DDI-DrugBank.d775.s13|373-387|succinylcholine|drug
DDI-MedLine.d181.s0|20-32|levothyroxine|drug
DDI-MedLine.d181.s1|16-30|Laboratories UK|brand
DDI-MedLine.d181.s1|33-36|Kent|brand
DDI-MedLine.d181.s1|39-40|UK|brand
DDI-MedLine.d181.s1|48-53|widely|drug
DDI-MedLine.d181.s2|4-9|active|drug
DDI-MedLine.d181.s2|25-34|simeticone|drug
DDI-MedLine.d181.s3|26-35|simeticone|drug
DDI-MedLine.d181.s3|86-100|characteristics|group
DDI-MedLine.d181.s4|85-97|levothyroxine|drug
DDI-MedLine.d181.s4|148-157|simeticone|drug
DDI-MedLine.d181.s5|17-29|levothyroxine|drug
DDI-MedLine.d181.s6|42-48|Infacol|brand
DDI-MedLine.d181.s6|78-90|levothyroxine|drug
DDI-MedLine.d181.s7|50-52|TSH|brand
DDI-MedLine.d181.s7|94-102|thyroxine|drug
DDI-MedLine.d181.s8|20-28|thyroxine|drug
DDI-MedLine.d181.s8|35-44|simeticone|drug
DDI-MedLine.d181.s8|112-129|National Formulary|brand
DDI-MedLine.d181.s8|135-142|Children|brand
DDI-MedLine.d181.s9|69-79|unnecessary|drug_n
DDI-DrugBank.d738.s0|35-42|VESIcare|brand
DDI-DrugBank.d738.s0|67-77|therapeutic|drug
DDI-DrugBank.d738.s0|88-99|ketoconazole|drug
DDI-DrugBank.d738.s0|124-133|inhibitors|group
DDI-DrugBank.d738.s1|14-23|Congenital|brand
DDI-DrugBank.d738.s1|40-54|Prolongation In|brand
DDI-DrugBank.d738.s1|81-91|solifenacin|drug
DDI-DrugBank.d738.s1|100-101|QT|brand
DDI-DrugBank.d738.s1|137-138|QT|brand
DDI-DrugBank.d738.s1|177-187|solifenacin|drug
DDI-DrugBank.d738.s1|273-283|solifenacin|drug
DDI-DrugBank.d738.s1|330-337|positive|drug
DDI-DrugBank.d738.s1|347-358|moxifloxacin|drug
DDI-DrugBank.d738.s1|367-377|therapeutic|drug
DDI-DrugBank.d738.s2|27-36|considered|drug
DDI-DrugBank.d738.s2|73-80|VESIcare|brand
DDI-DrugBank.d738.s2|119-120|QT|brand
DDI-DrugBank.d738.s2|195-196|QT|brand
DDI-DrugBank.d573.s0|17-28|Guanethidine|drug
DDI-DrugBank.d573.s0|31-38|Although|brand
DDI-DrugBank.d573.s0|72-82|orthostatic|drug
DDI-DrugBank.d573.s0|146-157|guanethidine|drug
DDI-DrugBank.d573.s0|182-192|orthostatic|drug
DDI-DrugBank.d573.s1|19-30|guanethidine|drug
DDI-DrugBank.d573.s2|141-151|orthostatic|drug
DDI-DrugBank.d695.s0|27-33|ZAVESCA|brand
DDI-DrugBank.d695.s0|76-83|Cerezyme|brand
DDI-DrugBank.d695.s0|115-124|conclusive|drug
DDI-DrugBank.d695.s0|218-225|Cerezyme|brand
DDI-DrugBank.d695.s1|25-32|Cerezyme|brand
DDI-DrugBank.d695.s1|56-62|ZAVESCA|brand
DDI-DrugBank.d623.s1|0-16|Aminoglutethimide|drug
DDI-DrugBank.d623.s1|127-129|MPA|brand
DDI-DrugBank.d623.s2|11-19|Tests The|brand
DDI-DrugBank.d623.s3|46-54|endocrine|drug
DDI-DrugBank.d623.s3|60-64|liver|drug
DDI-DrugBank.d623.s3|145-150|Plasma|brand
DDI-DrugBank.d623.s3|253-260|cortisol|drug
DDI-DrugBank.d623.s4|4-9|Plasma|brand
DDI-DrugBank.d623.s4|64-65|LH|brand
DDI-DrugBank.d623.s4|68-70|FSH|brand
DDI-DrugBank.d623.s5|4-7|SHBG|brand
DDI-DrugBank.d623.s6|4-12|T3-uptake|brand
DDI-DrugBank.d623.s7|4-8|There|brand
DDI-DrugBank.d623.s8|4-22|Sulfobromophthalein|brand
DDI-DrugBank.d623.s8|34-38|liver|drug
DDI-DrugBank.d623.s9|4-8|There|brand
DDI-DrugBank.d736.s1|62-65|ACTH|brand
DDI-DrugBank.d736.s2|24-31|diabetic|drug
DDI-DrugBank.d736.s3|0-8|Thiazides|group
DDI-DrugBank.d736.s3|32-45|responsiveness|drug
DDI-DrugBank.d736.s3|50-63|norepinephrine|drug
DDI-DrugBank.d736.s4|46-58|effectiveness|drug
DDI-DrugBank.d736.s4|85-95|therapeutic|drug
DDI-DrugBank.d736.s5|0-7|Thiazide|drug
DDI-DrugBank.d736.s5|32-45|responsiveness|drug
DDI-DrugBank.d736.s5|50-61|tubocurarine|drug
DDI-DrugBank.d736.s6|38-46|thiazides|group
DDI-DrugBank.d736.s7|0-8|Thiazides|group
DDI-DrugBank.d736.s7|55-70|antihypertensive|group
DDI-DrugBank.d781.s0|0-8|Diuretics|group
DDI-DrugBank.d781.s0|11-18|Patients|brand
DDI-DrugBank.d781.s0|23-31|diuretics|group
DDI-DrugBank.d781.s0|104-112|excessive|drug
DDI-DrugBank.d781.s0|162-166|ACEON|brand
DDI-DrugBank.d781.s1|19-29|hypotensive|drug
DDI-DrugBank.d781.s1|84-91|diuretic|group
DDI-DrugBank.d781.s1|161-171|perindopril|drug
DDI-DrugBank.d781.s2|3-11|diuretics|group
DDI-DrugBank.d781.s2|104-108|ACEON|brand
DDI-DrugBank.d781.s3|23-33|perindopril|drug
DDI-DrugBank.d781.s3|94-102|diuretics|group
DDI-DrugBank.d781.s4|23-35|perindoprilat|drug
DDI-DrugBank.d781.s4|52-60|diuretics|group
DDI-DrugBank.d781.s4|122-124|ACE|brand
DDI-DrugBank.d781.s5|10-20|Supplements|brand
DDI-DrugBank.d781.s5|26-52|Potassium-Sparing Diuretics|group
DDI-DrugBank.d781.s5|55-59|ACEON|brand
DDI-DrugBank.d781.s6|25-49|diuretics (spironolactone|drug_n
DDI-DrugBank.d781.s6|52-60|amiloride|drug
DDI-DrugBank.d781.s6|178-184|heparin|drug
DDI-DrugBank.d781.s6|187-198|cyclosporine|drug
DDI-DrugBank.d781.s7|38-43|agents|group
DDI-DrugBank.d781.s7|74-78|given|drug
DDI-DrugBank.d781.s8|9-17|Increased|brand
DDI-DrugBank.d781.s8|131-133|ACE|brand
DDI-DrugBank.d781.s10|9-16|diuretic|group
DDI-DrugBank.d781.s11|0-6|Digoxin|drug
DDI-DrugBank.d781.s11|22-36|pharmacokinetic|drug
DDI-DrugBank.d781.s11|74-80|digoxin|drug
DDI-DrugBank.d781.s11|122-126|ACEON|brand
DDI-DrugBank.d781.s11|157-163|digoxin|drug
DDI-DrugBank.d781.s11|196-220|perindopril/perindoprilat|drug
DDI-DrugBank.d781.s12|0-9|Gentamicin|drug
DDI-DrugBank.d781.s12|12-17|Animal|brand
DDI-DrugBank.d781.s12|78-88|perindopril|drug
DDI-DrugBank.d781.s12|94-103|gentamicin|drug
DDI-DrugBank.d781.s15|5-15|Interaction|brand
DDI-DrugBank.d781.s15|18-21|Oral|brand
DDI-DrugBank.d781.s15|41-45|ACEON|brand
DDI-DrugBank.d781.s15|119-129|perindopril|drug
DDI-DrugBank.d781.s15|142-149|relative|drug
DDI-DrugBank.d781.s16|44-54|perindopril|drug
DDI-DrugBank.d781.s16|63-68|active|drug
DDI-DrugBank.d781.s16|82-94|perindoprilat|drug
DDI-DrugBank.d781.s16|166-168|ACE|brand
DDI-DrugBank.d781.s17|20-30|perindopril|drug
DDI-DrugBank.d600.s0|36-44|addictive|drug
DDI-DrugBank.d600.s1|36-38|CNS|brand
DDI-DrugBank.d600.s1|84-86|CNS|brand
DDI-DrugBank.d687.s0|60-71|temozolomide|drug
DDI-DrugBank.d687.s2|14-19|Severe|brand
DDI-DrugBank.d687.s2|21-27|Hepatic|drug
DDI-DrugBank.d687.s2|38-55|Impairment Caution|brand
DDI-DrugBank.d687.s2|82-97|TEMODAR Capsules|brand
DDI-DrugBank.d687.s2|140-146|hepatic|drug
DDI-DrugBank.d575.s0|52-66|therapeutically|drug
DDI-DrugBank.d575.s0|95-105|tolbutamide|drug
DDI-DrugBank.d575.s0|130-143|sulfamethizole|drug
DDI-DrugBank.d575.s0|169-178|teniposide|drug
DDI-DrugBank.d575.s1|41-50|teniposide|drug
DDI-DrugBank.d575.s1|117-127|substantial|group
DDI-DrugBank.d575.s2|51-55|VUMON|brand
DDI-DrugBank.d575.s2|57-67|(teniposide|drug
DDI-DrugBank.d575.s2|114-119|agents|group
DDI-DrugBank.d575.s3|34-41|kinetics|group
DDI-DrugBank.d575.s3|46-55|teniposide|drug
DDI-DrugBank.d575.s5|93-102|teniposide|drug
DDI-DrugBank.d634.s0|0-13|Anticoagulants|group
DDI-DrugBank.d634.s0|23-25|The|brand
DDI-DrugBank.d634.s0|44-57|anticoagulants|group
DDI-DrugBank.d634.s0|81-94|anti-vitamin-K|group
DDI-DrugBank.d634.s1|21-26|agents|group
DDI-DrugBank.d634.s1|29-43|Hyperthyroidism|brand
DDI-DrugBank.d634.s1|81-84|beta|group
DDI-DrugBank.d634.s2|20-34|beta-adrenergic|group
DDI-DrugBank.d634.s3|10-19|glycosides|group
DDI-DrugBank.d634.s3|22-26|Serum|brand
DDI-DrugBank.d634.s3|111-119|glycoside|drug
DDI-DrugBank.d634.s4|28-37|glycosides|group
DDI-DrugBank.d634.s5|0-11|Theophylline|drug
DDI-DrugBank.d634.s5|14-25|Theophylline|drug
DDI-DrugBank.d634.s5|89-100|theophylline|drug
DDI-DrugBank.d634.s6|18-29|theophylline|drug
DDI-MedLine.d213.s0|49-68|cyclosporine-treated|drug
DDI-MedLine.d213.s1|22-44|identified cyclosporine|drug
DDI-MedLine.d213.s1|70-79|inhibitors|group
DDI-MedLine.d213.s2|98-106|midazolam|drug
DDI-MedLine.d213.s2|203-210|practice|drug
DDI-MedLine.d213.s2|249-255|hepatic|drug
DDI-MedLine.d213.s3|0-7|Systemic|group
DDI-MedLine.d213.s3|27-35|midazolam|drug
DDI-MedLine.d213.s3|158-169|respectively|drug
DDI-MedLine.d213.s3|181-200|cyclosporine-treated|drug
DDI-MedLine.d213.s4|21-29|midazolam|drug
DDI-MedLine.d213.s4|168-178|calcineurin|drug
DDI-MedLine.d213.s5|26-32|hepatic|drug
DDI-MedLine.d213.s5|112-123|cyclosporine|drug
DDI-MedLine.d213.s5|218-225|practice|drug
DDI-MedLine.d213.s5|228-239|cyclosporine|drug
DDI-DrugBank.d671.s0|19-24|CYLERT|brand
DDI-DrugBank.d671.s0|26-34|(pemoline|drug
DDI-DrugBank.d671.s1|27-32|CYLERT|brand
DDI-DrugBank.d671.s1|87-89|CNS|brand
DDI-DrugBank.d671.s2|68-73|CYLERT|brand
DDI-DrugBank.d671.s2|94-106|antiepileptic|group
DDI-MedLine.d208.s0|25-36|HIV-positive|drug
DDI-MedLine.d208.s0|47-60|antiretroviral|group
DDI-MedLine.d208.s1|32-39|Implanon|brand
DDI-MedLine.d208.s1|72-84|contraceptive|drug
DDI-MedLine.d208.s1|131-139|effective|drug
DDI-MedLine.d208.s2|18-31|contraceptives|group
DDI-MedLine.d208.s2|42-48|hepatic|drug
DDI-MedLine.d208.s3|37-48|HIV-positive|drug
DDI-MedLine.d208.s3|59-72|antiretroviral|group
DDI-MedLine.d208.s3|138-145|Implanon|brand
DDI-DrugBank.d588.s0|0-8|Diuretics|group
DDI-DrugBank.d588.s0|11-20|Furosemide|drug
DDI-DrugBank.d588.s0|46-54|diuretics|group
DDI-DrugBank.d588.s0|56-60|given|drug
DDI-DrugBank.d588.s1|6-22|Antihypertensives|group
DDI-DrugBank.d588.s1|25-35|When MYKROX|brand
DDI-DrugBank.d588.s1|65-80|antihypertensive|group
DDI-DrugBank.d588.s2|28-44|antihypertensives|group
DDI-DrugBank.d588.s3|9-20|Barbiturates|group
DDI-DrugBank.d588.s3|27-35|Narcotics|group
DDI-DrugBank.d588.s3|38-40|The|brand
DDI-DrugBank.d588.s3|42-52|hypotensive|drug
DDI-DrugBank.d588.s4|10-19|Glycosides|group
DDI-DrugBank.d588.s4|22-37|Diuretic-induced|group
DDI-DrugBank.d588.s6|0-14|Corticosteroids|drug
DDI-DrugBank.d588.s6|19-22|ACTH|brand
DDI-DrugBank.d588.s6|25-27|May|brand
DDI-DrugBank.d588.s7|9-13|Serum|brand
DDI-DrugBank.d588.s8|11-15|Drugs|brand
DDI-DrugBank.d588.s8|18-33|Diuretic-induced|group
DDI-DrugBank.d588.s8|119-130|tubocurarine|drug
DDI-DrugBank.d588.s9|48-53|MYKROX|brand
DDI-DrugBank.d588.s9|81-88|elective|drug
DDI-DrugBank.d588.s10|22-52|Non-Steroidal Anti-Inflammatory|group
DDI-DrugBank.d588.s10|54-58|Drugs|brand
DDI-DrugBank.d588.s10|61-63|May|brand
DDI-DrugBank.d588.s10|78-93|antihypertensive|group
DDI-DrugBank.d588.s10|106-111|MYKROX|brand
DDI-DrugBank.d588.s11|0-15|Sympathomimetics|group
DDI-DrugBank.d588.s11|18-27|Metolazone|brand
DDI-DrugBank.d588.s11|51-64|responsiveness|drug
DDI-DrugBank.d588.s11|69-82|norepinephrine|drug
DDI-DrugBank.d588.s11|135-147|effectiveness|drug
DDI-DrugBank.d588.s11|174-184|therapeutic|drug
DDI-DrugBank.d588.s12|0-10|Methenamine|drug
DDI-DrugBank.d588.s12|13-20|Efficacy|brand
DDI-DrugBank.d588.s13|0-13|Anticoagulants|group
DDI-DrugBank.d588.s13|16-25|Metolazone|brand
DDI-DrugBank.d588.s13|45-67|thiazide-like diuretics|group
DDI-DrugBank.d588.s13|85-103|hypoprothrombinemic|drug
DDI-DrugBank.d588.s13|117-130|anticoagulants|group
DDI-DrugBank.d585.s0|14-19|agents|group
DDI-DrugBank.d585.s0|53-56|side|drug
DDI-DrugBank.d585.s0|69-83|anticholinergic|group
DDI-DrugBank.d585.s0|92-101|amantadine|drug
DDI-DrugBank.d585.s0|104-124|antiarrhythmic agents|group
DDI-DrugBank.d585.s0|144-152|quinidine|drug
DDI-DrugBank.d585.s0|156-169|antihistamines|group
DDI-DrugBank.d585.s0|172-191|antipsychotic agents|group
DDI-DrugBank.d585.s0|200-213|phenothiazines|group
DDI-DrugBank.d585.s0|217-231|benzodiazepines|group
DDI-DrugBank.d585.s0|234-247|MAO inhibitors|group
DDI-DrugBank.d585.s0|250-257|narcotic|drug
DDI-DrugBank.d585.s0|277-286|meperidine|drug
DDI-DrugBank.d585.s0|313-334|sympathomimetic agents|group
DDI-DrugBank.d585.s0|337-361|tricyclic antidepressants|group
DDI-DrugBank.d585.s0|387-401|anticholinergic|group
DDI-DrugBank.d585.s1|0-15|Anticholinergics|group
DDI-DrugBank.d585.s1|43-61|antiglaucoma agents|group
DDI-DrugBank.d585.s2|0-14|Anticholinergic|group
DDI-DrugBank.d585.s2|118-123|agents|group
DDI-DrugBank.d585.s2|133-147|corticosteroids|drug
DDI-DrugBank.d585.s3|0-21|Anticholinergic agents|group
DDI-DrugBank.d585.s3|122-128|digoxin|drug
DDI-DrugBank.d585.s4|16-22|digoxin|drug
DDI-DrugBank.d585.s5|0-14|Anticholinergic|group
DDI-DrugBank.d585.s5|104-117|metoclopramide|drug
DDI-DrugBank.d585.s6|8-15|antacids|group
DDI-DrugBank.d585.s6|54-75|anticholinergic agents|group
DDI-DrugBank.d585.s6|120-126|avoided|drug
DDI-DrugBank.d585.s7|26-40|anticholinergic|group
DDI-DrugBank.d585.s7|106-111|agents|group
DDI-DrugBank.d591.s0|0-10|Ropivacaine|drug
DDI-DrugBank.d591.s0|74-84|anesthetics|group
DDI-DrugBank.d591.s0|89-94|agents|group
DDI-DrugBank.d591.s0|120-129|amide-type|drug
DDI-DrugBank.d591.s0|137-147|anesthetics|group
DDI-DrugBank.d591.s0|193-200|additive|drug
DDI-DrugBank.d591.s1|61-71|ropivacaine|drug
DDI-DrugBank.d591.s2|33-43|ropivacaine|drug
DDI-DrugBank.d591.s2|91-101|fluvoxamine|drug
DDI-DrugBank.d591.s2|129-137|selective|drug
DDI-DrugBank.d591.s2|150-155|CYP1A2|brand
DDI-DrugBank.d591.s3|12-21|inhibitors|group
DDI-DrugBank.d591.s3|54-64|fluvoxamine|drug
DDI-DrugBank.d591.s3|67-71|given|drug
DDI-DrugBank.d591.s3|112-122|Ropivacaine|drug
DDI-DrugBank.d591.s3|143-153|Ropivacaine|drug
DDI-DrugBank.d591.s3|176-186|ropivacaine|drug
DDI-DrugBank.d591.s4|33-49|CYP1A2 inhibitors|group
DDI-DrugBank.d591.s5|60-65|CYP1A2|brand
DDI-DrugBank.d591.s5|71-81|competitive|drug
DDI-DrugBank.d591.s5|102-113|theophylline|drug
DDI-DrugBank.d591.s5|119-128|imipramine|drug
DDI-DrugBank.d591.s6|22-30|selective|drug
DDI-DrugBank.d591.s6|64-75|ketoconazole|drug
DDI-DrugBank.d591.s6|105-115|ropivacaine|drug
DDI-DrugBank.d591.s6|152-163|ketoconazole|drug
DDI-DrugBank.d591.s6|220-230|ropivacaine|drug
DDI-DrugBank.d577.s0|51-59|diuretics|group
DDI-DrugBank.d577.s0|72-80|thiazides|group
DDI-DrugBank.d577.s0|96-104|incidence|drug
DDI-DrugBank.d577.s1|26-41|sulfamethoxazole|drug
DDI-DrugBank.d577.s1|110-122|anticoagulant|group
DDI-DrugBank.d577.s1|124-131|warfarin|drug
DDI-DrugBank.d577.s2|45-52|Gantanol|brand
DDI-DrugBank.d577.s2|57-61|given|drug
DDI-DrugBank.d577.s2|86-98|anticoagulant|group
DDI-DrugBank.d577.s3|33-39|hepatic|drug
DDI-DrugBank.d577.s4|17-32|sulfamethoxazole|drug
DDI-DrugBank.d577.s5|78-86|excessive|drug
DDI-DrugBank.d577.s6|0-11|Sulfonamides|group
DDI-DrugBank.d577.s7|16-31|sulfamethoxazole|drug
DDI-DrugBank.d577.s7|56-59|Jaff|brand
DDI-DrugBank.d577.s7|64-71|alkaline|drug
DDI-DrugBank.d577.s7|100-109|creatinine|drug
DDI-DrugBank.d722.s0|51-60|PURINETHOL|brand
DDI-DrugBank.d722.s0|62-76|(mercaptopurine|drug
DDI-DrugBank.d722.s0|83-89|TABLOID|brand
DDI-DrugBank.d722.s0|97-107|Thioguanine|drug
DDI-DrugBank.d722.s1|21-28|evidence|drug
DDI-DrugBank.d722.s1|51-61|derivatives|group
DDI-DrugBank.d722.s1|70-79|olsalazine|drug
DDI-DrugBank.d722.s1|82-91|mesalazine|drug
DDI-DrugBank.d722.s1|97-110|sulphasalazine|drug
DDI-DrugBank.d722.s1|125-128|TPMT|brand
DDI-DrugBank.d722.s1|212-222|thioguanine|drug
DDI-DrugBank.d604.s0|0-10|Thalidomide|drug
DDI-DrugBank.d604.s0|45-52|sedative|drug
DDI-DrugBank.d604.s0|66-77|barbiturates|group
DDI-DrugBank.d604.s0|89-102|chlorpromazine|drug
DDI-DrugBank.d604.s0|109-117|reserpine|drug
DDI-DrugBank.d604.s1|11-20|Neuropathy|brand
DDI-DrugBank.d604.s1|23-33|Medications|brand
DDI-DrugBank.d604.s1|135-145|thalidomide|drug
DDI-DrugBank.d604.s2|5-18|Contraceptives|group
DDI-DrugBank.d604.s2|21-22|In|brand
DDI-DrugBank.d604.s2|46-60|pharmacokinetic|drug
DDI-DrugBank.d604.s3|62-72|thalidomide|drug
DDI-DrugBank.d604.s4|10-24|Non-Thalidomide|drug
DDI-DrugBank.d604.s4|50-63|That Interfere|brand
DDI-DrugBank.d604.s4|70-77|Hormonal|brand
DDI-DrugBank.d604.s4|79-92|Contraceptives|group
DDI-DrugBank.d604.s4|95-105|Concomitant|brand
DDI-DrugBank.d604.s4|114-136|HIV-protease inhibitors|group
DDI-DrugBank.d604.s4|164-174|penicillins|group
DDI-DrugBank.d604.s4|187-195|rifabutin|drug
DDI-DrugBank.d604.s4|209-221|carbamazepine|drug
DDI-DrugBank.d604.s4|262-263|St|brand
DDI-DrugBank.d604.s5|7-10|Wort|brand
DDI-DrugBank.d604.s5|26-45|contraceptive agents|group
DDI-DrugBank.d604.s5|62-74|effectiveness|drug
DDI-DrugBank.d604.s6|82-86|OTHER|brand
DDI-DrugBank.d604.s6|88-96|effective|drug
DDI-DrugBank.d604.s6|108-116|effective|drug
DDI-DrugBank.d604.s6|200-210|thalidomide|drug
DDI-DrugBank.d706.s0|0-22|Catecholamine-depleting|drug
DDI-DrugBank.d706.s0|37-45|reserpine|drug
DDI-DrugBank.d706.s0|60-67|additive|drug
DDI-DrugBank.d706.s0|81-85|given|drug
DDI-DrugBank.d706.s0|92-111|beta-blocking agents|group
DDI-DrugBank.d706.s1|39-48|metoprolol|drug
DDI-DrugBank.d706.s1|67-79|catecholamine|drug
DDI-DrugBank.d706.s1|131-138|evidence|drug
DDI-DrugBank.d690.s0|4-17|CNS-depressant|brand
DDI-DrugBank.d690.s0|45-52|additive|drug
DDI-DrugBank.d690.s0|73-75|CNS|brand
DDI-DrugBank.d690.s1|25-40|medicinal agents|group
DDI-DrugBank.d690.s3|86-100|antidepressants|group
DDI-DrugBank.d690.s3|103-117|anticonvulsants|group
DDI-DrugBank.d690.s3|123-135|warfarin-like|drug
DDI-DrugBank.d690.s4|77-89|carbamazepine|drug
DDI-DrugBank.d739.s0|17-20|Dose|brand
DDI-DrugBank.d739.s0|36-46|Daily Dosed|brand
DDI-DrugBank.d739.s0|51-65|Pharmacokinetic|drug
DDI-DrugBank.d739.s0|67-78|Steady State|brand
DDI-DrugBank.d739.s0|135-142|kinetics|group
DDI-DrugBank.d739.s0|176-202|theophylline (predominantly|drug
DDI-DrugBank.d739.s1|21-35|pharmacokinetic|drug
DDI-DrugBank.d739.s1|48-55|warfarin|drug
DDI-DrugBank.d739.s1|158-165|warfarin|drug
DDI-DrugBank.d739.s1|194-196|INR|brand
DDI-DrugBank.d739.s1|213-228|Normalized Ratio|brand
DDI-DrugBank.d739.s2|21-35|pharmacokinetic|drug
DDI-DrugBank.d739.s2|69-90|immunoreactive digoxin|drug
DDI-DrugBank.d739.s3|53-63|terfenadine|drug
DDI-DrugBank.d739.s3|105-116|fexofenadine|drug
DDI-DrugBank.d739.s3|172-174|QTc|brand
DDI-DrugBank.d739.s3|218-228|terfenadine|drug
DDI-DrugBank.d739.s4|15-19|Doses|brand
DDI-DrugBank.d739.s4|34-44|Daily Dosed|brand
DDI-DrugBank.d739.s4|49-63|Pharmacokinetic|drug
DDI-DrugBank.d739.s4|65-76|Steady State|brand
DDI-DrugBank.d739.s4|167-179|contraceptive|drug
DDI-DrugBank.d739.s5|72-81|prednisone|drug
DDI-DrugBank.d739.s5|86-97|prednisolone|drug
DDI-DrugBank.d739.s5|139-148|prednisone|drug
DDI-DrugBank.d739.s5|165-176|prednisolone|drug
DDI-DrugBank.d739.s6|0-12|Phenobarbital|drug
DDI-DrugBank.d739.s6|29-35|hepatic|drug
DDI-DrugBank.d739.s6|63-65|AUC|brand
DDI-DrugBank.d739.s8|112-124|phenobarbital|drug
DDI-DrugBank.d739.s9|55-63|routinely|drug
DDI-DrugBank.d739.s10|123-138|pharmacokinetics|group
DDI-DrugBank.d739.s10|164-175|theophylline|drug
DDI-DrugBank.d739.s10|178-187|prednisone|drug
DDI-DrugBank.d739.s10|190-201|prednisolone|drug
DDI-DrugBank.d739.s10|209-222|contraceptives|group
DDI-DrugBank.d739.s10|271-281|terfenadine|drug
DDI-DrugBank.d739.s10|284-290|digoxin|drug
DDI-DrugBank.d739.s10|297-304|warfarin|drug
DDI-DrugBank.d739.s11|111-114|wide|drug
DDI-DrugBank.d739.s11|179-186|evidence|drug
DDI-DrugBank.d739.s12|45-52|sedative|drug
DDI-DrugBank.d739.s12|54-62|hypnotics|group
DDI-DrugBank.d739.s12|79-102|anti-inflammatory agents|group
DDI-DrugBank.d739.s12|105-119|benzodiazepines|group
DDI-DrugBank.d739.s13|0-12|Phenobarbital|drug
DDI-DrugBank.d739.s13|29-35|hepatic|drug
DDI-DrugBank.d739.s13|63-65|AUC|brand
DDI-DrugBank.d739.s15|112-124|phenobarbital|drug
DDI-DrugBank.d737.s0|20-37|Carbidopa/Levodopa|brand
DDI-DrugBank.d737.s0|62-77|pharmacokinetics|group
DDI-DrugBank.d737.s2|0-9|Selegiline|drug
DDI-DrugBank.d737.s2|12-13|In|brand
DDI-DrugBank.d737.s2|43-52|selegiline|drug
DDI-DrugBank.d737.s2|76-91|pharmacokinetics|group
DDI-DrugBank.d737.s3|0-9|Amantadine|drug
DDI-DrugBank.d737.s3|12-21|Population|brand
DDI-DrugBank.d737.s3|23-37|pharmacokinetic|drug
DDI-DrugBank.d737.s3|62-71|amantadine|drug
DDI-DrugBank.d737.s4|0-9|Cimetidine|drug
DDI-DrugBank.d737.s4|12-21|Cimetidine|drug
DDI-DrugBank.d737.s4|158-160|AUC|brand
DDI-DrugBank.d737.s5|0-9|Probenecid|drug
DDI-DrugBank.d737.s5|12-21|Probenecid|drug
DDI-DrugBank.d737.s5|80-84|acids|group
DDI-DrugBank.d737.s5|123-132|noticeably|drug
DDI-DrugBank.d737.s5|156-171|pharmacokinetics|group
DDI-DrugBank.d737.s6|44-53|Population|brand
DDI-DrugBank.d737.s6|55-69|pharmacokinetic|drug
DDI-DrugBank.d737.s6|178-187|cimetidine|drug
DDI-DrugBank.d737.s6|190-199|ranitidine|drug
DDI-DrugBank.d737.s6|237-245|quinidine|drug
DDI-DrugBank.d737.s6|252-258|quinine|drug
DDI-DrugBank.d737.s6|379-392|cephalosporins|drug
DDI-DrugBank.d737.s6|395-405|penicillins|group
DDI-DrugBank.d737.s6|422-440|hydrochlorothiazide|drug
DDI-DrugBank.d737.s6|447-460|chlorpropamide|drug
DDI-DrugBank.d737.s7|18-27|Inhibitors|group
DDI-DrugBank.d737.s8|29-31|CYP|brand
DDI-DrugBank.d737.s8|41-46|CYPIA2|brand
DDI-DrugBank.d737.s8|49-54|CYP2C9|drug
DDI-DrugBank.d737.s8|57-63|CYP2CI9|brand
DDI-DrugBank.d737.s8|66-71|CYP2EI|brand
DDI-DrugBank.d737.s9|14-19|CYP2D6|drug
DDI-DrugBank.d737.s9|51-52|Ki|brand
DDI-DrugBank.d737.s9|109-111|CYP|brand
DDI-DrugBank.d737.s10|0-7|Dopamine|drug
DDI-DrugBank.d737.s10|22-26|Since|brand
DDI-DrugBank.d737.s10|45-52|dopamine|drug
DDI-DrugBank.d737.s10|83-90|dopamine|drug
DDI-DrugBank.d737.s10|117-144|neuroleptics (phenothiazines|group
DDI-DrugBank.d737.s10|181-194|metoclopramide|drug
DDI-DrugBank.d737.s10|214-226|effectiveness|drug
DDI-DrugBank.d737.s10|231-237|MIRAPEX|brand
DDI-DrugBank.d737.s11|22-39|Interactions There|brand
DDI-DrugBank.d737.s11|75-81|MIRAPEX|brand
DDI-DrugBank.d680.s0|0-11|Pantoprazole|drug
DDI-DrugBank.d680.s0|78-84|CYP2C19|brand
DDI-DrugBank.d680.s0|134-141|Phase II|brand
DDI-DrugBank.d680.s1|53-64|pantoprazole|drug
DDI-DrugBank.d680.s1|154-165|theophylline|drug
DDI-DrugBank.d680.s1|168-176|cisapride|drug
DDI-DrugBank.d680.s1|179-188|antipyrine|group
DDI-DrugBank.d680.s1|191-198|caffeine|drug
DDI-DrugBank.d680.s1|201-213|carbamazepine|drug
DDI-DrugBank.d680.s1|216-223|diazepam|drug
DDI-DrugBank.d680.s1|234-239|active|drug
DDI-DrugBank.d680.s1|253-269|desmethyldiazepam|drug
DDI-DrugBank.d680.s1|273-282|diclofenac|drug
DDI-DrugBank.d680.s1|306-312|digoxin|drug
DDI-DrugBank.d680.s1|324-332|glyburide|drug
DDI-DrugBank.d680.s1|343-379|contraceptive (levonorgestrel/ethinyl|drug
DDI-DrugBank.d680.s1|393-402|metoprolol|drug
DDI-DrugBank.d680.s1|405-414|nifedipine|drug
DDI-DrugBank.d680.s1|428-435|warfarin|drug
DDI-DrugBank.d680.s1|438-446|midazolam|drug
DDI-DrugBank.d680.s1|449-462|clarithromycin|drug
DDI-DrugBank.d680.s1|465-477|metronidazole|drug
DDI-DrugBank.d680.s1|483-493|amoxicillin|drug
DDI-DrugBank.d680.s2|36-47|pantoprazole|drug
DDI-DrugBank.d680.s3|36-47|pantoprazole|drug
DDI-DrugBank.d680.s3|78-89|pantoprazole|drug
DDI-DrugBank.d680.s4|62-69|antacids|group
DDI-DrugBank.d680.s5|51-53|INR|brand
DDI-DrugBank.d680.s5|110-119|inhibitors|group
DDI-DrugBank.d680.s5|132-143|pantoprazole|drug
DDI-DrugBank.d680.s5|150-157|warfarin|drug
DDI-DrugBank.d680.s6|13-15|INR|brand
DDI-DrugBank.d680.s7|34-43|inhibitors|group
DDI-DrugBank.d680.s7|49-56|warfarin|drug
DDI-DrugBank.d680.s7|109-111|INR|brand
DDI-DrugBank.d680.s8|75-86|pantoprazole|drug
DDI-DrugBank.d680.s8|202-213|ketoconazole|drug
DDI-DrugBank.d680.s8|216-225|ampicillin|drug
DDI-DrugBank.d680.s8|239-242|iron|drug_n
DDI-DrugBank.d680.s9|11-21|Tests There|brand
DDI-DrugBank.d680.s9|44-63|false-positive urine|drug
DDI-DrugBank.d680.s9|85-104|tetrahydrocannabinol|drug_n
DDI-DrugBank.d680.s9|151-160|inhibitors|group
DDI-DrugBank.d680.s9|173-184|pantoprazole|drug
DDI-DrugBank.d680.s10|3-13|alternative|drug
DDI-DrugBank.d680.s10|45-54|considered|drug
DDI-DrugBank.d680.s10|66-73|positive|drug
DDI-DrugBank.d723.s0|39-60|acetylcholine chloride|drug
DDI-DrugBank.d723.s0|86-95|(Carboptic|drug
DDI-DrugBank.d723.s0|98-113|Isopto Carbachol|brand
DDI-DrugBank.d723.s0|144-151|suprofen|drug
DDI-DrugBank.d716.s0|45-53|monoamine|drug
DDI-DrugBank.d716.s0|113-127|tranylcypromine|drug
DDI-DrugBank.d716.s0|143-152|phenelzine|drug
DDI-DrugBank.d716.s2|35-46|guanethidine|drug
DDI-DrugBank.d716.s4|35-46|guanethidine|drug
DDI-DrugBank.d716.s5|68-91|tricyclic antidepressant|group
DDI-DrugBank.d716.s5|101-113|amitriptyline|drug
DDI-DrugBank.d716.s5|125-133|amoxapine|drug
DDI-DrugBank.d716.s5|154-162|(Sinequan|drug
DDI-DrugBank.d716.s5|166-178|nortriptyline|drug
DDI-DrugBank.d716.s5|191-200|imipramine|drug
DDI-DrugBank.d716.s5|214-225|clomipramine|drug
DDI-DrugBank.d716.s5|240-252|protriptyline|drug
DDI-DrugBank.d716.s5|269-279|desipramine|drug
DDI-MedLine.d179.s0|0-10|Synergistic|drug
DDI-MedLine.d179.s0|32-40|sunitinib|drug
DDI-MedLine.d179.s0|114-132|EGFR TKIs-resistant|brand
DDI-MedLine.d179.s1|40-48|sunitinib|drug
DDI-MedLine.d179.s1|58-67|anti-tumor|group
DDI-MedLine.d179.s2|66-74|sunitinib|drug
DDI-MedLine.d179.s2|131-139|sunitinib|drug
DDI-MedLine.d179.s2|158-162|NSCLC|brand
DDI-MedLine.d179.s2|169-173|lines|group
DDI-MedLine.d179.s2|197-205|EGFR TKIs|brand
DDI-MedLine.d179.s3|11-15|lines|group
DDI-MedLine.d179.s3|22-31|EGFR T790M|brand
DDI-MedLine.d179.s3|46-50|K-ras|brand
DDI-MedLine.d179.s3|84-92|sunitinib|drug
DDI-MedLine.d179.s4|51-53|MTT|brand
DDI-MedLine.d179.s4|67-71|cycle|drug
DDI-MedLine.d179.s4|160-169|determined|drug
DDI-MedLine.d179.s5|0-8|Sunitinib|drug
DDI-MedLine.d179.s5|56-60|NSCLC|brand
DDI-MedLine.d179.s5|67-71|lines|group
DDI-MedLine.d179.s5|91-95|cycle|drug
DDI-MedLine.d179.s5|100-101|G1|brand
DDI-MedLine.d179.s6|37-45|sunitinib|drug
DDI-MedLine.d179.s6|70-87|anti-proliferative|group
DDI-MedLine.d179.s6|163-172|anti-tumor|group
DDI-MedLine.d179.s7|49-57|sunitinib|drug
DDI-MedLine.d179.s8|179-187|sunitinib|drug
DDI-MedLine.d179.s9|132-136|cycle|drug
DDI-MedLine.d179.s10|0-8|Sunitinib|drug
DDI-MedLine.d179.s10|37-54|anti-proliferative|group
DDI-MedLine.d179.s10|76-80|NSCLC|brand
DDI-MedLine.d179.s10|87-91|lines|group
DDI-MedLine.d179.s10|98-107|EGFR T790M|brand
DDI-MedLine.d179.s10|113-117|K-ras|brand
DDI-MedLine.d179.s10|188-196|sunitinib|drug
DDI-MedLine.d179.s10|213-221|sunitinib|drug
DDI-DrugBank.d610.s0|0-14|Pharmacokinetic|drug
DDI-DrugBank.d610.s0|30-37|abacavir|drug
DDI-DrugBank.d610.s0|82-91|lamivudine|drug
DDI-DrugBank.d610.s0|96-105|zidovudine|drug
DDI-DrugBank.d610.s0|129-138|lamivudine|drug
DDI-DrugBank.d610.s0|144-153|zidovudine|drug
DDI-DrugBank.d610.s1|37-46|lamivudine|drug
DDI-DrugBank.d610.s1|51-60|zidovudine|drug
DDI-DrugBank.d610.s1|62-77|pharmacokinetics|group
DDI-DrugBank.d610.s1|133-140|abacavir|drug
DDI-DrugBank.d610.s2|0-7|Abacavir|drug
DDI-DrugBank.d610.s2|30-44|pharmacokinetic|drug
DDI-DrugBank.d610.s3|37-44|abacavir|drug
DDI-DrugBank.d610.s3|88-90|The|brand
DDI-DrugBank.d610.s3|158-172|pharmacokinetic|drug
DDI-DrugBank.d610.s3|188-195|abacavir|drug
DDI-DrugBank.d610.s4|17-28|HIV-infected|brand
DDI-DrugBank.d610.s4|118-123|ZIAGEN|brand
DDI-DrugBank.d610.s4|221-222|CI|brand
DDI-DrugBank.d682.s0|38-49|barbiturates|group
DDI-DrugBank.d682.s0|52-62|tolbutamide|drug
DDI-DrugBank.d682.s1|26-34|thiazides|group
DDI-DrugBank.d682.s1|66-77|cyclosporine|drug
DDI-DrugBank.d682.s1|107-125|sulfonylurea agents|group
DDI-DrugBank.d682.s1|138-149|hypoglycemic|group
DDI-DrugBank.d682.s1|162-169|warfarin|drug
DDI-DrugBank.d682.s1|182-194|anticoagulant|group
DDI-DrugBank.d682.s1|284-290|hepatic|drug
DDI-DrugBank.d677.s0|0-13|Phenothiazines|group
DDI-DrugBank.d677.s0|43-45|CNS|brand
DDI-DrugBank.d677.s0|66-77|barbiturates|group
DDI-DrugBank.d677.s0|80-90|anesthetics|group
DDI-DrugBank.d677.s1|11-18|atropine|drug
DDI-DrugBank.d677.s1|36-47|insecticides|group
DDI-MedLine.d161.s0|54-65|dopaminergic|drug
DDI-MedLine.d161.s0|114-125|MPTP-treated|drug_n
DDI-MedLine.d161.s1|20-31|dopaminergic|drug
DDI-MedLine.d161.s1|145-155|Parkinson's|brand
DDI-MedLine.d161.s2|100-110|Parkinson's|brand
DDI-MedLine.d161.s3|146-153|pyridine|drug
DDI-MedLine.d161.s3|164-175|dopaminergic|drug
DDI-MedLine.d161.s3|281-324|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug
DDI-MedLine.d161.s4|21-64|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug
DDI-MedLine.d161.s4|190-197|pyridine|drug
DDI-MedLine.d161.s4|320-394|(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl|drug
DDI-MedLine.d161.s4|406-413|pyridine|drug
DDI-MedLine.d161.s4|422-473|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle|drug
DDI-MedLine.d161.s5|18-61|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug
DDI-MedLine.d161.s5|78-137|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated|drug
DDI-MedLine.d161.s5|200-273|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl|drug
DDI-MedLine.d161.s5|285-300|pyridine-treated|drug
DDI-MedLine.d161.s6|89-96|dopamine|drug
DDI-MedLine.d161.s6|178-189|dopaminergic|drug
DDI-MedLine.d161.s6|246-253|dopamine|drug
DDI-MedLine.d161.s6|271-278|tyrosine|drug
DDI-MedLine.d161.s6|349-422|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl|drug
DDI-MedLine.d161.s6|434-449|pyridine-treated|drug
DDI-MedLine.d161.s6|467-526|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated|drug
DDI-MedLine.d161.s7|44-51|pyridine|drug
DDI-MedLine.d161.s7|100-151|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced|drug
DDI-MedLine.d161.s7|161-174|norepinephrine|drug
DDI-MedLine.d161.s7|221-222|A5|brand
DDI-MedLine.d161.s7|228-229|A7|brand
DDI-MedLine.d161.s7|231-243|noradrenaline|drug
DDI-MedLine.d161.s8|3-62|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated|drug
DDI-MedLine.d161.s8|101-135|hydroxylase-positive norepinephrine|drug
DDI-MedLine.d161.s8|180-192|noradrenaline|drug
DDI-MedLine.d161.s8|283-356|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl|drug
DDI-MedLine.d161.s8|368-383|pyridine-treated|drug
DDI-MedLine.d161.s9|139-146|pyridine|drug
DDI-MedLine.d161.s9|171-214|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug
DDI-MedLine.d161.s9|233-244|dopaminergic|drug
DDI-MedLine.d161.s10|127-143|catecholaminergic|drug
DDI-MedLine.d161.s10|156-166|Parkinson's|brand
DDI-DrugBank.d688.s0|0-14|Pharmacokinetic|drug
DDI-DrugBank.d688.s0|74-88|pharmacokinetic|drug
DDI-DrugBank.d688.s0|104-113|zidovudine|drug
DDI-DrugBank.d688.s0|118-126|rifabutin|drug
DDI-DrugBank.d688.s1|2-16|pharmacokinetic|drug
DDI-DrugBank.d688.s1|84-92|indinavir|drug
DDI-DrugBank.d688.s1|135-149|pharmacokinetic|drug
DDI-DrugBank.d688.s1|172-175|Cmax|brand
DDI-DrugBank.d688.s1|190-192|AUC|brand
DDI-DrugBank.d688.s1|198-206|indinavir|drug
DDI-DrugBank.d688.s2|35-43|indinavir|drug
DDI-DrugBank.d688.s2|55-64|considered|drug
DDI-DrugBank.d688.s3|15-23|indinavir|drug
DDI-DrugBank.d688.s3|26-35|zidovudine|drug
DDI-DrugBank.d688.s3|40-48|rifabutin|drug
DDI-DrugBank.d688.s3|57-72|pharmacokinetics|group
DDI-DrugBank.d647.s0|24-31|additive|drug
DDI-DrugBank.d647.s1|71-81|doxorubicin|drug
DDI-DrugBank.d647.s2|19-29|doxorubicin|drug
DDI-DrugBank.d647.s2|48-57|considered|drug
DDI-DrugBank.d647.s2|81-87|ZANOSAR|brand
DDI-DrugBank.d746.s0|100-114|sympathomimetic|drug
DDI-DrugBank.d746.s0|116-121|amines|group
DDI-DrugBank.d746.s1|0-8|Monoamine|drug
DDI-DrugBank.d746.s1|18-27|inhibitors|group
DDI-DrugBank.d746.s1|32-56|tricyclic antidepressants|group
DDI-DrugBank.d746.s1|87-101|sympathomimetic|drug
DDI-DrugBank.d746.s1|103-108|amines|group
DDI-DrugBank.d746.s2|115-119|given|drug
DDI-DrugBank.d699.s0|0-10|Mequitazine|drug
DDI-DrugBank.d699.s0|30-32|CNS|brand
DDI-DrugBank.d699.s0|46-61|antichlolinergic|group
DDI-DrugBank.d699.s0|64-66|TCA|brand
DDI-DrugBank.d699.s0|69-73|MAOIs|brand
DDI-DrugBank.d601.s0|0-11|Barbiturates|group
DDI-DrugBank.d601.s0|30-42|effectiveness|drug
DDI-DrugBank.d601.s0|52-65|contraceptives|group
DDI-DrugBank.d601.s0|76-86|antibiotics|group
DDI-DrugBank.d601.s0|89-97|quinidine|drug
DDI-DrugBank.d601.s0|100-111|theophylline|drug
DDI-DrugBank.d601.s0|114-128|corticosteroids|drug
DDI-DrugBank.d601.s0|131-144|anticoagulants|group
DDI-DrugBank.d601.s0|151-154|beta|group
DDI-DrugBank.d649.s0|43-54|barbiturates|group
DDI-DrugBank.d649.s0|57-67|tolbutamide|drug
DDI-DrugBank.d649.s1|26-34|thiazides|group
DDI-DrugBank.d649.s1|66-77|cyclosporine|drug
DDI-DrugBank.d649.s1|107-125|sulfonylurea agents|group
DDI-DrugBank.d649.s1|138-149|hypoglycemic|group
DDI-DrugBank.d649.s1|162-169|warfarin|drug
DDI-DrugBank.d649.s1|182-194|anticoagulant|group
DDI-DrugBank.d649.s1|284-290|hepatic|drug
DDI-DrugBank.d773.s0|30-35|TNKase|brand
DDI-DrugBank.d773.s1|39-44|TNKase|brand
DDI-DrugBank.d773.s1|51-59|routinely|drug
DDI-DrugBank.d773.s1|74-80|heparin|drug
DDI-DrugBank.d773.s2|0-13|Anticoagulants|group
DDI-DrugBank.d773.s2|24-30|heparin|drug
DDI-DrugBank.d773.s2|36-44|vitamin K|group
DDI-DrugBank.d773.s2|150-168|IIb/IIIa inhibitors|group
DDI-DrugBank.d773.s2|248-253|TNKase|brand
DDI-DrugBank.d773.s3|34-46|During TNKase|brand
DDI-DrugBank.d773.s3|105-116|fibrinolytic|drug
DDI-DrugBank.d773.s4|95-100|active|drug
DDI-DrugBank.d710.s0|0-9|Cimetidine|drug
DDI-DrugBank.d710.s0|12-14|The|brand
DDI-DrugBank.d710.s0|35-44|cimetidine|drug
DDI-DrugBank.d710.s0|71-81|rimantadine|drug
DDI-DrugBank.d710.s1|29-39|rimantadine|drug
DDI-DrugBank.d710.s1|41-43|HCl|brand
DDI-DrugBank.d710.s1|95-104|Cimetidine|drug
DDI-DrugBank.d710.s1|152-162|rimantadine|drug
DDI-DrugBank.d710.s1|270-280|rimantadine|drug
DDI-DrugBank.d710.s1|331-340|cimetidine|drug
DDI-DrugBank.d710.s2|0-12|Acetaminophen|drug
DDI-DrugBank.d710.s2|15-25|Rimantadine|drug
DDI-DrugBank.d710.s2|27-29|HCl|brand
DDI-DrugBank.d710.s2|44-48|given|drug
DDI-DrugBank.d710.s3|11-23|acetaminophen|drug
DDI-DrugBank.d710.s4|4-19|pharmacokinetics|group
DDI-DrugBank.d710.s4|24-34|rimantadine|drug
DDI-DrugBank.d710.s5|22-34|acetaminophen|drug
DDI-DrugBank.d710.s5|71-73|AUC|brand
DDI-DrugBank.d710.s5|86-96|rimantadine|drug
DDI-DrugBank.d710.s6|9-19|Rimantadine|drug
DDI-DrugBank.d710.s6|21-23|HCl|brand
DDI-DrugBank.d710.s6|38-42|given|drug
DDI-DrugBank.d710.s8|4-19|pharmacokinetics|group
DDI-DrugBank.d710.s8|24-34|rimantadine|drug
DDI-DrugBank.d710.s9|31-33|AUC|brand
DDI-DrugBank.d710.s9|38-48|rimantadine|drug
DDI-DrugBank.d598.s0|29-35|hepatic|drug
DDI-DrugBank.d598.s1|14-18|given|drug
DDI-DrugBank.d598.s2|78-86|excessive|drug
DDI-DrugBank.d595.s0|0-8|Additives|group
DDI-DrugBank.d595.s1|0-13|norepinephrine|drug
DDI-DrugBank.d595.s1|19-28|dobutamine|drug
DDI-DrugBank.d595.s2|88-94|avoided|drug
DDI-DrugBank.d595.s4|6-7|Do|brand
DDI-DrugBank.d595.s5|0-8|Additives|group
DDI-DrugBank.d595.s7|17-25|additives|group
DDI-DrugBank.d595.s7|32-38|aseptic|drug
DDI-DrugBank.d627.s0|0-10|Pilocarpine|drug
DDI-DrugBank.d627.s0|67-70|beta|group
DDI-DrugBank.d627.s1|11-29|parasympathomimetic|drug
DDI-DrugBank.d627.s1|70-80|pilocarpine|drug
DDI-DrugBank.d627.s1|113-120|additive|drug
DDI-DrugBank.d627.s2|0-10|Pilocarpine|drug
DDI-DrugBank.d627.s2|33-47|anticholinergic|group
DDI-DrugBank.d627.s3|24-33|considered|drug
DDI-DrugBank.d627.s3|40-54|anticholinergic|group
DDI-DrugBank.d627.s3|94-104|therapeutic|drug
DDI-DrugBank.d627.s3|146-153|atropine|drug
DDI-DrugBank.d627.s4|150-151|Sj|brand
DDI-DrugBank.d627.s4|250-275|hydroxychloroquine sulfate|drug
DDI-DrugBank.d627.s4|278-286|ibuprofen|drug
DDI-DrugBank.d627.s4|289-301|levothyroxine|drug
DDI-DrugBank.d627.s4|354-366|multivitamins|group
DDI-DrugBank.d627.s4|379-388|omeprazole|drug
DDI-DrugBank.d627.s4|408-417|prednisone|drug
DDI-DrugBank.d578.s0|4-18|pharmacokinetic|drug
DDI-DrugBank.d578.s1|62-72|cyclosporin|drug
DDI-DrugBank.d578.s1|78-95|methylprednisolone|drug
DDI-DrugBank.d578.s3|54-71|methylprednisolone|drug
DDI-DrugBank.d578.s3|77-87|cyclosporin|drug
DDI-DrugBank.d578.s4|18-24|hepatic|drug
DDI-DrugBank.d578.s4|42-54|phenobarbital|drug
DDI-DrugBank.d578.s4|111-128|methylprednisolone|drug
DDI-DrugBank.d578.s4|159-176|methylprednisolone|drug
DDI-DrugBank.d578.s5|14-27|troleandomycin|drug
DDI-DrugBank.d578.s5|33-44|ketoconazole|drug
DDI-DrugBank.d578.s5|76-93|methylprednisolone|drug
DDI-DrugBank.d578.s6|23-40|methylprednisolone|drug
DDI-DrugBank.d578.s7|0-17|Methylprednisolone|drug
DDI-DrugBank.d578.s8|102-119|methylprednisolone|drug
DDI-DrugBank.d578.s9|54-68|corticosteroids|drug
DDI-DrugBank.d578.s9|97-115|hypoprothrombinemia|drug
DDI-DrugBank.d578.s10|14-31|methylprednisolone|drug
DDI-DrugBank.d578.s10|41-54|anticoagulants|group
DDI-DrugBank.d578.s11|63-75|anticoagulant|group
DDI-DrugBank.d578.s11|82-86|given|drug
DDI-DrugBank.d578.s11|106-120|corticosteroids|drug
DDI-DrugBank.d578.s12|75-87|anticoagulant|group
DDI-DrugBank.d652.s0|15-28|metoclopramide|drug
DDI-DrugBank.d652.s0|78-92|anticholinergic|group
DDI-DrugBank.d652.s0|104-111|narcotic|drug
DDI-DrugBank.d652.s1|0-16|Additive sedative|drug
DDI-DrugBank.d652.s1|41-54|metoclopramide|drug
DDI-DrugBank.d652.s1|59-63|given|drug
DDI-DrugBank.d652.s1|79-87|sedatives|drug_n
DDI-DrugBank.d652.s1|90-98|hypnotics|group
DDI-DrugBank.d652.s1|101-109|narcotics|group
DDI-DrugBank.d652.s2|17-30|metoclopramide|drug
DDI-DrugBank.d652.s2|41-54|catecholamines|group
DDI-DrugBank.d652.s2|173-181|monoamine|drug
DDI-DrugBank.d652.s2|192-201|inhibitors|group
DDI-DrugBank.d652.s3|62-68|digoxin|drug
DDI-DrugBank.d652.s3|74-87|metoclopramide|drug
DDI-DrugBank.d652.s3|189-201|acetaminophen|drug
DDI-DrugBank.d652.s3|204-215|tetracycline|drug
DDI-DrugBank.d652.s3|237-248|cyclosporine|drug
DDI-DrugBank.d652.s4|59-66|diabetic|drug
DDI-DrugBank.d652.s6|22-35|metoclopramide|drug
DDI-DrugBank.d652.s6|56-63|delivery|drug
DDI-DrugBank.d652.s6|80-89|intestines|group
DDI-DrugBank.d725.s0|14-25|particularly|drug
DDI-DrugBank.d725.s1|4-13|Inhibitors|group
DDI-DrugBank.d725.s1|16-18|The|brand
DDI-DrugBank.d725.s1|38-52|sympathomimetic|drug
DDI-DrugBank.d725.s1|62-67|amines|group
DDI-DrugBank.d725.s1|115-123|monoamine|drug
DDI-DrugBank.d725.s1|133-142|inhibitors|group
DDI-DrugBank.d725.s3|35-40|agents|group
DDI-DrugBank.d725.s3|69-93|tricyclic antidepressants|group
DDI-MedLine.d143.s0|49-59|inhibitors]|group
DDI-MedLine.d143.s1|41-50|inhibitors|group
DDI-MedLine.d143.s2|58-67|inhibitors|group
DDI-MedLine.d143.s3|19-28|omeprazole|drug
DDI-MedLine.d143.s3|104-109|active|drug
DDI-MedLine.d143.s3|203-212|omeprazole|drug
DDI-MedLine.d143.s3|217-223|CYP2C19|brand
DDI-MedLine.d143.s4|0-11|Pantoprazole|drug
DDI-MedLine.d143.s4|55-70|pharmacokinetics|group
DDI-MedLine.d143.s5|39-48|inhibitors|group
DDI-MedLine.d143.s6|70-87|CYP2C19 inhibitors|group
DDI-MedLine.d143.s6|89-98|omeprazole|drug
DDI-MedLine.d143.s6|104-115|esomeprazole|drug
DDI-MedLine.d143.s6|127-133|avoided|drug
DDI-MedLine.d143.s7|21-39|conclusive evidence|drug
DDI-MedLine.d143.s7|109-118|inhibitors|group
DDI-DrugBank.d655.s0|0-14|Methscopolamine|drug
DDI-DrugBank.d655.s0|34-48|antidepressants|group
DDI-DrugBank.d655.s0|50-59|(tricyclic|drug
DDI-DrugBank.d655.s0|68-81|MAO inhibitors|group
DDI-DrugBank.d655.s0|90-99|phenelzine|drug
DDI-DrugBank.d655.s0|102-110|linezolid|drug
DDI-DrugBank.d655.s0|113-127|tranylcypromine|drug
DDI-DrugBank.d655.s0|145-154|selegiline|drug
DDI-DrugBank.d655.s0|172-180|quinidine|drug
DDI-DrugBank.d655.s0|183-192|amantadine|drug
DDI-DrugBank.d655.s0|195-208|antihistamines|group
DDI-DrugBank.d655.s0|217-231|diphenhydramine|drug
DDI-DrugBank.d655.s0|241-256|anticholinergics|group
DDI-DrugBank.d655.s0|269-276|chloride|drug
DDI-DrugBank.d655.s0|291-298|antacids|group
DDI-DrugBank.d655.s0|316-338|anti-diarrhea medicines|group
DDI-DrugBank.d655.s0|363-376|phenothiazines|group
DDI-DrugBank.d655.s0|385-398|chlorpromazine|drug
DDI-DrugBank.d655.s0|401-412|promethazine|drug
DDI-MedLine.d185.s0|10-30|ketoconazole-mediated|drug
DDI-MedLine.d185.s0|62-77|pharmacokinetics|group
DDI-MedLine.d185.s0|115-120|active|drug
DDI-MedLine.d185.s2|61-72|ketoconazole|drug
DDI-MedLine.d185.s2|82-97|pharmacokinetics|group
DDI-MedLine.d185.s3|9-16|received|drug
DDI-MedLine.d185.s4|13-24|ketoconazole|drug
DDI-MedLine.d185.s5|62-73|ketoconazole|drug
DDI-MedLine.d185.s7|19-30|ketoconazole|drug
DDI-MedLine.d185.s7|85-87|AUC|brand
DDI-MedLine.d185.s7|106-117|respectively|drug
DDI-MedLine.d185.s8|3-13|substantial|group
DDI-MedLine.d185.s9|17-45|panobinostat-pharmacokinetics|group
DDI-MedLine.d185.s11|13-24|asymptomatic|drug
DDI-MedLine.d185.s11|54-58|urine|drug
DDI-MedLine.d185.s12|45-54|inhibitors|group
DDI-MedLine.d185.s12|109-110|PK|brand
DDI-MedLine.d185.s12|131-140|considered|drug
DDI-MedLine.d185.s13|0-10|Considering|drug
DDI-MedLine.d185.s13|144-153|inhibitors|group
DDI-MedLine.d211.s0|17-28|lenalidomide|drug
DDI-MedLine.d211.s0|34-40|CCI-779|brand
DDI-MedLine.d211.s0|86-93|evidence|drug
DDI-MedLine.d211.s0|99-118|lenalidomide-CCI-779|drug
DDI-MedLine.d211.s0|136-149|P-glycoprotein|brand
DDI-MedLine.d211.s1|95-105|therapeutic|drug
DDI-MedLine.d211.s1|113-120|combined|drug
DDI-MedLine.d211.s1|127-139|dexamethasone|drug
DDI-MedLine.d211.s2|31-42|lenalidomide|drug
DDI-MedLine.d211.s2|68-74|CCI-779|brand
DDI-MedLine.d211.s2|145-146|MM|brand
DDI-DrugBank.d632.s0|40-45|SYMLIN|brand
DDI-DrugBank.d632.s0|69-78|considered|drug
DDI-DrugBank.d632.s0|150-171|anticholinergic agents|group
DDI-DrugBank.d632.s0|181-188|atropine|drug
DDI-DrugBank.d632.s0|195-200|agents|group
DDI-DrugBank.d632.s0|258-262|alpha|group
DDI-DrugBank.d632.s0|276-285|inhibitors|group
DDI-DrugBank.d632.s3|69-76|critical|drug
DDI-DrugBank.d632.s3|93-105|effectiveness|drug
DDI-DrugBank.d632.s3|204-209|SYMLIN|brand
DDI-DrugBank.d632.s4|43-55|sulfonylureas|group
DDI-DrugBank.d632.s4|60-69|biguanides|group
DDI-DrugBank.d632.s4|114-119|SYMLIN|brand
DDI-DrugBank.d632.s5|74-79|SYMLIN|brand
DDI-DrugBank.d632.s5|88-95|kinetics|group
DDI-DrugBank.d632.s5|105-123|antidiabetic agents|group
DDI-DrugBank.d632.s6|7-12|SYMLIN|brand
DDI-DrugBank.d632.s6|18-28|Insulin The|brand
DDI-DrugBank.d632.s6|30-44|pharmacokinetic|drug
DDI-DrugBank.d632.s6|60-65|SYMLIN|brand
DDI-DrugBank.d632.s6|105-107|NPH|brand
DDI-DrugBank.d632.s7|6-11|SYMLIN|brand
DDI-MedLine.d193.s1|4-6|FDA|brand
DDI-MedLine.d193.s1|21-30|ticagrelor|drug
DDI-MedLine.d193.s1|64-75|antiplatelet|group
DDI-MedLine.d193.s1|135-144|thrombotic|drug
DDI-MedLine.d193.s3|63-64|US|brand
DDI-MedLine.d216.s0|17-26|S-ketamine|drug
DDI-MedLine.d216.s0|45-56|itraconazole|drug
DDI-MedLine.d216.s0|83-93|ticlopidine|drug
DDI-MedLine.d216.s1|11-18|examined|drug
DDI-MedLine.d216.s1|51-60|S-ketamine|drug
DDI-MedLine.d216.s1|107-117|ticlopidine|drug
DDI-MedLine.d216.s1|143-154|itraconazole|drug
DDI-MedLine.d216.s2|87-96|S-ketamine|drug
DDI-MedLine.d216.s2|128-138|ticlopidine|drug
DDI-MedLine.d216.s2|162-173|itraconazole|drug
DDI-MedLine.d216.s3|0-10|Ticlopidine|drug
DDI-MedLine.d216.s3|134-141|ketamine|drug
DDI-MedLine.d216.s3|164-175|itraconazole|drug
DDI-MedLine.d216.s3|220-229|S-ketamine|drug
DDI-MedLine.d216.s4|13-23|norketamine|drug
DDI-MedLine.d216.s4|25-30|AUC(0-|brand
DDI-MedLine.d216.s4|39-46|ketamine|drug
DDI-MedLine.d216.s4|48-53|AUC(0-|brand
DDI-MedLine.d216.s4|94-104|ticlopidine|drug
DDI-MedLine.d216.s4|125-136|itraconazole|drug
DDI-MedLine.d216.s5|7-17|ticlopidine|drug
DDI-MedLine.d216.s5|23-34|itraconazole|drug
DDI-MedLine.d216.s5|98-107|drowsiness|group
DDI-MedLine.d216.s6|40-49|S-ketamine|drug
DDI-MedLine.d216.s6|91-101|ticlopidine|drug
DDI-DrugBank.d579.s0|19-29|antibiotics|group
DDI-DrugBank.d579.s0|35-46|sulfonamides|group
DDI-DrugBank.d579.s1|14-25|Mecamylamine|drug
DDI-DrugBank.d579.s1|67-82|antihypertensive|group
DDI-DrugBank.d629.s0|5-17|metronidazole|drug
DDI-DrugBank.d629.s0|55-67|anticoagulant|group
DDI-DrugBank.d629.s0|79-86|coumarin|group
DDI-DrugBank.d629.s0|92-99|warfarin|drug
DDI-DrugBank.d629.s1|46-53|METROGEL|brand
DDI-DrugBank.d629.s1|55-68|(metronidazole|drug
DDI-DrugBank.d629.s1|124-136|anticoagulant|group
DDI-DrugBank.d629.s1|201-213|metronidazole|drug
DDI-DrugBank.d750.s0|32-56|phentermine hydrochloride|drug
DDI-DrugBank.d635.s0|19-22|beta|group
DDI-DrugBank.d635.s0|43-57|bronchodilators|group
DDI-DrugBank.d635.s0|97-112|MAXAIR AUTOHALER|brand
DDI-DrugBank.d635.s0|136-143|additive|drug
DDI-DrugBank.d613.s0|57-69|statistically|drug
DDI-DrugBank.d613.s0|115-127|carbamazepine|drug
DDI-DrugBank.d613.s1|9-18|Drs Rimmer|brand
DDI-DrugBank.d613.s1|24-30|Richens|brand
DDI-DrugBank.d613.s1|39-48|University|drug
DDI-DrugBank.d613.s1|53-57|Wales|brand
DDI-DrugBank.d613.s2|51-54|five|drug
DDI-DrugBank.d613.s2|160-168|elucidate|drug
DDI-DrugBank.d780.s0|0-18|Anticholinesterases|group
DDI-DrugBank.d780.s0|21-30|Concurrent|brand
DDI-DrugBank.d780.s0|39-60|procaine hydrochloride|drug
DDI-DrugBank.d780.s0|66-90|anticholinesterase agents|group
DDI-DrugBank.d780.s0|116-123|systemic|group
DDI-DrugBank.d780.s0|140-158|anticholinesterases|group
DDI-DrugBank.d780.s0|185-206|procaine hydrochloride|drug
DDI-DrugBank.d780.s1|0-14|Antimyasthenics|group
DDI-DrugBank.d780.s1|16-25|Concurrent|brand
DDI-DrugBank.d780.s1|34-55|procaine hydrochloride|drug
DDI-DrugBank.d780.s1|61-75|antimyasthenics|group
DDI-DrugBank.d780.s1|176-190|antimyasthenics|group
DDI-DrugBank.d780.s2|31-45|antimyasthenics|group
DDI-DrugBank.d780.s3|5-19|antimyasthenics|group
DDI-DrugBank.d780.s3|30-47|anticholinesterase|group
DDI-DrugBank.d780.s4|28-37|Concurrent|brand
DDI-DrugBank.d780.s4|46-67|procaine hydrochloride|drug
DDI-DrugBank.d780.s4|73-75|CNS|brand
DDI-DrugBank.d780.s4|114-121|additive|drug
DDI-DrugBank.d780.s5|15-27|Hyaluronidase|brand
DDI-DrugBank.d780.s5|64-85|procaine hydrochloride|drug
DDI-DrugBank.d780.s5|147-154|systemic|group
DDI-DrugBank.d780.s6|23-28|agents|group
DDI-DrugBank.d780.s6|53-60|chloride|drug
DDI-DrugBank.d780.s6|64-73|Concurrent|brand
DDI-DrugBank.d780.s6|82-103|procaine hydrochloride|drug
DDI-DrugBank.d780.s6|132-137|agents|group
DDI-DrugBank.d780.s7|0-11|Sulfonamides|group
DDI-DrugBank.d780.s7|14-23|Concurrent|brand
DDI-DrugBank.d780.s7|32-53|procaine hydrochloride|drug
DDI-DrugBank.d780.s7|59-70|sulfonamides|group
DDI-DrugBank.d780.s7|105-117|antibacterial|group
DDI-DrugBank.d780.s7|133-143|sulfonamide|drug
DDI-DrugBank.d780.s8|0-12|Acetazolamide|drug
DDI-DrugBank.d780.s8|15-24|Concurrent|brand
DDI-DrugBank.d780.s8|33-45|acetazolamide|drug
DDI-DrugBank.d780.s8|51-72|procaine hydrochloride|drug
DDI-DrugBank.d780.s8|109-116|procaine|drug
DDI-DrugBank.d639.s0|21-26|SUTENT|brand
DDI-DrugBank.d639.s0|40-49|inhibitors|group
DDI-DrugBank.d639.s0|79-90|ketoconazole|drug
DDI-DrugBank.d639.s0|93-104|itraconazole|drug
DDI-DrugBank.d639.s0|107-120|clarithromycin|drug
DDI-DrugBank.d639.s0|123-132|atazanavir|drug
DDI-DrugBank.d639.s0|135-143|indinavir|drug
DDI-DrugBank.d639.s0|146-155|nefazodone|drug
DDI-DrugBank.d639.s0|158-167|nelfinavir|drug
DDI-DrugBank.d639.s0|170-178|ritonavir|drug
DDI-DrugBank.d639.s0|181-190|saquinavir|drug
DDI-DrugBank.d639.s0|193-205|telithromycin|drug
DDI-DrugBank.d639.s0|236-244|sunitinib|drug
DDI-DrugBank.d639.s1|54-59|SUTENT|brand
DDI-DrugBank.d639.s2|21-26|SUTENT|brand
DDI-DrugBank.d639.s2|70-82|dexamethasone|drug
DDI-DrugBank.d639.s2|96-108|carbamazepine|drug
DDI-DrugBank.d639.s2|121-129|rifabutin|drug
DDI-DrugBank.d639.s2|144-156|phenobarbital|drug
DDI-DrugBank.d639.s2|159-160|St|brand
DDI-DrugBank.d639.s2|163-172|Johns Wort|brand
DDI-DrugBank.d639.s2|188-196|sunitinib|drug
DDI-DrugBank.d639.s4|6-9|Wort|brand
DDI-DrugBank.d639.s4|24-29|SUTENT|brand
DDI-DrugBank.d639.s4|53-65|unpredictably|drug
DDI-DrugBank.d639.s5|19-24|SUTENT|brand
DDI-DrugBank.d639.s5|42-43|St|brand
DDI-DrugBank.d639.s6|6-9|Wort|brand
DDI-DrugBank.d639.s7|77-86|inhibitors|group
DDI-DrugBank.d653.s0|4-18|pharmacokinetic|drug
DDI-DrugBank.d653.s1|18-24|hepatic|drug
DDI-DrugBank.d653.s1|42-54|phenobarbital|drug
DDI-DrugBank.d653.s1|110-124|corticosteroids|drug
DDI-DrugBank.d653.s1|155-168|corticosteroid|drug
DDI-DrugBank.d653.s2|14-27|troleandomycin|drug
DDI-DrugBank.d653.s2|33-44|ketoconazole|drug
DDI-DrugBank.d653.s2|76-90|corticosteroids|drug
DDI-DrugBank.d653.s3|23-36|corticosteroid|drug
DDI-DrugBank.d653.s4|0-14|Corticosteroids|drug
DDI-DrugBank.d653.s5|102-115|corticosteroid|drug
DDI-DrugBank.d653.s6|54-68|corticosteroids|drug
DDI-DrugBank.d653.s6|97-115|hypoprothrombinemia|drug
DDI-DrugBank.d653.s7|14-28|corticosteroids|drug
DDI-DrugBank.d653.s7|38-51|anticoagulants|group
DDI-DrugBank.d653.s8|63-76|anticoagulants|group
DDI-DrugBank.d653.s8|83-87|given|drug
DDI-DrugBank.d653.s8|107-121|corticosteroids|drug
DDI-DrugBank.d653.s9|75-87|anticoagulant|group
DDI-DrugBank.d697.s0|17-26|Vitamin B1|group
DDI-DrugBank.d697.s0|28-36|(Thiamine|drug
DDI-DrugBank.d697.s0|41-54|Loop Diuretics|group
DDI-DrugBank.d697.s0|57-60|Oral|brand
DDI-DrugBank.d697.s0|62-75|Contraceptives|group
DDI-DrugBank.d697.s0|78-86|Stavudine|drug
DDI-DrugBank.d697.s0|89-113|Tricyclic Antidepressants|group
DDI-DrugBank.d596.s0|10-28|Interactions Effect|brand
DDI-DrugBank.d596.s0|33-38|Exelon|brand
DDI-DrugBank.d596.s0|43-55|(rivastigmine|drug
DDI-DrugBank.d596.s0|74-83|Metabolism|brand
DDI-DrugBank.d596.s0|88-98|Other Drugs|brand
DDI-DrugBank.d596.s0|101-112|Rivastigmine|drug
DDI-DrugBank.d596.s2|30-44|pharmacokinetic|drug
DDI-DrugBank.d596.s2|136-141|CYP1A2|brand
DDI-DrugBank.d596.s2|144-149|CYP2D6|drug
DDI-DrugBank.d596.s2|162-167|CYP2E1|brand
DDI-DrugBank.d596.s2|170-175|CYP2C9|drug
DDI-DrugBank.d596.s2|178-183|CYP2C8|brand
DDI-DrugBank.d596.s2|189-195|CYP2C19|brand
DDI-DrugBank.d596.s3|3-17|pharmacokinetic|drug
DDI-DrugBank.d596.s3|52-63|rivastigmine|drug
DDI-DrugBank.d596.s3|69-75|digoxin|drug
DDI-DrugBank.d596.s3|78-85|warfarin|drug
DDI-DrugBank.d596.s3|88-95|diazepam|drug
DDI-DrugBank.d596.s3|101-110|fluoxetine|drug
DDI-DrugBank.d596.s4|45-52|warfarin|drug
DDI-DrugBank.d596.s4|91-96|Exelon|brand
DDI-DrugBank.d596.s5|10-20|Other Drugs|brand
DDI-DrugBank.d596.s5|29-38|Metabolism|brand
DDI-DrugBank.d596.s5|43-48|Exelon|brand
DDI-DrugBank.d596.s5|51-55|Drugs|brand
DDI-DrugBank.d596.s5|142-153|rivastigmine|drug
DDI-DrugBank.d596.s6|12-26|pharmacokinetic|drug
DDI-DrugBank.d596.s6|72-83|rivastigmine|drug
DDI-DrugBank.d596.s6|147-153|digoxin|drug
DDI-DrugBank.d596.s6|156-163|warfarin|drug
DDI-DrugBank.d596.s6|166-173|diazepam|drug
DDI-DrugBank.d596.s6|179-188|fluoxetine|drug
DDI-DrugBank.d596.s7|11-12|PK|brand
DDI-DrugBank.d596.s7|71-86|pharmacokinetics|group
DDI-DrugBank.d596.s7|91-102|rivastigmine|drug
DDI-DrugBank.d596.s7|167-174|antacids|group
DDI-DrugBank.d596.s7|184-200|antihypertensives|group
DDI-DrugBank.d596.s7|218-224|channel|drug_n
DDI-DrugBank.d596.s7|243-255|antidiabetics|group
DDI-DrugBank.d596.s7|278-294|anti-inflammatory|group
DDI-DrugBank.d596.s7|359-370|antianginals|group
DDI-DrugBank.d596.s7|384-397|antihistamines|group
DDI-DrugBank.d596.s8|9-24|Anticholinergics|group
DDI-DrugBank.d596.s8|27-33|Because|brand
DDI-DrugBank.d596.s8|65-89|cholinesterase inhibitors|group
DDI-DrugBank.d596.s8|144-158|anticholinergic|group
DDI-DrugBank.d596.s9|9-23|Cholinomimetics|group
DDI-DrugBank.d596.s9|29-33|Other|brand
DDI-DrugBank.d596.s9|35-59|Cholinesterase Inhibitors|group
DDI-DrugBank.d596.s9|64-74|synergistic|drug
DDI-DrugBank.d596.s9|104-128|cholinesterase inhibitors|group
DDI-DrugBank.d596.s9|134-138|given|drug
DDI-DrugBank.d596.s9|158-172|succinylcholine|drug
DDI-DrugBank.d596.s9|206-211|agents|group
DDI-DrugBank.d596.s9|216-226|cholinergic|drug
DDI-DrugBank.d743.s0|0-11|Ketoconazole|drug
DDI-DrugBank.d743.s0|14-24|Spontaneous|brand
DDI-DrugBank.d743.s0|82-93|ketoconazole|drug
DDI-DrugBank.d743.s0|121-131|terfenadine|drug
DDI-DrugBank.d743.s0|145-146|QT|brand
DDI-DrugBank.d743.s2|0-14|Pharmacokinetic|drug
DDI-DrugBank.d743.s2|35-46|ketoconazole|drug
DDI-DrugBank.d743.s2|84-94|terfenadine|drug
DDI-DrugBank.d743.s2|126-136|terfenadine|drug
DDI-DrugBank.d743.s3|22-32|terfenadine|drug
DDI-DrugBank.d743.s3|53-65|statistically|drug
DDI-DrugBank.d743.s3|99-100|QT|brand
DDI-DrugBank.d743.s3|106-108|QTc|brand
DDI-DrugBank.d743.s4|30-41|ketoconazole|drug
DDI-DrugBank.d743.s4|47-57|terfenadine|drug
DDI-DrugBank.d743.s5|0-11|Itraconazole|drug
DDI-DrugBank.d743.s5|14-21|Torsades|brand
DDI-DrugBank.d743.s5|54-64|terfenadine|drug
DDI-DrugBank.d743.s5|118-128|terfenadine|drug
DDI-DrugBank.d743.s5|134-145|itraconazole|drug
DDI-DrugBank.d743.s5|169-180|itraconazole|drug
DDI-DrugBank.d743.s7|30-41|itraconazole|drug
DDI-DrugBank.d743.s7|47-57|terfenadine|drug
DDI-DrugBank.d743.s8|51-67|antifungal agents|group
DDI-DrugBank.d743.s8|80-90|fluconazole|drug
DDI-DrugBank.d743.s8|93-105|metronidazole|drug
DDI-DrugBank.d743.s8|112-121|miconazole|drug
DDI-DrugBank.d743.s8|127-138|ketoconazole|drug
DDI-DrugBank.d743.s8|145-156|itraconazole|drug
DDI-DrugBank.d743.s8|198-208|terfenadine|drug
DDI-DrugBank.d743.s9|0-9|Macrolides|group
DDI-DrugBank.d743.s9|12-19|Clinical|brand
DDI-DrugBank.d743.s9|60-71|erythromycin|drug
DDI-DrugBank.d743.s9|77-90|clarithromycin|drug
DDI-DrugBank.d743.s9|115-125|terfenadine|drug
DDI-DrugBank.d743.s9|185-196|ketoconazole|drug
DDI-DrugBank.d743.s10|9-20|erythromycin|drug
DDI-DrugBank.d743.s10|64-79|terfenadine acid|drug
DDI-DrugBank.d743.s10|110-120|terfenadine|drug
DDI-DrugBank.d743.s11|30-31|QT|brand
DDI-DrugBank.d743.s11|155-166|erythromycin|drug
DDI-DrugBank.d743.s11|171-184|troleandomycin|drug
DDI-DrugBank.d743.s12|30-40|terfenadine|drug
DDI-DrugBank.d743.s12|47-60|clarithromycin|drug
DDI-DrugBank.d743.s12|63-74|erythromycin|drug
DDI-DrugBank.d743.s12|80-93|troleandomycin|drug
DDI-DrugBank.d743.s12|115-121|Pending|brand
DDI-DrugBank.d743.s12|202-212|terfenadine|drug
DDI-DrugBank.d743.s12|225-245|macrolide antibiotics|group
DDI-DrugBank.d743.s12|258-269|azithromycin|drug
DDI-DrugBank.d743.s13|46-56|terfenadine|drug
DDI-DrugBank.d743.s13|63-74|azithromycin|drug
DDI-DrugBank.d602.s0|42-48|NEXAVAR|brand
DDI-DrugBank.d602.s0|97-109|predominantly|drug
DDI-DrugBank.d602.s0|118-123|UGT1A1|brand
DDI-DrugBank.d602.s1|27-33|NEXAVAR|brand
DDI-DrugBank.d602.s1|69-71|AUC|brand
DDI-DrugBank.d602.s1|76-86|doxorubicin|drug
DDI-DrugBank.d602.s2|42-52|doxorubicin|drug
DDI-DrugBank.d602.s2|59-65|NEXAVAR|brand
DDI-DrugBank.d602.s3|19-24|CYP2B6|brand
DDI-DrugBank.d602.s3|30-35|CYP2C8|brand
DDI-DrugBank.d602.s3|51-52|Ki|brand
DDI-DrugBank.d602.s3|78-89|respectively|drug
DDI-DrugBank.d602.s4|0-7|Systemic|group
DDI-DrugBank.d602.s4|35-40|CYP2B6|brand
DDI-DrugBank.d602.s4|46-51|CYP2C8|brand
DDI-DrugBank.d602.s4|103-109|NEXAVAR|brand
DDI-DrugBank.d602.s5|56-61|CYP2B6|brand
DDI-DrugBank.d602.s5|67-72|CYP2C8|brand
DDI-DrugBank.d602.s5|79-85|NEXAVAR|brand
DDI-DrugBank.d633.s0|6-12|MEXITIL|brand
DDI-DrugBank.d633.s0|66-71|CYP2D6|drug
DDI-DrugBank.d633.s0|77-82|CYP1A2|brand
DDI-DrugBank.d633.s0|171-180|mexiletine|drug
DDI-DrugBank.d633.s1|74-83|mexiletine|drug
DDI-DrugBank.d633.s1|140-150|fluvoxamine|drug
DDI-DrugBank.d633.s1|169-174|CYP1A2|brand
DDI-DrugBank.d633.s2|31-39|extensive|drug
DDI-DrugBank.d633.s2|72-77|CYP2D6|drug
DDI-DrugBank.d633.s2|131-138|kinetics|group
DDI-DrugBank.d633.s2|143-152|mexiletine|drug
DDI-DrugBank.d633.s2|166-171|CYP2D6|drug
DDI-DrugBank.d633.s3|36-45|mexiletine|drug
DDI-DrugBank.d633.s3|54-62|extensive|drug
DDI-DrugBank.d633.s3|129-137|extensive|drug
DDI-DrugBank.d633.s4|42-57|pharmacokinetics|group
DDI-DrugBank.d633.s4|137-146|mexiletine|drug
DDI-DrugBank.d633.s5|12-21|mexiletine|drug
DDI-DrugBank.d633.s5|105-107|QRS|brand
DDI-DrugBank.d633.s5|110-112|QTc|brand
DDI-DrugBank.d633.s5|115-116|RR|brand
DDI-DrugBank.d633.s5|123-124|PR|brand
DDI-DrugBank.d633.s6|66-75|mexiletine|drug
DDI-DrugBank.d633.s6|103-112|mexiletine|drug
DDI-DrugBank.d633.s7|37-43|Mexitil|brand
DDI-DrugBank.d633.s7|98-108|antianginal|group
DDI-DrugBank.d633.s7|111-126|antihypertensive|group
DDI-DrugBank.d633.s7|133-145|anticoagulant|group
DDI-DrugBank.d633.s8|13-27|antiarrhythmics|group
DDI-DrugBank.d633.s8|37-45|quinidine|drug
DDI-DrugBank.d633.s8|50-60|propranolol|drug
DDI-DrugBank.d633.s9|24-30|hepatic|drug
DDI-DrugBank.d633.s9|69-81|phenobarbital|drug
DDI-DrugBank.d633.s9|117-123|Mexitil|brand
DDI-DrugBank.d633.s9|137-143|Mexitil|brand
DDI-DrugBank.d633.s10|14-20|Mexitil|brand
DDI-DrugBank.d633.s10|90-100|ineffective|drug
DDI-DrugBank.d633.s11|19-33|benzodiazepines|group
DDI-DrugBank.d633.s11|60-66|Mexitil|brand
DDI-DrugBank.d633.s12|19-21|QRS|brand
DDI-DrugBank.d633.s12|28-29|QT|brand
DDI-DrugBank.d633.s12|64-70|Mexitil|brand
DDI-DrugBank.d633.s12|79-85|digoxin|drug
DDI-DrugBank.d633.s12|88-96|diuretics|group
DDI-DrugBank.d633.s12|102-112|propranolol|drug
DDI-DrugBank.d633.s13|29-38|cimetidine|drug
DDI-DrugBank.d633.s13|44-50|Mexitil|brand
DDI-DrugBank.d633.s13|115-121|Mexitil|brand
DDI-DrugBank.d633.s15|32-38|digoxin|drug
DDI-DrugBank.d633.s15|70-78|hydroxide|drug
DDI-DrugBank.d633.s15|133-139|Mexitil|brand
DDI-DrugBank.d633.s15|178-184|digoxin|drug
DDI-DrugBank.d633.s16|18-24|Mexitil|brand
DDI-DrugBank.d633.s16|33-44|theophylline|drug
DDI-DrugBank.d633.s16|75-86|theophylline|drug
DDI-DrugBank.d633.s17|99-110|theophylline|drug
DDI-DrugBank.d633.s18|91-97|Mexitil|brand
DDI-DrugBank.d633.s18|103-114|Theophylline|drug
DDI-DrugBank.d633.s18|200-206|Mexitil|brand
DDI-DrugBank.d633.s18|212-221|If Mexitil|brand
DDI-DrugBank.d633.s18|227-238|theophylline|drug
DDI-DrugBank.d633.s18|269-280|theophylline|drug
DDI-DrugBank.d633.s18|316-327|particularly|drug
DDI-DrugBank.d633.s18|338-344|Mexitil|brand
DDI-DrugBank.d633.s19|29-40|theophylline|drug
DDI-DrugBank.d633.s19|57-66|considered|drug
DDI-DrugBank.d633.s20|41-44|five|drug
DDI-DrugBank.d633.s20|99-106|caffeine|drug
DDI-DrugBank.d633.s20|158-164|Mexitil|brand
DDI-DrugBank.d757.s0|11-17|Alcohol|brand
DDI-DrugBank.d757.s0|20-22|Due|brand
DDI-DrugBank.d757.s0|55-57|CNS|brand
DDI-DrugBank.d757.s0|156-166|pentazocine|drug
DDI-MedLine.d166.s2|37-45|effective|drug
DDI-MedLine.d166.s3|8-15|AND AIMS|brand
DDI-MedLine.d166.s3|18-19|We|brand
DDI-MedLine.d166.s3|33-45|retrospective|drug
DDI-MedLine.d166.s3|130-131|SD|brand
DDI-MedLine.d166.s6|12-20|objective|drug
DDI-MedLine.d166.s6|82-95|responsiveness|drug
DDI-MedLine.d166.s7|14-22|objective|drug
DDI-MedLine.d166.s7|31-39|determine|drug
DDI-MedLine.d166.s7|92-94|PTH|brand
DDI-MedLine.d166.s8|9-11|PTH|brand
DDI-MedLine.d166.s13|11-18|remained|drug
DDI-MedLine.d166.s14|86-89|iron|drug_n
DDI-MedLine.d166.s14|103-111|vitamin D|group
DDI-MedLine.d166.s14|117-124|remained|drug
DDI-MedLine.d166.s15|15-17|PTH|brand
DDI-MedLine.d166.s16|34-36|PTH|brand
DDI-MedLine.d166.s17|13-15|PTH|brand
DDI-MedLine.d166.s18|66-73|critical|drug
DDI-DrugBank.d686.s0|0-12|Thiabendazole|drug
DDI-DrugBank.d686.s0|52-63|theophylline|drug
DDI-DrugBank.d686.s0|97-101|liver|drug
DDI-DrugBank.d686.s1|35-47|thiabendazole|drug
DDI-DrugBank.d686.s1|53-60|xanthine|drug
DDI-DrugBank.d686.s1|62-72|derivatives|group
DDI-DrugBank.d686.s1|77-87|anticipated|group
DDI-DrugBank.d631.s0|0-12|Pyrimethamine|drug
DDI-DrugBank.d631.s0|31-42|sulfonamides|group
DDI-DrugBank.d631.s0|45-51|quinine|drug
DDI-DrugBank.d631.s0|63-75|antimalarials|group
DDI-DrugBank.d631.s0|93-103|antibiotics|group
DDI-DrugBank.d631.s1|39-51|pyrimethamine|drug
DDI-DrugBank.d631.s3|60-68|lorazepam|drug
DDI-DrugBank.d631.s3|74-86|pyrimethamine|drug
DDI-MedLine.d218.s0|0-22|Antidepressant-warfarin|group
DDI-MedLine.d218.s1|60-67|warfarin|drug
DDI-MedLine.d218.s2|104-111|warfarin|drug
DDI-MedLine.d218.s3|47-60|antidepressant|group
DDI-MedLine.d218.s3|133-140|warfarin|drug
DDI-MedLine.d218.s4|127-134|warfarin|drug
DDI-MedLine.d218.s5|18-25|warfarin|drug
DDI-MedLine.d218.s5|69-76|warfarin|drug
DDI-MedLine.d218.s6|4-12|incidence|drug
DDI-MedLine.d218.s6|42-43|GI|brand
DDI-MedLine.d218.s6|60-67|warfarin|drug
DDI-MedLine.d218.s6|110-111|CI|brand
DDI-MedLine.d218.s8|0-7|Warfarin|drug
DDI-MedLine.d218.s8|122-123|CI|brand
DDI-MedLine.d218.s8|139-148|fluoxetine|drug
DDI-MedLine.d218.s8|170-171|CI|brand
DDI-MedLine.d218.s8|187-196|paroxetine|drug
DDI-MedLine.d218.s8|218-219|CI|brand
DDI-MedLine.d218.s8|235-247|amitriptyline|drug
DDI-MedLine.d218.s8|269-270|CI|brand
DDI-MedLine.d218.s9|5-15|mirtazapine|drug
DDI-MedLine.d218.s9|57-64|warfarin|drug
DDI-MedLine.d218.s9|89-90|GI|brand
DDI-MedLine.d218.s9|121-122|CI|brand
DDI-MedLine.d218.s10|0-7|Warfarin|drug
DDI-MedLine.d218.s10|41-50|fluoxetine|drug
DDI-MedLine.d218.s10|53-62|paroxetine|drug
DDI-MedLine.d218.s10|65-77|amitriptyline|drug
DDI-MedLine.d218.s10|83-93|mirtazapine|drug
DDI-MedLine.d218.s11|32-42|mirtazapine|drug
DDI-DrugBank.d599.s0|0-23|Excessive glucocorticoid|drug
DDI-DrugBank.d599.s0|83-84|GH|brand
DDI-DrugBank.d599.s1|14-17|ACTH|brand
DDI-DrugBank.d599.s1|48-73|glucocorticoid-replacement|drug
DDI-DrugBank.d599.s2|11-18|Nutropin|brand
DDI-DrugBank.d599.s2|75-88|glucocorticoid|drug
DDI-DrugBank.d599.s3|12-25|glucocorticoid|drug
DDI-DrugBank.d599.s3|78-85|Nutropin|brand
DDI-DrugBank.d599.s4|3-16|glucocorticoid|drug
DDI-DrugBank.d599.s4|47-60|glucocorticoid|drug
DDI-DrugBank.d599.s5|13-20|evidence|drug
DDI-DrugBank.d599.s5|51-58|Nutropin|brand
DDI-DrugBank.d599.s6|37-38|GH|brand
DDI-DrugBank.d599.s6|93-102|antipyrine|group
DDI-DrugBank.d599.s7|24-25|GH|brand
DDI-DrugBank.d599.s7|112-116|liver|drug
DDI-DrugBank.d599.s7|133-147|corticosteroids|drug
DDI-DrugBank.d599.s7|164-178|anticonvulsants|group
DDI-DrugBank.d599.s7|181-191|cyclosporin|drug
DDI-DrugBank.d599.s8|37-38|GH|brand
DDI-DrugBank.d599.s8|121-125|liver|drug
DDI-DrugBank.d783.s0|29-35|liver's|drug
DDI-DrugBank.d783.s0|78-88|terfenadine|drug
DDI-DrugBank.d783.s0|103-111|cisapride|drug
DDI-DrugBank.d783.s0|114-125|cyclosporine|drug
DDI-DrugBank.d783.s0|132-156|tricyclic antidepressants|group
DDI-DrugBank.d783.s1|62-65|side|drug
DDI-MedLine.d154.s0|55-63|Newcastle|brand
DDI-MedLine.d154.s0|93-100|vaccines|group
DDI-MedLine.d154.s2|4-12|objective|drug
DDI-MedLine.d154.s2|178-179|ND|brand
DDI-MedLine.d154.s2|185-186|AI|brand
DDI-MedLine.d154.s2|188-195|vaccines|group
DDI-MedLine.d154.s3|40-43|GSLS|brand
DDI-MedLine.d154.s3|69-70|BW|brand
DDI-MedLine.d154.s3|157-158|ND|brand
DDI-MedLine.d154.s3|160-166|vaccine|drug
DDI-MedLine.d154.s4|20-23|GSLS|brand
DDI-MedLine.d154.s4|53-60|antibody|group
DDI-MedLine.d154.s4|76-77|ND|brand
DDI-MedLine.d154.s5|37-40|GSLS|brand
DDI-MedLine.d154.s5|99-100|AI|brand
DDI-MedLine.d154.s5|102-109|vaccines|group
DDI-MedLine.d154.s5|134-141|antibody|group
DDI-MedLine.d154.s5|155-156|AI|brand
DDI-MedLine.d154.s6|0-10|Considering|drug
DDI-MedLine.d154.s6|26-29|GSLS|brand
DDI-MedLine.d154.s6|96-99|GSLS|brand
DDI-DrugBank.d774.s0|29-45|aminoglutethimide|drug
DDI-DrugBank.d641.s1|85-90|ALIMTA|brand
DDI-DrugBank.d641.s2|81-90|probenecid|drug
DDI-DrugBank.d641.s2|142-147|ALIMTA|brand
DDI-DrugBank.d641.s3|9-17|ibuprofen|drug
DDI-DrugBank.d641.s3|57-62|ALIMTA|brand
DDI-DrugBank.d641.s3|103-113|(creatinine|drug
DDI-DrugBank.d641.s3|182-190|ibuprofen|drug
DDI-DrugBank.d641.s3|210-215|ALIMTA|brand
DDI-DrugBank.d641.s3|271-281|(creatinine|drug
DDI-DrugBank.d641.s4|71-76|NSAIDs|brand
DDI-DrugBank.d641.s4|101-110|half-lives|group
DDI-DrugBank.d641.s4|194-199|ALIMTA|brand
DDI-DrugBank.d641.s5|63-68|ALIMTA|brand
DDI-DrugBank.d641.s5|74-79|NSAIDs|brand
DDI-DrugBank.d641.s5|93-102|half-lives|group
DDI-DrugBank.d641.s5|131-136|NSAIDs|brand
DDI-DrugBank.d641.s5|223-228|ALIMTA|brand
DDI-DrugBank.d641.s6|36-40|NSAID|brand
DDI-DrugBank.d641.s7|21-37|Interactions None|brand
DDI-MedLine.d169.s0|75-78|iron|drug_n
DDI-MedLine.d169.s1|100-103|iron|drug_n
DDI-MedLine.d169.s2|13-20|evidence|drug
DDI-MedLine.d169.s2|46-49|iron|drug_n
DDI-MedLine.d169.s3|4-12|objective|drug
DDI-MedLine.d169.s3|94-97|iron|drug_n
DDI-MedLine.d169.s4|55-65|participate|drug
DDI-MedLine.d169.s4|72-75|iron|drug_n
DDI-MedLine.d169.s4|102-105|iron|drug_n
DDI-MedLine.d169.s4|107-117|radioactive|drug
DDI-MedLine.d169.s5|96-99|iron|drug_n
DDI-MedLine.d169.s5|113-119|sulfate|drug
DDI-MedLine.d169.s6|97-100|iron|drug_n
DDI-MedLine.d169.s6|119-121|RBC|brand
DDI-MedLine.d169.s7|36-43|chloride|drug
DDI-MedLine.d169.s7|64-71|minerals|drug
DDI-MedLine.d169.s8|43-46|iron|drug_n
DDI-MedLine.d169.s9|60-63|iron|drug_n
DDI-MedLine.d169.s10|65-72|chloride|drug
DDI-MedLine.d169.s10|100-103|iron|drug_n
DDI-MedLine.d169.s10|129-135|sulfate|drug
DDI-MedLine.d169.s10|151-154|CRBC|brand
DDI-MedLine.d169.s10|157-160|iron|drug_n
DDI-DrugBank.d638.s0|25-35|hypotensive|drug
DDI-DrugBank.d638.s0|47-58|guanethidine|drug
DDI-DrugBank.d638.s1|28-33|agents|group
DDI-DrugBank.d638.s2|44-50|Ritalin|brand
DDI-DrugBank.d638.s2|82-104|coumarin anticoagulants|group
DDI-DrugBank.d638.s2|107-121|anticonvulsants|group
DDI-DrugBank.d638.s2|123-136|(phenobarbital|drug
DDI-DrugBank.d638.s2|190-198|tricyclic|drug
DDI-DrugBank.d638.s2|206-216|(imipramine|drug
DDI-DrugBank.d638.s2|219-230|clomipramine|drug
DDI-DrugBank.d638.s2|233-243|desipramine|drug
DDI-DrugBank.d638.s3|64-68|given|drug
DDI-DrugBank.d638.s3|89-95|Ritalin|brand
DDI-DrugBank.d638.s4|66-74|clonidine|drug
DDI-DrugBank.d638.s5|56-64|clonidine|drug
DDI-DrugBank.d638.s5|92-98|alpha-2|group
DDI-DrugBank.d638.s5|122-133|systemically|group
DDI-DrugBank.d769.s0|0-33|Coumarin-Derivative Anticoagulants|group
DDI-DrugBank.d769.s0|36-47|Prolongation|brand
DDI-DrugBank.d769.s0|92-107|Normalized Ratio|brand
DDI-DrugBank.d769.s0|151-157|ZOLINZA|brand
DDI-DrugBank.d769.s0|178-211|coumarin-derivative anticoagulants|group
DDI-DrugBank.d769.s1|36-37|PT|brand
DDI-DrugBank.d769.s1|43-45|INR|brand
DDI-DrugBank.d769.s1|85-91|ZOLINZA|brand
DDI-DrugBank.d769.s1|97-116|coumarin derivatives|group
DDI-DrugBank.d769.s2|6-20|HDAC Inhibitors|group
DDI-DrugBank.d769.s2|22-27|Severe|brand
DDI-DrugBank.d769.s2|119-125|ZOLINZA|brand
DDI-DrugBank.d769.s2|137-151|HDAC inhibitors|group
DDI-DrugBank.d728.s1|3-17|pharmacokinetic|drug
DDI-DrugBank.d728.s1|48-55|ELOXATIN|brand
DDI-DrugBank.d728.s1|72-75|5-FU|drug_n
DDI-DrugBank.d728.s2|13-16|5-FU|drug_n
DDI-DrugBank.d728.s2|104-111|ELOXATIN|brand
DDI-DrugBank.d761.s0|9-10|In|brand
DDI-DrugBank.d761.s0|84-90|XENICAL|brand
DDI-DrugBank.d761.s0|150-153|wine|drug
DDI-DrugBank.d761.s0|196-211|pharmacokinetics|group
DDI-DrugBank.d761.s0|266-273|systemic|group
DDI-DrugBank.d761.s1|0-11|Cyclosporine|drug
DDI-DrugBank.d761.s1|14-24|Preliminary|brand
DDI-DrugBank.d761.s1|38-44|XENICAL|brand
DDI-DrugBank.d761.s1|50-61|cyclosporine|drug
DDI-DrugBank.d761.s1|110-121|cyclosporine|drug
DDI-DrugBank.d761.s1|142-148|XENICAL|brand
DDI-DrugBank.d761.s1|174-185|cyclosporine|drug
DDI-DrugBank.d761.s2|0-6|Digoxin|drug
DDI-DrugBank.d761.s2|9-10|In|brand
DDI-DrugBank.d761.s2|48-54|XENICAL|brand
DDI-DrugBank.d761.s2|93-99|XENICAL|brand
DDI-DrugBank.d761.s2|119-134|pharmacokinetics|group
DDI-DrugBank.d761.s2|156-162|digoxin|drug
DDI-DrugBank.d761.s3|12-30|Vitamin Supplements|group
DDI-DrugBank.d761.s3|36-44|Analogues|brand
DDI-DrugBank.d761.s3|49-63|pharmacokinetic|drug
DDI-DrugBank.d761.s3|109-121|beta-carotene|group
DDI-DrugBank.d761.s3|182-188|XENICAL|brand
DDI-DrugBank.d761.s4|34-42|vitamin E|group
DDI-DrugBank.d761.s5|57-65|vitamin D|group
DDI-DrugBank.d761.s5|68-76|vitamin A|group
DDI-DrugBank.d761.s5|83-103|nutritionally-derived|drug
DDI-DrugBank.d761.s5|105-113|vitamin K|group
DDI-DrugBank.d761.s6|0-8|Glyburide|drug
DDI-DrugBank.d761.s6|11-12|In|brand
DDI-DrugBank.d761.s6|122-137|pharmacokinetics|group
DDI-DrugBank.d761.s6|187-195|glyburide|drug
DDI-DrugBank.d761.s7|0-9|Nifedipine|drug
DDI-DrugBank.d761.s7|39-40|In|brand
DDI-DrugBank.d761.s7|78-84|XENICAL|brand
DDI-DrugBank.d761.s7|123-129|XENICAL|brand
DDI-DrugBank.d761.s7|168-177|nifedipine|drug
DDI-DrugBank.d761.s8|5-18|Contraceptives|group
DDI-DrugBank.d761.s8|21-22|In|brand
DDI-DrugBank.d761.s8|75-81|XENICAL|brand
DDI-DrugBank.d761.s8|187-200|contraceptives|group
DDI-DrugBank.d761.s9|11-12|In|brand
DDI-DrugBank.d761.s9|50-56|XENICAL|brand
DDI-DrugBank.d761.s9|95-101|XENICAL|brand
DDI-DrugBank.d761.s9|121-136|pharmacokinetics|group
DDI-DrugBank.d761.s10|0-10|Pravastatin|drug
DDI-DrugBank.d761.s10|13-14|In|brand
DDI-DrugBank.d761.s10|68-87|hypercholesterolemic|drug
DDI-DrugBank.d761.s10|108-114|XENICAL|brand
DDI-DrugBank.d761.s10|153-159|XENICAL|brand
DDI-DrugBank.d761.s10|180-195|pharmacokinetics|group
DDI-DrugBank.d761.s10|200-210|pravastatin|drug
DDI-DrugBank.d761.s11|0-7|Warfarin|drug
DDI-DrugBank.d761.s11|10-11|In|brand
DDI-DrugBank.d761.s11|58-64|XENICAL|brand
DDI-DrugBank.d761.s11|142-149|warfarin|drug
DDI-DrugBank.d761.s11|151-166|pharmacokinetics|group
DDI-DrugBank.d761.s11|174-175|R-|brand
DDI-DrugBank.d761.s11|181-193|S-enantiomers|group
DDI-DrugBank.d761.s11|244-253|Factor VII|brand
DDI-DrugBank.d761.s12|52-60|vitamin K|group
DDI-DrugBank.d761.s12|101-107|XENICAL|brand
DDI-DrugBank.d761.s12|125-133|vitamin K|group
DDI-DrugBank.d761.s12|152-158|decline|drug
DDI-DrugBank.d761.s12|179-185|XENICAL|brand
DDI-DrugBank.d761.s13|14-22|vitamin K|group
DDI-DrugBank.d761.s13|57-63|XENICAL|brand
DDI-DrugBank.d761.s13|102-109|warfarin|drug
DDI-DrugBank.d761.s13|130-136|XENICAL|brand
DDI-DrugBank.d645.s0|28-32|liver|drug
DDI-DrugBank.d645.s0|57-67|terbinafine|drug
DDI-DrugBank.d645.s0|104-114|tolbutamide|drug
DDI-DrugBank.d645.s0|135-148|ethoxycoumarin|group
DDI-DrugBank.d645.s0|155-166|cyclosporine|drug
DDI-DrugBank.d645.s1|38-48|terbinafine|drug
DDI-DrugBank.d645.s1|59-73|CYP2D6-mediated|drug
DDI-DrugBank.d645.s2|48-60|predominantly|drug
DDI-DrugBank.d645.s2|98-122|tricyclic antidepressants|group
DDI-DrugBank.d645.s2|139-147|selective|drug
DDI-DrugBank.d645.s2|168-177|inhibitors|group
DDI-DrugBank.d645.s2|192-200|monoamine|drug
DDI-DrugBank.d645.s2|210-219|inhibitors|group
DDI-DrugBank.d645.s2|230-233|Type|brand
DDI-DrugBank.d645.s2|260-270|therapeutic|drug
DDI-DrugBank.d645.s3|89-99|terbinafine|drug
DDI-DrugBank.d645.s3|134-143|antipyrine|group
DDI-DrugBank.d645.s3|148-154|digoxin|drug
DDI-DrugBank.d645.s4|0-10|Terbinafine|drug
DDI-DrugBank.d645.s4|39-46|caffeine|drug
DDI-DrugBank.d645.s5|0-10|Terbinafine|drug
DDI-DrugBank.d645.s5|39-50|cyclosporine|drug
DDI-DrugBank.d645.s6|119-129|terbinafine|drug
DDI-DrugBank.d645.s6|135-142|warfarin|drug
DDI-DrugBank.d645.s6|184-190|LAMISIL|brand
DDI-DrugBank.d645.s7|0-10|Terbinafine|drug
DDI-DrugBank.d645.s7|99-108|cimetidine|drug
DDI-DrugBank.d645.s8|0-10|Terbinafine|drug
DDI-DrugBank.d645.s8|39-50|cyclosporine|drug
DDI-DrugBank.d645.s9|120-133|contraceptives|group
DDI-DrugBank.d645.s9|167-179|hypoglycemics|group
DDI-DrugBank.d645.s9|182-194|theophyllines|group
DDI-DrugBank.d645.s9|209-226|thiazide diuretics|group
DDI-DrugBank.d645.s9|229-232|beta|group
DDI-DrugBank.d645.s9|256-262|channel|drug_n
DDI-DrugBank.d576.s1|124-135|TOXIC LEVELS|brand
DDI-DrugBank.d576.s2|27-31|urine|drug
DDI-DrugBank.d576.s3|0-9|acidifying|drug
DDI-DrugBank.d576.s4|12-16|given|drug
DDI-DrugBank.d576.s4|37-49|anticoagulant|group
DDI-DrugBank.d576.s4|61-70|predispose|drug
DDI-DrugBank.d576.s4|75-82|systemic|group
DDI-DrugBank.d576.s5|28-39|hypoglycemic|group
DDI-DrugBank.d576.s5|56-67|antidiabetic|group
DDI-DrugBank.d576.s5|82-93|sulfonylurea|drug
DDI-DrugBank.d576.s6|78-87|penicillin|drug
DDI-DrugBank.d576.s6|102-110|thyroxine|drug
DDI-DrugBank.d576.s6|113-128|triiodothyronine|drug
DDI-DrugBank.d576.s6|168-175|warfarin|drug
DDI-DrugBank.d576.s6|205-219|corticosteroids|drug
DDI-DrugBank.d576.s7|22-44|Interactions Salicylate|brand
DDI-DrugBank.d576.s7|153-154|T4|brand
DDI-DrugBank.d666.s0|0-22|Catecholamine-depleting|drug
DDI-DrugBank.d666.s0|37-45|reserpine|drug
DDI-DrugBank.d666.s0|60-67|additive|drug
DDI-DrugBank.d666.s0|81-85|given|drug
DDI-DrugBank.d666.s0|92-111|beta-blocking agents|group
DDI-DrugBank.d666.s1|19-26|pindolol|drug
DDI-DrugBank.d666.s1|35-57|catecholamine-depleting|drug
DDI-DrugBank.d666.s1|108-115|evidence|drug
DDI-DrugBank.d666.s2|0-7|Pindolol|drug
DDI-DrugBank.d666.s2|41-63|antihypertensive agents|group
DDI-DrugBank.d666.s2|76-94|hydrochlorothiazide|drug
DDI-DrugBank.d666.s2|97-107|hydralazine|drug
DDI-DrugBank.d666.s2|114-125|guanethidine|drug
DDI-DrugBank.d666.s3|0-7|Pindolol|drug
DDI-DrugBank.d666.s3|42-53|thioridazine|drug
DDI-DrugBank.d666.s4|0-7|Pindolol|drug
DDI-DrugBank.d666.s5|8-19|anaphylactic|drug
DDI-DrugBank.d666.s5|31-35|While|brand
DDI-DrugBank.d666.s5|44-47|beta|group
DDI-DrugBank.d666.s5|93-104|anaphylactic|drug
DDI-DrugBank.d666.s5|153-160|reactive|drug
DDI-DrugBank.d666.s5|192-201|accidental|drug
DDI-DrugBank.d666.s5|204-213|diagnostic|drug
DDI-DrugBank.d666.s5|219-229|therapeutic|drug
DDI-DrugBank.d666.s6|21-32|unresponsive|drug
DDI-DrugBank.d666.s6|56-66|epinephrine|drug
DDI-DrugBank.d668.s0|129-131|CYP|brand
DDI-DrugBank.d668.s0|158-169|ketoconazole|drug
DDI-DrugBank.d668.s0|172-183|itraconazole|drug
DDI-DrugBank.d668.s0|186-197|erythromycin|drug
DDI-DrugBank.d668.s1|23-35|dexamethasone|drug
DDI-DrugBank.d668.s1|38-39|St|brand
DDI-DrugBank.d668.s2|9-12|Wort|brand
DDI-DrugBank.d668.s2|27-41|anticonvulsants|group
DDI-DrugBank.d668.s2|55-67|phenobarbital|drug
DDI-DrugBank.d668.s2|70-82|carbamazepine|drug
DDI-DrugBank.d668.s3|133-135|CYP|brand
DDI-DrugBank.d668.s5|93-95|CYP|brand
DDI-DrugBank.d668.s5|128-138|therapeutic|drug
DDI-DrugBank.d668.s5|162-167|agents|group
DDI-DrugBank.d741.s0|5-19|pharmacokinetic|drug
DDI-DrugBank.d741.s0|112-121|PEG-Intron|brand
DDI-DrugBank.d741.s0|203-205|AUC|brand
DDI-DrugBank.d741.s1|35-37|AUC|brand
DDI-DrugBank.d741.s3|78-85|narcotic|drug
DDI-DrugBank.d618.s0|19-26|Retavase|brand
DDI-DrugBank.d618.s0|42-53|cardioactive|drug
DDI-DrugBank.d618.s1|40-46|heparin|drug
DDI-DrugBank.d618.s1|52-60|vitamin K|group
DDI-DrugBank.d618.s1|146-154|abciximab|drug
DDI-DrugBank.d618.s1|225-232|Retavase|brand
DDI-DrugBank.d619.s0|152-161|selegiline|drug
DDI-DrugBank.d619.s0|167-176|meperidine|drug
DDI-DrugBank.d619.s2|38-47|meperidine|drug
DDI-DrugBank.d619.s2|53-57|MAOIs|brand
DDI-DrugBank.d619.s4|80-104|tricyclic antidepressants|group
DDI-DrugBank.d619.s4|110-117|ELDEPRYL|brand
DDI-DrugBank.d619.s4|123-131|selective|drug
DDI-DrugBank.d619.s4|152-161|inhibitors|group
DDI-DrugBank.d619.s4|167-174|ELDEPRYL|brand
DDI-DrugBank.d619.s5|12-23|hypertensive|drug
DDI-DrugBank.d619.s5|95-104|selegiline|drug
DDI-DrugBank.d619.s5|112-126|sympathomimetic|drug
DDI-DrugBank.d619.s5|139-148|(ephedrine|drug
DDI-MedLine.d184.s0|0-10|Amphetamine|drug
DDI-MedLine.d184.s1|71-78|dopamine|drug
DDI-MedLine.d184.s1|80-86|D2-like|brand
DDI-MedLine.d184.s2|4-12|objective|drug
DDI-MedLine.d184.s2|88-98|amphetamine|drug
DDI-MedLine.d184.s3|62-67|saline|drug
DDI-MedLine.d184.s3|97-99|P11|brand
DDI-MedLine.d184.s4|43-59|given amphetamine|drug
DDI-MedLine.d184.s4|74-79|saline|drug
DDI-MedLine.d184.s4|103-105|P35|brand
DDI-MedLine.d184.s4|110-112|P47|brand
DDI-MedLine.d184.s5|55-65|amphetamine|drug
DDI-MedLine.d184.s5|144-154|amphetamine|drug
DDI-MedLine.d184.s6|40-50|amphetamine|drug
DDI-MedLine.d184.s7|66-76|consecutive|drug
DDI-MedLine.d184.s7|97-107|amphetamine|drug
DDI-MedLine.d184.s7|122-127|saline|drug
DDI-MedLine.d184.s7|178-180|P40|brand
DDI-MedLine.d184.s8|65-82|amphetamine-paired|drug
DDI-MedLine.d184.s8|148-158|amphetamine|drug
DDI-MedLine.d184.s8|203-213|amphetamine|drug
DDI-MedLine.d184.s8|272-285|saline-treated|drug
DDI-MedLine.d184.s9|92-102|amphetamine|drug
DDI-DrugBank.d616.s0|21-27|ZADAXIN|brand
DDI-DrugBank.d616.s1|47-53|ZADAXIN|brand
DDI-DrugBank.d715.s0|44-49|DEMSER|brand
DDI-DrugBank.d715.s0|73-86|phenothiazines|group
DDI-DrugBank.d715.s0|204-216|catecholamine|drug
DDI-DrugBank.d715.s1|18-23|DEMSER|brand
DDI-DrugBank.d715.s1|47-49|CNS|brand
DDI-DrugBank.d715.s1|82-89|sedative|drug
DDI-DrugBank.d678.s0|29-42|adrenocortical|drug
DDI-DrugBank.d678.s0|68-81|corticosteroid|drug
DDI-DrugBank.d678.s0|146-155|Metopirone|drug_n
DDI-DrugBank.d678.s1|18-27|Metopirone|drug_n
DDI-DrugBank.d678.s4|0-9|Metopirone|drug_n
DDI-DrugBank.d678.s4|43-55|acetaminophen|drug
DDI-DrugBank.d678.s4|87-99|acetaminophen|drug
DDI-DrugBank.d650.s0|0-7|Dopamine|drug
DDI-DrugBank.d650.s0|34-61|neuroleptics (phenothiazines|group
DDI-DrugBank.d650.s0|80-92|thioxanthines|group
DDI-DrugBank.d650.s0|99-112|metoclopramide|drug
DDI-DrugBank.d650.s0|171-176|Permax|brand
DDI-DrugBank.d650.s0|181-188|dopamine|drug
DDI-DrugBank.d650.s1|6-11|agents|group
DDI-DrugBank.d650.s1|30-42|effectiveness|drug
DDI-DrugBank.d650.s1|47-52|Permax|brand
DDI-DrugBank.d650.s2|8-16|pergolide|drug
DDI-DrugBank.d650.s2|105-113|pergolide|drug
DDI-DrugBank.d654.s0|26-37|ketoconazole|drug
DDI-DrugBank.d654.s0|95-102|AUC(0-24|brand
DDI-DrugBank.d654.s0|109-112|Cmax|brand
DDI-DrugBank.d654.s1|11-18|systemic|group
DDI-DrugBank.d654.s1|126-136|unnecessary|drug_n
DDI-DrugBank.d654.s1|171-180|inhibitors|group
DDI-DrugBank.d654.s1|191-202|ketoconazole|drug
DDI-DrugBank.d654.s2|54-61|systemic|group
DDI-DrugBank.d654.s2|114-120|ALTABAX|brand
DDI-DrugBank.d654.s3|40-46|ALTABAX|brand
DDI-DrugBank.d726.s0|102-107|CYP1A2|brand
DDI-DrugBank.d726.s0|110-115|CYP2A6|brand
DDI-DrugBank.d726.s0|118-123|CYP2B6|brand
DDI-DrugBank.d726.s0|126-131|CYP2C8|brand
DDI-DrugBank.d726.s0|134-139|CYP2C9|drug
DDI-DrugBank.d726.s0|142-148|CYP2C19|brand
DDI-DrugBank.d726.s0|151-156|CYP2D6|drug
DDI-DrugBank.d726.s0|158-163|CYP2E1|brand
DDI-DrugBank.d726.s0|223-228|CYP2B6|brand
DDI-DrugBank.d726.s0|231-236|CYP2C9|drug
DDI-DrugBank.d726.s1|62-73|ketoconazole|drug
DDI-DrugBank.d726.s1|110-114|AUC0-|brand
DDI-DrugBank.d726.s1|120-124|Since|brand
DDI-DrugBank.d726.s1|177-188|ketoconazole|drug
DDI-DrugBank.d726.s1|309-320|ketoconazole|drug
DDI-DrugBank.d726.s1|347-356|inhibitors|group
DDI-DrugBank.d726.s1|368-377|atazanavir|drug
DDI-DrugBank.d726.s1|380-393|clarithromycin|drug
DDI-DrugBank.d726.s1|396-404|indinavir|drug
DDI-DrugBank.d726.s1|407-418|itraconazole|drug
DDI-DrugBank.d726.s1|421-430|nefazodone|drug
DDI-DrugBank.d726.s1|433-442|nelfinavir|drug
DDI-DrugBank.d726.s1|445-453|ritonavir|drug
DDI-DrugBank.d726.s1|456-465|saquinavir|drug
DDI-DrugBank.d726.s1|468-480|telithromycin|drug
DDI-DrugBank.d726.s1|485-496|voriconazole|drug
DDI-DrugBank.d726.s2|19-34|Zemplar Capsules|brand
DDI-DrugBank.d726.s2|209-220|ketoconazole|drug
DDI-DrugBank.d726.s3|55-62|vitamins|group
DDI-DrugBank.d726.s3|73-86|cholestyramine|drug
DDI-DrugBank.d726.s3|126-141|Zemplar Capsules|brand
DDI-MedLine.d163.s0|21-40|minocycline combined|drug
DDI-MedLine.d163.s0|47-56|fosfomycin|drug
DDI-MedLine.d163.s0|87-107|methicillin-resistant|drug
DDI-MedLine.d163.s0|109-122|Staphylococcus|brand
DDI-MedLine.d163.s1|54-73|minocycline combined|drug
DDI-MedLine.d163.s1|80-89|fosfomycin|drug
DDI-MedLine.d163.s1|111-131|methicillin-resistant|drug
DDI-MedLine.d163.s1|133-146|Staphylococcus|brand
DDI-MedLine.d163.s2|35-38|MRSA|brand
DDI-MedLine.d163.s2|61-67|Chinese|group
DDI-MedLine.d163.s3|61-62|IC|brand
DDI-MedLine.d163.s3|89-97|determine|drug
DDI-MedLine.d163.s3|107-116|antibiotic|group
DDI-MedLine.d163.s3|135-149|synergistically|drug
DDI-MedLine.d163.s4|31-41|minocycline|drug
DDI-MedLine.d163.s4|47-56|fosfomycin|drug
DDI-MedLine.d163.s5|80-90|synergistic|drug
DDI-MedLine.d163.s6|3-14|antagonistic|drug
DDI-MedLine.d163.s7|19-29|minocycline|drug
DDI-MedLine.d163.s7|35-44|fosfomycin|drug
DDI-MedLine.d163.s7|53-63|synergistic|drug
DDI-MedLine.d163.s7|73-76|MRSA|brand
DDI-MedLine.d163.s8|32-40|determine|drug
DDI-MedLine.d163.s8|103-125|therapeutic alternative|drug
DDI-MedLine.d163.s8|148-151|MRSA|brand
DDI-DrugBank.d630.s0|0-12|Methazolamide|drug
DDI-DrugBank.d630.s1|64-76|methazolamide|drug
DDI-DrugBank.d630.s1|226-235|inhibitors|group
DDI-MedLine.d164.s0|0-8|Lapatinib|drug
DDI-MedLine.d164.s0|38-55|antibody-dependent|group
DDI-MedLine.d164.s0|112-115|HER2|brand
DDI-MedLine.d164.s1|41-58|lapatinib combined|drug
DDI-MedLine.d164.s1|65-73|Herceptin|brand
DDI-MedLine.d164.s1|133-141|lapatinib|drug
DDI-MedLine.d164.s1|167-186|Herceptin-refractory|brand
DDI-MedLine.d164.s1|188-211|HER2-positive metastatic|drug
DDI-MedLine.d164.s1|264-280|antiproliferative|group
DDI-MedLine.d164.s1|328-333|agents|group
DDI-MedLine.d164.s2|17-25|lapatinib|drug
DDI-MedLine.d164.s2|42-50|Herceptin|brand
DDI-MedLine.d164.s2|55-67|HER2-positive|drug
DDI-MedLine.d164.s2|91-100|particular|drug
DDI-MedLine.d164.s2|111-147|Herceptin-mediated antibody-dependent|group
DDI-MedLine.d164.s3|22-30|lapatinib|drug
DDI-MedLine.d164.s3|40-43|HER2|brand
DDI-MedLine.d164.s3|79-91|HER2-positive|drug
DDI-MedLine.d164.s3|112-116|lines|group
DDI-MedLine.d164.s3|149-171|Herceptin-mediated ADCC|brand
DDI-MedLine.d164.s4|56-64|Herceptin|brand
DDI-MedLine.d164.s4|86-94|lapatinib|drug
DDI-MedLine.d164.s4|141-150|metastatic|drug
DDI-MedLine.d164.s4|162-174|HER2-positive|drug
DDI-MedLine.d164.s5|0-8|Lapatinib|drug
DDI-MedLine.d164.s5|44-63|Herceptin-refractory|brand
DDI-MedLine.d164.s5|68-86|Herceptin-sensitive|drug
DDI-MedLine.d164.s5|98-110|HER2-positive|drug
DDI-MedLine.d164.s5|177-180|HER2|brand
DDI-MedLine.d195.s0|13-20|piperine|drug
DDI-MedLine.d195.s0|25-33|ibuprofen|drug
DDI-MedLine.d195.s0|43-57|antinociception|group
DDI-MedLine.d195.s0|67-82|pharmacokinetics|group
DDI-MedLine.d195.s1|0-7|Piperine|drug
DDI-MedLine.d195.s1|36-43|obtained|drug
DDI-MedLine.d195.s1|50-54|Piper|brand
DDI-MedLine.d195.s3|39-46|piperine|drug
DDI-MedLine.d195.s4|21-28|piperine|drug
DDI-MedLine.d195.s4|84-98|antinociceptive|group
DDI-MedLine.d195.s4|112-120|ibuprofen|drug
DDI-MedLine.d195.s4|140-150|acetic acid|drug
DDI-MedLine.d195.s4|210-218|ibuprofen|drug
DDI-MedLine.d195.s5|0-8|Ibuprofen|drug
DDI-MedLine.d195.s5|80-87|piperine|drug
DDI-MedLine.d195.s6|4-30|synergistic antinociception|group
DDI-MedLine.d195.s6|44-52|ibuprofen|drug
DDI-MedLine.d195.s6|77-84|piperine|drug
DDI-MedLine.d195.s6|141-149|ibuprofen|drug
DDI-MedLine.d195.s7|41-48|piperine|drug
DDI-MedLine.d195.s7|90-98|ibuprofen|drug
DDI-DrugBank.d704.s0|10-21|Interactions|brand
DDI-DrugBank.d704.s0|24-26|The|brand
DDI-DrugBank.d704.s0|28-42|pharmacokinetic|drug
DDI-DrugBank.d704.s0|85-90|FLOMAX|brand
DDI-DrugBank.d704.s0|111-126|alpha-adrenergic|group
DDI-DrugBank.d704.s0|137-142|agents|group
DDI-DrugBank.d704.s0|158-167|determined|drug
DDI-DrugBank.d704.s1|42-47|FLOMAX|brand
DDI-DrugBank.d704.s1|65-67|NOT|brand
DDI-DrugBank.d704.s1|103-118|alpha-adrenergic|group
DDI-DrugBank.d704.s1|129-134|agents|group
DDI-DrugBank.d704.s2|4-18|pharmacokinetic|drug
DDI-DrugBank.d704.s2|40-49|cimetidine|drug
DDI-DrugBank.d704.s2|55-60|FLOMAX|brand
DDI-DrugBank.d704.s3|44-53|tamsulosin|drug
DDI-DrugBank.d704.s3|55-57|HCI|brand
DDI-DrugBank.d704.s3|88-90|AUC|brand
DDI-DrugBank.d704.s4|11-16|FLOMAX|brand
DDI-DrugBank.d704.s4|75-84|cimetidine|drug
DDI-DrugBank.d704.s4|87-98|particularly|drug
DDI-DrugBank.d704.s5|80-89|tamsulosin|drug
DDI-DrugBank.d704.s5|91-93|HCI|brand
DDI-DrugBank.d704.s5|99-106|warfarin|drug
DDI-DrugBank.d704.s5|112-123|inconclusive|drug
DDI-DrugBank.d704.s6|74-81|warfarin|drug
DDI-DrugBank.d704.s6|87-92|FLOMAX|brand
DDI-DrugBank.d758.s0|4-6|CNS|brand
DDI-DrugBank.d758.s0|40-52|hydrochloride|drug
DDI-DrugBank.d758.s0|61-68|additive|drug
DDI-DrugBank.d758.s0|89-91|CNS|brand
DDI-DrugBank.d637.s0|31-48|System Depressants|brand
DDI-DrugBank.d637.s0|51-53|The|brand
DDI-DrugBank.d637.s0|77-84|morphine|drug
DDI-DrugBank.d637.s0|127-129|CNS|brand
DDI-DrugBank.d637.s0|160-168|sedatives|drug_n
DDI-DrugBank.d637.s0|171-185|antihistaminics|group
DDI-DrugBank.d637.s1|7-18|neuroleptics|group
DDI-DrugBank.d637.s1|45-52|morphine|drug
DDI-DrugBank.d637.s2|42-58|Opioid Analgesics|brand
DDI-DrugBank.d637.s2|61-78|Agonist/antagonist|brand
DDI-DrugBank.d637.s2|98-108|pentazocine|drug
DDI-DrugBank.d637.s2|111-120|nalbuphine|drug
DDI-DrugBank.d637.s2|139-151|buprenorphine|drug
DDI-DrugBank.d637.s2|161-163|NOT|brand
DDI-DrugBank.d637.s2|202-209|received|drug
DDI-DrugBank.d720.s0|61-71|vasospastic|drug
DDI-DrugBank.d720.s1|19-29|theoretical|drug
DDI-DrugBank.d720.s1|63-70|additive|drug
DDI-DrugBank.d720.s1|80-100|ergotamine-containing|drug
DDI-DrugBank.d720.s1|134-150|dihydroergotamine|drug
DDI-DrugBank.d720.s1|155-166|methysergide|drug
DDI-DrugBank.d720.s1|173-183|sumatriptan|drug
DDI-DrugBank.d720.s1|225-231|avoided|drug
DDI-DrugBank.d720.s2|6-15|inhibitors|group
DDI-DrugBank.d720.s2|24-34|sumatriptan|drug
DDI-DrugBank.d720.s2|72-79|systemic|group
DDI-DrugBank.d720.s3|22-32|sumatriptan|drug
DDI-DrugBank.d720.s3|74-89|MAO-A inhibitors|group
DDI-DrugBank.d720.s3|112-120|Selective|drug
DDI-DrugBank.d720.s3|141-150|inhibitors|group
DDI-DrugBank.d720.s3|167-176|fluoxetine|drug
DDI-DrugBank.d720.s3|179-189|fluvoxamine|drug
DDI-DrugBank.d720.s3|192-201|paroxetine|drug
DDI-DrugBank.d720.s3|204-213|sertraline|drug
DDI-DrugBank.d720.s3|322-332|sumatriptan|drug
DDI-DrugBank.d720.s4|30-40|sumatriptan|drug
DDI-DrugBank.d720.s4|49-52|SSRI|brand
DDI-DrugBank.d656.s1|56-83|coumarin-type anticoagulants|group
DDI-DrugBank.d656.s1|104-131|coumarin-type anticoagulants|group
DDI-DrugBank.d656.s1|157-163|FELDENE|brand
DDI-DrugBank.d656.s1|291-297|FELDENE|brand
DDI-DrugBank.d656.s1|314-341|coumarin-type anticoagulants|group
DDI-DrugBank.d656.s2|90-96|FELDENE|brand
DDI-DrugBank.d656.s2|191-198|antacids|group
DDI-DrugBank.d656.s2|256-279|anti-inflammatory agents|group
DDI-DrugBank.d656.s2|292-298|FELDENE|brand
DDI-DrugBank.d656.s3|103-109|FELDENE|brand
DDI-DrugBank.d689.s0|14-25|particularly|drug
DDI-DrugBank.d689.s1|4-13|Inhibitors|group
DDI-DrugBank.d689.s1|17-19|The|brand
DDI-DrugBank.d689.s1|39-53|sympathomimetic|drug
DDI-DrugBank.d689.s1|63-68|amines|group
DDI-DrugBank.d689.s1|116-124|monoamine|drug
DDI-DrugBank.d689.s1|134-143|inhibitors|group
DDI-DrugBank.d689.s3|35-40|agents|group
DDI-DrugBank.d689.s3|69-93|tricyclic antidepressants|group
DDI-DrugBank.d744.s0|83-101|hypoglycemic agents|group
DDI-DrugBank.d744.s0|140-157|therapeutic agents|group
DDI-DrugBank.d744.s0|196-203|SOMAVERT|brand
DDI-DrugBank.d744.s1|117-121|IGF-I|brand
DDI-DrugBank.d694.s0|0-6|Digoxin|drug
DDI-DrugBank.d694.s0|9-13|There|brand
DDI-DrugBank.d694.s0|124-130|digoxin|drug
DDI-DrugBank.d694.s0|169-179|sitagliptin|drug
DDI-DrugBank.d694.s1|19-25|digoxin|drug
DDI-DrugBank.d694.s2|24-30|digoxin|drug
DDI-DrugBank.d694.s2|35-41|JANUVIA|brand
DDI-DrugBank.d782.s0|0-8|Vindesine|drug
DDI-DrugBank.d782.s0|70-74|Blood|brand
DDI-DrugBank.d782.s0|127-130|Bone|brand
DDI-DrugBank.d782.s0|205-213|Radiation|brand
DDI-DrugBank.d782.s0|254-263|Neurotoxic|brand
DDI-DrugBank.d782.s0|310-318|Phenytoin|brand
DDI-DrugBank.d782.s0|353-362|Live virus|drug
DDI-DrugBank.d782.s0|364-371|vaccines|group
DDI-DrugBank.d782.s0|412-424|vaccine virus|drug
DDI-DrugBank.d782.s0|444-447|side|drug
DDI-DrugBank.d782.s0|516-522|vaccine|drug
DDI-DrugBank.d782.s0|526-536|Mitomycin-C|drug
DDI-DrugBank.d782.s0|588-593|Killed|brand
DDI-DrugBank.d782.s0|595-599|virus|drug
DDI-DrugBank.d782.s0|601-608|vaccines|group
DDI-DrugBank.d782.s0|650-656|vaccine|drug
DDI-DrugBank.d640.s0|0-8|Diuretics|group
DDI-DrugBank.d640.s0|11-19|Excessive|drug
DDI-DrugBank.d640.s0|75-82|diuretic|group
DDI-DrugBank.d640.s0|97-110|ACE inhibitors|group
DDI-DrugBank.d640.s1|19-29|hypotensive|drug
DDI-DrugBank.d640.s1|44-50|UNIVASC|brand
DDI-DrugBank.d640.s1|89-96|diuretic|group
DDI-DrugBank.d640.s1|196-202|UNIVASC|brand
DDI-DrugBank.d640.s1|208-209|If|brand
DDI-DrugBank.d640.s1|254-261|moexpril|drug
DDI-DrugBank.d640.s2|10-20|Supplements|brand
DDI-DrugBank.d640.s2|26-52|Potassium-Sparing Diuretics|group
DDI-DrugBank.d640.s2|55-61|UNIVASC|brand
DDI-DrugBank.d640.s3|25-49|diuretics (spironolactone|drug_n
DDI-DrugBank.d640.s3|65-73|amiloride|drug
DDI-DrugBank.d640.s3|120-133|ACE inhibitors|group
DDI-DrugBank.d640.s4|38-43|agents|group
DDI-DrugBank.d640.s4|74-78|given|drug
DDI-DrugBank.d640.s5|5-18|Anticoagulants|group
DDI-DrugBank.d640.s5|21-31|Interaction|brand
DDI-DrugBank.d640.s5|46-53|warfarin|drug
DDI-DrugBank.d640.s5|65-72|identify|drug
DDI-DrugBank.d640.s5|141-153|anticoagulant|group
DDI-DrugBank.d640.s5|165-177|anticoagulant|group
DDI-DrugBank.d640.s6|9-17|Increased|brand
DDI-DrugBank.d640.s6|114-127|ACE inhibitors|group
DDI-DrugBank.d640.s8|5-12|diuretic|group
DDI-DrugBank.d640.s9|6-11|Agents|group
DDI-DrugBank.d640.s9|14-15|No|brand
DDI-DrugBank.d640.s9|38-52|pharmacokinetic|drug
DDI-DrugBank.d640.s9|81-87|UNIVASC|brand
DDI-DrugBank.d640.s9|128-146|hydrochlorothiazide|drug
DDI-DrugBank.d640.s9|149-155|digoxin|drug
DDI-DrugBank.d640.s9|161-170|cimetidine|drug
DDI-DrugBank.d640.s10|63-93|calcium-channel-blocking agents|group
DDI-DrugBank.d640.s10|96-104|diuretics|group
DDI-DrugBank.d640.s10|107-108|H2|brand
DDI-DrugBank.d640.s10|120-126|digoxin|drug
DDI-DrugBank.d640.s10|134-152|hypoglycemic agents|group
DDI-DrugBank.d640.s10|159-185|cholesterol-lowering agents|group
DDI-DrugBank.d640.s11|13-20|evidence|drug
DDI-DrugBank.d643.s0|67-72|NSAIDs|brand
DDI-DrugBank.d643.s0|104-114|fluvoxamine|drug
DDI-DrugBank.d643.s0|188-191|beta|group
DDI-DrugBank.d643.s0|235-244|fluoxetine|drug
DDI-DrugBank.d643.s0|258-266|psychotic|drug
DDI-DrugBank.d643.s0|451-458|additive|drug
DDI-DrugBank.d643.s0|486-494|incidence|drug
DDI-DrugBank.d643.s0|521-535|corticosteroids|drug
DDI-DrugBank.d643.s0|572-586|corticosteroids|drug
DDI-DrugBank.d643.s0|627-641|corticosteroids|drug
DDI-DrugBank.d742.s0|102-116|pharmacokinetic|drug
DDI-DrugBank.d742.s2|6-14|Affecting|brand
DDI-DrugBank.d742.s2|16-22|Hepatic|drug
DDI-DrugBank.d742.s2|24-37|Metabolism The|brand
DDI-DrugBank.d742.s2|54-69|pharmacokinetics|group
DDI-DrugBank.d742.s2|74-87|REMERON SolTab|brand
DDI-DrugBank.d742.s2|92-103|(mirtazapine|drug
DDI-DrugBank.d742.s2|106-126|Orally Disintegrating|brand
DDI-DrugBank.d742.s3|15-25|Metabolized|brand
DDI-DrugBank.d742.s3|37-54|Inhibit Cytochrome|brand
DDI-DrugBank.d742.s3|61-72|Enzymes Many|brand
DDI-DrugBank.d742.s4|33-43|mirtazapine|drug
DDI-DrugBank.d742.s5|39-49|mirtazapine|drug
DDI-DrugBank.d742.s5|121-131|mirtazapine|drug
DDI-DrugBank.d742.s5|309-322|REMERON SolTab|brand
DDI-DrugBank.d742.s6|45-54|definitive|drug
DDI-DrugBank.d742.s6|106-119|REMERON SolTab|brand
DDI-DrugBank.d742.s7|9-19|Concomitant|brand
DDI-DrugBank.d742.s7|109-119|mirtazapine|drug
DDI-DrugBank.d742.s8|27-35|cognitive|drug
DDI-DrugBank.d742.s8|66-72|REMERON|brand
DDI-DrugBank.d742.s8|94-101|additive|drug
DDI-DrugBank.d742.s9|70-83|REMERON SolTab|brand
DDI-DrugBank.d742.s9|86-93|Diazepam|drug
DDI-DrugBank.d742.s9|96-106|Concomitant|brand
DDI-DrugBank.d742.s9|126-133|diazepam|drug
DDI-DrugBank.d742.s9|184-194|mirtazapine|drug
DDI-DrugBank.d742.s10|52-58|REMERON|brand
DDI-DrugBank.d742.s10|81-88|additive|drug
DDI-DrugBank.d742.s10|111-118|diazepam|drug
DDI-DrugBank.d742.s11|49-56|diazepam|drug
DDI-DrugBank.d742.s11|95-108|REMERON SolTab|brand
DDI-DrugBank.d703.s0|39-56|System Depressants|brand
DDI-DrugBank.d703.s0|175-193|NARCOTIC ANALGESICS|brand
DDI-DrugBank.d703.s0|196-202|GENERAL|brand
DDI-DrugBank.d703.s0|204-214|ANESTHETICS|group
DDI-DrugBank.d703.s0|217-230|PHENOTHIAZINES|group
DDI-DrugBank.d703.s0|233-251|OTHER TRANQUILIZERS|brand
DDI-DrugBank.d703.s0|254-271|SEDATIVE-HYPNOTICS|group
DDI-DrugBank.d703.s0|284-295|BARBITURATES|group
DDI-DrugBank.d703.s0|299-323|TRICYCLIC ANTIDEPRESSANTS|group
DDI-DrugBank.d703.s0|335-349|CNS DEPRESSANTS|brand
DDI-DrugBank.d703.s0|362-368|ALCOHOL|brand
DDI-DrugBank.d703.s1|12-21|DEPRESSION|brand
DDI-DrugBank.d703.s1|24-34|HYPOTENSION|brand
DDI-DrugBank.d703.s1|67-76|MAY RESULT|brand
DDI-DrugBank.d732.s0|59-62|iron|drug_n
DDI-DrugBank.d732.s1|27-40|systematically|drug
DDI-DrugBank.d732.s2|30-35|CHEMET|brand
DDI-DrugBank.d732.s2|75-78|CaNa|brand
DDI-DrugBank.d732.s2|82-85|EDTA|brand
DDI-DrugBank.d732.s3|16-32|Tests Interaction|brand
DDI-DrugBank.d732.s3|35-42|Succimer|brand
DDI-DrugBank.d732.s4|52-59|positive|drug
DDI-DrugBank.d732.s4|84-88|urine|drug
DDI-DrugBank.d732.s4|96-117|nitroprusside reagents|group
DDI-DrugBank.d732.s4|127-134|Ketostix|brand
DDI-DrugBank.d732.s4|197-199|CPK|brand
DDI-MedLine.d190.s0|71-78|delivery|drug
DDI-MedLine.d190.s0|83-86|AAV2|brand
DDI-MedLine.d190.s1|3-11|determine|drug
DDI-MedLine.d190.s1|133-140|delivery|drug
DDI-MedLine.d190.s1|162-168|virus-2|drug
DDI-MedLine.d190.s2|126-134|delivered|drug
DDI-MedLine.d190.s2|245-254|heparinase|drug
DDI-MedLine.d190.s2|256-258|III|brand
DDI-MedLine.d190.s2|276-278|ABC|brand
DDI-MedLine.d190.s3|41-48|examined|drug
DDI-MedLine.d190.s3|54-56|GFP|brand
DDI-MedLine.d190.s5|16-25|heparinase|drug
DDI-MedLine.d190.s5|27-29|III|brand
DDI-MedLine.d190.s5|46-48|ABC|brand
DDI-MedLine.d190.s6|58-68|ineffective|drug
DDI-MedLine.d190.s7|19-26|survived|drug
DDI-MedLine.d190.s7|58-67|heparinase|drug
DDI-MedLine.d190.s7|69-71|III|brand
DDI-MedLine.d190.s7|89-91|ABC|brand
DDI-MedLine.d190.s8|66-75|heparinase|drug
DDI-MedLine.d190.s8|77-79|III|brand
DDI-MedLine.d190.s8|96-98|ABC|brand
DDI-MedLine.d190.s9|100-109|delivering|drug
DDI-MedLine.d190.s9|136-140|inner|drug_n
DDI-DrugBank.d779.s0|35-50|antihypertensive|group
DDI-DrugBank.d779.s0|75-90|antihypertensive|group
DDI-DrugBank.d779.s1|48-51|side|drug
DDI-DrugBank.d779.s2|38-48|anesthetics|group
DDI-DrugBank.d779.s4|32-40|sensitive|drug
DDI-DrugBank.d779.s5|32-36|given|drug
DDI-DrugBank.d779.s6|30-41|preparations|group
DDI-DrugBank.d779.s7|109-115|sulfate|drug
DDI-DrugBank.d779.s9|44-50|sulfate|drug
DDI-DrugBank.d779.s10|0-8|Monoamine|drug
DDI-DrugBank.d779.s10|24-33|inhibitors|group
DDI-DrugBank.d779.s10|36-56|See CONTRAINDICATIONS|brand
DDI-DrugBank.d779.s11|21-43|Interactions Methyldopa|brand
DDI-DrugBank.d779.s11|136-145|creatinine|drug
DDI-DrugBank.d779.s11|154-161|alkaline|drug
DDI-DrugBank.d779.s11|183-186|SGOT|brand
DDI-DrugBank.d779.s12|49-52|SGOT|brand
DDI-DrugBank.d779.s13|40-44|urine|drug
DDI-DrugBank.d779.s13|82-95|catecholamines|group
DDI-DrugBank.d779.s13|129-142|catecholamines|group
DDI-DrugBank.d779.s16|50-52|VMA|brand
DDI-DrugBank.d779.s16|139-141|VMA|brand
DDI-DrugBank.d779.s18|13-17|urine|drug
DDI-MedLine.d201.s0|0-8|Antitumor|group
DDI-MedLine.d201.s0|21-26|CRM197|brand
DDI-MedLine.d201.s0|53-58|HB-EGF|brand
DDI-MedLine.d201.s0|64-69|T-cell|brand
DDI-MedLine.d201.s0|77-89|lymphoblastic|drug
DDI-MedLine.d201.s1|4-14|therapeutic|drug
DDI-MedLine.d201.s1|28-33|T-cell|brand
DDI-MedLine.d201.s1|41-53|lymphoblastic|drug
DDI-MedLine.d201.s3|25-49|heparin-binding epidermal|drug
DDI-MedLine.d201.s3|110-112|EGF|brand
DDI-MedLine.d201.s4|56-61|HB-EGF|brand
DDI-MedLine.d201.s4|68-78|therapeutic|drug
DDI-MedLine.d201.s4|91-95|T-ALL|brand
DDI-MedLine.d201.s4|113-121|elucidate|drug
DDI-MedLine.d201.s4|127-135|antitumor|group
DDI-MedLine.d201.s4|172-177|HB-EGF|brand
DDI-MedLine.d201.s5|3-12|elucidated|drug
DDI-MedLine.d201.s5|32-37|HB-EGF|brand
DDI-MedLine.d201.s5|42-46|T-ALL|brand
DDI-MedLine.d201.s5|53-57|lines|group
DDI-MedLine.d201.s5|88-93|CRM197|brand
DDI-MedLine.d201.s5|139-148|anticancer|group
DDI-MedLine.d201.s6|18-21|EGFR|brand
DDI-MedLine.d201.s6|27-30|EGFR|brand
DDI-MedLine.d201.s6|44-53|determined|drug
DDI-MedLine.d201.s6|74-79|RT-PCR|brand
DDI-MedLine.d201.s6|95-106|quantitative|group
DDI-MedLine.d201.s6|108-110|PCR|brand
DDI-MedLine.d201.s7|39-43|TUNEL|brand
DDI-MedLine.d201.s8|33-37|T-ALL|brand
DDI-MedLine.d201.s8|44-48|lines|group
DDI-MedLine.d201.s8|78-83|HB-EGF|brand
DDI-MedLine.d201.s8|89-92|EGFR|brand
DDI-MedLine.d201.s8|110-120|doxorubicin|drug
DDI-MedLine.d201.s9|62-67|CRM197|brand
DDI-MedLine.d201.s9|74-84|doxorubicin|drug
DDI-MedLine.d201.s9|113-117|T-ALL|brand
DDI-MedLine.d201.s9|124-127|line|drug
DDI-MedLine.d201.s10|27-32|HB-EGF|brand
DDI-MedLine.d201.s10|49-59|therapeutic|drug
DDI-MedLine.d201.s10|72-76|T-ALL|brand
DDI-DrugBank.d721.s0|23-28|SKELID|brand
DDI-DrugBank.d721.s0|76-81|SKELID|brand
DDI-DrugBank.d721.s0|168-175|antacids|group
DDI-DrugBank.d721.s0|210-215|SKELID|brand
DDI-DrugBank.d721.s1|40-45|SKELID|brand
DDI-DrugBank.d721.s1|85-90|SKELID|brand
DDI-DrugBank.d721.s2|23-28|SKELID|brand
DDI-DrugBank.d721.s2|124-133|diclofenac|drug
DDI-DrugBank.d721.s3|4-18|pharmacokinetic|drug
DDI-DrugBank.d721.s3|34-40|digoxin|drug
DDI-DrugBank.d721.s3|76-81|SKELID|brand
DDI-DrugBank.d721.s4|27-37|tiludronate|drug
DDI-DrugBank.d721.s4|57-64|warfarin|drug
DDI-DrugBank.d747.s0|0-11|Tetracycline|drug
DDI-DrugBank.d747.s0|16-40|bacteriostatic antibiotic|group
DDI-DrugBank.d747.s0|62-73|bactericidal|drug
DDI-DrugBank.d747.s0|85-94|penicillin|drug
DDI-DrugBank.d747.s0|140-146|avoided|drug
DDI-DrugBank.d771.s0|81-91|scopolamine|drug
DDI-DrugBank.d771.s1|0-10|Scopolamine|drug
DDI-DrugBank.d771.s1|96-98|CNS|brand
DDI-DrugBank.d771.s1|116-124|sedatives|drug_n
DDI-DrugBank.d771.s2|77-91|anticholinergic|group
DDI-DrugBank.d771.s3|12-21|belladonna|drug_n
DDI-DrugBank.d771.s3|34-47|antihistamines|group
DDI-DrugBank.d771.s3|60-68|meclizine|drug
DDI-DrugBank.d771.s3|72-96|tricyclic antidepressants|group
DDI-DrugBank.d771.s4|11-27|Test Interactions|brand
DDI-DrugBank.d771.s4|29-39|Scopolamine|drug
DDI-DrugBank.d628.s0|35-42|DIPRIVAN|brand
DDI-DrugBank.d628.s0|55-62|Emulsion|brand
DDI-DrugBank.d628.s0|140-151|particularly|drug
DDI-DrugBank.d628.s0|158-166|narcotics|group
DDI-DrugBank.d628.s0|173-180|morphine|drug
DDI-DrugBank.d628.s0|183-192|meperidine|drug
DDI-DrugBank.d628.s1|32-40|sedatives|drug_n
DDI-DrugBank.d628.s1|47-61|benzodiazepines|group
DDI-DrugBank.d628.s1|64-75|barbiturates|group
DDI-DrugBank.d628.s2|6-11|agents|group
DDI-DrugBank.d628.s2|30-39|anesthetic|drug
DDI-DrugBank.d628.s2|44-51|sedative|drug
DDI-DrugBank.d628.s2|64-71|DIPRIVAN|brand
DDI-DrugBank.d628.s2|84-91|Emulsion|brand
DDI-DrugBank.d628.s3|58-65|DIPRIVAN|brand
DDI-DrugBank.d628.s3|78-85|Emulsion|brand
DDI-DrugBank.d628.s3|239-244|agents|group
DDI-DrugBank.d628.s3|259-263|oxide|drug
DDI-DrugBank.d628.s4|53-58|agents|group
DDI-DrugBank.d628.s4|127-134|DIPRIVAN|brand
DDI-DrugBank.d628.s4|147-154|Emulsion|brand
DDI-DrugBank.d628.s4|169-179|extensively|drug
DDI-DrugBank.d628.s5|19-24|agents|group
DDI-DrugBank.d628.s5|63-72|anesthetic|drug
DDI-DrugBank.d628.s5|77-84|sedative|drug
DDI-DrugBank.d628.s5|119-126|DIPRIVAN|brand
DDI-DrugBank.d628.s5|139-146|Emulsion|brand
DDI-DrugBank.d628.s6|20-27|Emulsion|brand
DDI-DrugBank.d628.s6|163-168|agents|group
DDI-DrugBank.d628.s6|175-189|succinylcholine|drug
DDI-DrugBank.d628.s7|167-172|agents|group
DDI-DrugBank.d628.s7|185-190|agents|group
DDI-DrugBank.d628.s7|203-219|anesthetic agents|group
DDI-MedLine.d199.s0|71-78|ketamine|drug
DDI-MedLine.d199.s1|46-49|side|drug
DDI-MedLine.d199.s2|3-17|retrospectively|drug
DDI-MedLine.d199.s2|77-84|received|drug
DDI-MedLine.d199.s2|95-102|ketamine|drug
DDI-MedLine.d199.s3|70-73|TIVA|brand
DDI-MedLine.d199.s3|118-128|anesthetics|group
DDI-MedLine.d199.s3|161-168|ketamine|drug
DDI-MedLine.d199.s4|51-58|ketamine|drug
DDI-MedLine.d199.s4|115-116|EA|brand
DDI-MedLine.d199.s4|148-149|EA|brand
DDI-MedLine.d199.s4|165-168|TIVA|brand
DDI-DrugBank.d608.s0|24-31|warfarin|drug
DDI-DrugBank.d608.s1|95-102|TOLECTIN|brand
DDI-DrugBank.d608.s1|108-115|warfarin|drug
DDI-DrugBank.d608.s2|58-65|TOLECTIN|brand
DDI-DrugBank.d608.s2|82-95|anticoagulants|group
DDI-DrugBank.d608.s3|9-16|diabetic|drug
DDI-DrugBank.d608.s3|55-67|sulfonylureas|group
DDI-DrugBank.d608.s3|133-140|TOLECTIN|brand
DDI-DrugBank.d608.s3|149-167|hypoglycemic agents|group
DDI-DrugBank.d608.s4|26-33|TOLECTIN|brand
DDI-DrugBank.d608.s5|32-48|anti-inflammatory|group
DDI-DrugBank.d608.s6|11-23|Tests Because|brand
DDI-DrugBank.d608.s6|33-34|GI|brand
DDI-DrugBank.d770.s0|6-10|Spray|brand
DDI-DrugBank.d770.s0|13-18|Formal|brand
DDI-DrugBank.d770.s0|72-81|Calcitonin|brand
DDI-DrugBank.d770.s1|53-62|Calcitonin|brand
DDI-DrugBank.d770.s2|37-46|Calcitonin|brand
DDI-DrugBank.d770.s4|26-40|Paget's Disease|brand
DDI-DrugBank.d770.s4|88-102|anti-resorptive|group
DDI-DrugBank.d770.s4|116-125|Calcitonin|brand
DDI-DrugBank.d651.s0|5-16|Interactions|brand
DDI-DrugBank.d651.s0|19-23|Women|brand
DDI-DrugBank.d651.s0|33-46|contraceptives|group
DDI-DrugBank.d651.s0|92-100|vitamin A|group
DDI-DrugBank.d665.s0|29-54|bacteriostatic antibiotics|group
DDI-DrugBank.d665.s0|63-74|erythromycin|drug
DDI-DrugBank.d665.s0|77-88|tetracycline|drug
DDI-DrugBank.d665.s0|108-119|bactericidal|drug
DDI-DrugBank.d665.s0|132-142|penicillins|group
DDI-DrugBank.d665.s1|0-18|Bactericidal agents|group
DDI-DrugBank.d665.s1|30-40|effectively|drug
DDI-DrugBank.d665.s4|65-74|''static''|drug
DDI-DrugBank.d665.s4|80-86|''cidal|drug
DDI-DrugBank.d665.s4|91-101|antibiotics|group
DDI-DrugBank.d665.s5|97-116|antibacterial agents|group
DDI-DrugBank.d665.s5|122-130|beginning|drug_n
DDI-DrugBank.d665.s5|132-141|penicillin|drug
DDI-DrugBank.d665.s6|0-9|Penicillin|drug
DDI-DrugBank.d665.s6|73-82|probenecid|drug
DDI-DrugBank.d665.s6|128-138|penicillins|group
DDI-DrugBank.d665.s7|16-25|penicillin|drug
DDI-DrugBank.d665.s7|92-101|penicillin|drug
DDI-DrugBank.d734.s0|0-17|Thiazide diuretics|group
DDI-DrugBank.d734.s0|38-48|orthostatic|drug
DDI-DrugBank.d734.s0|82-95|phenothiazines|group
DDI-DrugBank.d734.s1|0-15|Antihypertensive|group
DDI-DrugBank.d734.s1|28-39|guanethidine|drug
DDI-DrugBank.d734.s1|88-101|phenothiazines|group
DDI-DrugBank.d734.s2|30-40|propranolol|drug
DDI-DrugBank.d734.s2|47-60|phenothiazines|group
DDI-DrugBank.d624.s0|23-26|TOBI|brand
DDI-DrugBank.d624.s0|45-48|TOBI|brand
DDI-DrugBank.d624.s0|97-105|Genentech|brand
DDI-DrugBank.d624.s0|109-123|(beta)-agonists|group
DDI-DrugBank.d624.s0|134-148|corticosteroids|drug
DDI-DrugBank.d624.s0|157-184|anti-pseudomonal antibiotics|group
DDI-DrugBank.d624.s0|201-215|aminoglycosides|group
DDI-DrugBank.d624.s1|36-39|TOBI|brand
DDI-DrugBank.d624.s1|106-112|avoided|drug
DDI-DrugBank.d624.s2|5-13|diuretics|group
DDI-DrugBank.d624.s2|27-40|aminoglycoside|drug
DDI-DrugBank.d624.s2|63-72|antibiotic|group
DDI-DrugBank.d624.s3|68-77|furosemide|drug
DDI-DrugBank.d624.s3|80-83|urea|drug
DDI-DrugBank.d624.s3|89-96|mannitol|drug_n
DDI-DrugBank.d609.s0|16-21|CYP2C8|brand
DDI-DrugBank.d609.s0|62-64|AUC|brand
DDI-DrugBank.d609.s0|69-81|rosiglitazone|drug
DDI-DrugBank.d609.s0|101-106|CYP2C8|brand
DDI-DrugBank.d609.s0|144-146|AUC|brand
DDI-DrugBank.d609.s0|151-163|rosiglitazone|drug
DDI-DrugBank.d609.s1|44-49|CYP2C8|brand
DDI-DrugBank.d609.s1|95-107|rosiglitazone|drug
DDI-DrugBank.d648.s0|0-13|Cholestyramine|drug
DDI-DrugBank.d648.s0|16-29|Cholestyramine|drug
DDI-DrugBank.d648.s0|76-96|enterohepatic cycling|drug
DDI-DrugBank.d648.s0|150-155|EVISTA|brand
DDI-DrugBank.d648.s1|0-7|Warfarin|drug
DDI-DrugBank.d648.s1|10-12|The|brand
DDI-DrugBank.d648.s1|34-39|EVISTA|brand
DDI-DrugBank.d648.s1|45-52|warfarin|drug
DDI-DrugBank.d648.s3|3-8|EVISTA|brand
DDI-DrugBank.d648.s3|13-17|given|drug
DDI-DrugBank.d648.s3|37-44|warfarin|drug
DDI-DrugBank.d648.s4|13-31|Protein-Bound Drugs|brand
DDI-DrugBank.d648.s4|34-43|Raloxifene|brand
DDI-DrugBank.d648.s5|51-58|warfarin|drug
DDI-DrugBank.d648.s6|28-33|EVISTA|brand
DDI-DrugBank.d648.s6|136-144|ibuprofen|drug
DDI-DrugBank.d648.s6|147-154|diazepam|drug
DDI-DrugBank.d648.s6|161-169|diazoxide|drug
DDI-DrugBank.d648.s7|9-29|CLINICAL PHARMACOLOGY|brand
DDI-DrugBank.d648.s7|32-53|Drug-Drug Interactions|brand
DDI-DrugBank.d762.s0|0-9|Probenecid|drug
DDI-DrugBank.d762.s0|39-44|active|drug
DDI-DrugBank.d762.s1|12-24|statistically|drug
DDI-DrugBank.d762.s1|104-111|systemic|group
DDI-DrugBank.d762.s2|35-44|probenecid|drug
DDI-DrugBank.d762.s3|9-16|evidence|drug
DDI-DrugBank.d762.s3|77-90|subtherapeutic|drug
DDI-DrugBank.d762.s3|99-110|(therapeutic|drug
DDI-DrugBank.d762.s3|118-127|considered|drug
DDI-DrugBank.d611.s0|6-9|beta|group
DDI-DrugBank.d611.s0|30-44|bronchodilators|group
DDI-DrugBank.d611.s0|84-90|Alupent|brand
DDI-DrugBank.d611.s0|111-117|sulfate|drug
DDI-DrugBank.d611.s0|119-121|USP|brand
DDI-DrugBank.d611.s0|146-153|additive|drug
DDI-DrugBank.d611.s1|0-3|Beta|group
DDI-DrugBank.d611.s1|92-100|monoamine|drug
DDI-DrugBank.d611.s1|110-119|inhibitors|group
DDI-DrugBank.d611.s1|124-148|tricyclic antidepressants|group
DDI-DrugBank.d611.s1|171-174|beta|group
DDI-DrugBank.d661.s0|5-16|Interactions|brand
DDI-DrugBank.d661.s0|19-21|The|brand
DDI-DrugBank.d661.s0|30-36|ZEMURON|brand
DDI-DrugBank.d661.s0|53-59|bromide|drug
DDI-DrugBank.d661.s0|62-70|Injection|brand
DDI-DrugBank.d661.s0|79-93|succinylcholine|drug
DDI-DrugBank.d661.s0|139-142|side|drug
DDI-DrugBank.d661.s0|155-169|succinylcholine|drug
DDI-DrugBank.d661.s1|3-9|ZEMURON|brand
DDI-DrugBank.d661.s1|58-72|succinylcholine|drug
DDI-DrugBank.d661.s1|92-96|given|drug
DDI-DrugBank.d661.s1|118-132|succinylcholine|drug
DDI-DrugBank.d661.s2|33-39|ZEMURON|brand
DDI-DrugBank.d661.s2|91-105|succinylcholine|drug
DDI-DrugBank.d661.s3|33-47|succinylcholine|drug
DDI-DrugBank.d661.s4|55-61|ZEMURON|brand
DDI-DrugBank.d661.s6|16-32|Test Interactions|brand
DDI-DrugBank.d661.s6|41-44|None|brand
DDI-DrugBank.d763.s0|0-10|Ondansetron|drug
DDI-DrugBank.d763.s0|71-75|P-450|brand
DDI-DrugBank.d763.s0|116-120|liver|drug
DDI-DrugBank.d763.s1|8-18|ondansetron|drug
DDI-DrugBank.d763.s1|38-44|hepatic|drug
DDI-DrugBank.d763.s1|57-61|P-450|brand
DDI-DrugBank.d763.s1|98-103|CYP2D6|drug
DDI-DrugBank.d763.s1|106-111|CYP1A2|brand
DDI-DrugBank.d763.s1|127-136|inhibitors|group
DDI-DrugBank.d763.s1|209-219|ondansetron|drug
DDI-DrugBank.d763.s3|11-23|Carbamazepine|drug
DDI-DrugBank.d763.s3|30-39|Rifampicin|drug
DDI-DrugBank.d763.s3|42-43|In|brand
DDI-DrugBank.d763.s3|111-123|carbamazepine|drug
DDI-DrugBank.d763.s3|130-139|rifampicin|drug
DDI-DrugBank.d763.s3|160-170|ondansetron|drug
DDI-DrugBank.d763.s3|204-214|ondansetron|drug
DDI-DrugBank.d763.s4|66-76|ondansetron|drug
DDI-DrugBank.d763.s4|126-133|Tramadol|brand
DDI-DrugBank.d763.s4|136-143|Although|brand
DDI-DrugBank.d763.s4|148-162|pharmacokinetic|drug
DDI-DrugBank.d763.s4|189-199|ondansetron|drug
DDI-DrugBank.d763.s4|273-283|ondansetron|drug
DDI-DrugBank.d763.s4|374-385|Chemotherapy|brand
DDI-DrugBank.d763.s4|388-392|Tumor|brand
DDI-DrugBank.d763.s4|472-482|ondansetron|drug
DDI-DrugBank.d763.s5|11-20|carmustine|drug
DDI-DrugBank.d763.s5|23-31|etoposide|drug
DDI-DrugBank.d763.s5|66-81|pharmacokinetics|group
DDI-DrugBank.d763.s5|86-96|ondansetron|drug
DDI-DrugBank.d763.s6|47-49|I.V|brand
DDI-DrugBank.d763.s7|0-10|ondansetron|drug
DDI-DrugBank.d712.s0|66-74|HERCEPTIN|brand
DDI-DrugBank.d712.s1|49-57|HERCEPTIN|brand
DDI-DrugBank.d712.s1|94-102|HERCEPTIN|brand
DDI-DrugBank.d712.s1|173-181|HERCEPTIN|brand
DDI-DrugBank.d709.s0|48-63|Vasoconstrictive|drug
DDI-DrugBank.d709.s1|48-58|Terfenadine|drug
DDI-DrugBank.d709.s1|76-82|Certain|brand
DDI-DrugBank.d709.s1|84-93|macrolides|group
DDI-DrugBank.d709.s1|109-119|terfenadine|drug
DDI-DrugBank.d709.s3|56-68|roxithromycin|drug
DDI-DrugBank.d709.s3|101-113|roxithromycin|drug
DDI-DrugBank.d709.s3|120-130|terfenadine|drug
DDI-DrugBank.d709.s4|2-10|Cisapride|drug
DDI-DrugBank.d709.s4|13-20|pimozide|drug
DDI-DrugBank.d709.s4|23-27|Other|brand
DDI-DrugBank.d709.s4|43-51|cisapride|drug
DDI-DrugBank.d709.s4|56-63|pimozide|drug
DDI-DrugBank.d709.s4|91-97|hepatic|drug
DDI-DrugBank.d709.s4|140-141|QT|brand
DDI-DrugBank.d709.s4|310-319|inhibitors|group
DDI-DrugBank.d709.s4|352-375|macrolide antibacterials|group
DDI-DrugBank.d709.s5|41-53|roxithromycin|drug
DDI-DrugBank.d709.s5|71-83|roxithromycin|drug
DDI-DrugBank.d636.s0|5-19|anticonvulsants|group
DDI-DrugBank.d636.s0|39-49|Mephenytoin|brand
DDI-DrugBank.d636.s1|51-61|Mephenytoin|brand
DDI-DrugBank.d636.s2|6-20|anticonvulsants|group
DDI-DrugBank.d636.s2|68-80|phenobarbital|drug
DDI-DrugBank.d636.s3|96-103|warfarin|drug
DDI-DrugBank.d636.s3|120-128|medicines|group
DDI-DrugBank.d636.s3|152-175|anti-infective medicines|group
DDI-DrugBank.d636.s3|178-187|furosemide|drug
DDI-DrugBank.d636.s3|193-204|theophylline|drug
DDI-DrugBank.d636.s3|206-211|Please|brand
DDI-DrugBank.d636.s3|223-233|Mephenytoin|brand
DDI-DrugBank.d777.s0|19-27|Streptase|brand
DDI-DrugBank.d777.s0|30-42|Streptokinase|brand
DDI-DrugBank.d777.s1|7-20|Anticoagulants|group
DDI-DrugBank.d777.s1|26-44|Antiplatelet Agents|group
DDI-DrugBank.d777.s1|49-57|Streptase|brand
DDI-DrugBank.d777.s1|60-72|Streptokinase|brand
DDI-DrugBank.d777.s1|104-122|antiplatelet agents|group
DDI-DrugBank.d777.s1|128-141|anticoagulants|group
DDI-DrugBank.d777.s3|26-27|MI|brand
DDI-DrugBank.d777.s3|103-115|Streptokinase|brand
DDI-DrugBank.d777.s4|0-14|Anticoagulation|group
DDI-DrugBank.d777.s4|20-32|Antiplatelets|group
DDI-DrugBank.d777.s4|34-48|After Treatment|brand
DDI-DrugBank.d777.s4|54-74|Myocardial Infarction|brand
DDI-DrugBank.d777.s4|79-80|In|brand
DDI-DrugBank.d777.s4|176-184|incidence|drug
DDI-DrugBank.d777.s5|27-39|Streptokinase|brand
DDI-DrugBank.d777.s5|150-158|incidence|drug
DDI-DrugBank.d759.s0|8-15|evidence|drug
DDI-DrugBank.d759.s0|99-116|bishydroxycoumarin|group
DDI-DrugBank.d606.s0|4-13|inhibitors|group
DDI-DrugBank.d606.s0|19-22|beta|group
DDI-DrugBank.d606.s0|68-82|pseudoephedrine|drug
DDI-DrugBank.d606.s1|0-15|Sympathomimetics|group
DDI-DrugBank.d606.s1|32-47|antihypertensive|group
DDI-DrugBank.d606.s1|72-83|mecamylamine|drug
DDI-DrugBank.d606.s1|86-94|reserpine|drug
DDI-MedLine.d204.s0|9-19|synergistic|drug
DDI-MedLine.d204.s0|31-42|piperacillin|drug
DDI-MedLine.d204.s0|70-80|Pseudomonas|brand
DDI-MedLine.d204.s1|66-71|Manuka|brand
DDI-MedLine.d204.s1|93-98|Manuka|brand
DDI-MedLine.d204.s1|111-121|New Zealand|brand
DDI-MedLine.d204.s2|28-37|anticancer|group
DDI-MedLine.d204.s2|43-55|antibacterial|group
DDI-MedLine.d204.s3|116-126|Pseudomonas|brand
DDI-MedLine.d204.s5|98-108|antibiotics|group
DDI-MedLine.d204.s7|84-95|piperacillin|drug
DDI-MedLine.d204.s7|98-110|carbenicillin|drug
DDI-MedLine.d204.s7|126-138|ciprofloxacin|drug
DDI-MedLine.d204.s7|162-174|comparatively|drug
DDI-MedLine.d204.s8|80-91|antimicrobic|group
DDI-MedLine.d204.s9|13-25|statistically|drug
DDI-MedLine.d204.s9|88-99|piperacillin|drug
DDI-MedLine.d204.s11|48-55|combined|drug
DDI-MedLine.d204.s11|62-74|carbenicillin|drug
DDI-DrugBank.d711.s0|8-20|tetracyclines|group
DDI-DrugBank.d711.s0|98-110|anticoagulant|group
DDI-DrugBank.d711.s0|161-173|anticoagulant|group
DDI-DrugBank.d711.s1|6-19|bacteriostatic|drug
DDI-DrugBank.d711.s1|50-61|bactericidal|drug
DDI-DrugBank.d711.s1|73-82|penicillin|drug
DDI-DrugBank.d711.s1|117-128|tetracycline|drug
DDI-DrugBank.d711.s1|162-171|penicillin|drug
DDI-DrugBank.d711.s2|14-26|tetracyclines|group
DDI-DrugBank.d711.s2|43-50|antacids|group
DDI-DrugBank.d711.s2|99-126|iron-containing preparations|group
DDI-DrugBank.d711.s3|22-33|tetracycline|drug
DDI-DrugBank.d711.s4|18-30|tetracyclines|group
DDI-DrugBank.d711.s4|42-55|contraceptives|group
DDI-DrugBank.d711.s4|73-86|contraceptives|group
DDI-DrugBank.d711.s4|93-101|effective|drug
DDI-DrugBank.d713.s0|23-30|Sanctura|brand
DDI-DrugBank.d713.s0|43-64|anticholinergic agents|group
DDI-DrugBank.d713.s0|114-128|anticholinergic|group
DDI-DrugBank.d713.s1|0-21|Anticholinergic agents|group
DDI-DrugBank.d713.s1|108-122|anticholinergic|group
DDI-DrugBank.d713.s2|6-15|Eliminated|brand
DDI-DrugBank.d713.s2|20-25|Active|drug
DDI-DrugBank.d713.s2|27-43|Tubular Secretion|brand
DDI-DrugBank.d713.s2|46-53|Although|brand
DDI-DrugBank.d713.s2|101-108|Sanctura|brand
DDI-DrugBank.d713.s2|135-142|Sanctura|brand
DDI-DrugBank.d713.s2|166-180|pharmacokinetic|drug
DDI-DrugBank.d713.s2|235-240|active|drug
DDI-DrugBank.d713.s2|266-272|digoxin|drug
DDI-DrugBank.d713.s2|275-286|procainamide|drug
DDI-DrugBank.d713.s2|302-309|morphine|drug
DDI-DrugBank.d713.s2|312-321|vancomycin|drug
DDI-DrugBank.d713.s2|338-346|tenofovir|drug
DDI-DrugBank.d713.s3|20-27|Sanctura|brand
DDI-DrugBank.d713.s3|63-68|active|drug
DDI-DrugBank.d713.s3|134-141|Sanctura|brand
DDI-DrugBank.d713.s5|21-45|Interactions Interactions|brand
DDI-DrugBank.d713.s5|55-62|Sanctura|brand
DDI-DrugBank.d625.s0|5-23|INTERACTIONS There|brand
DDI-DrugBank.d625.s0|71-91|ALKERAN Vaccinations|brand
DDI-DrugBank.d625.s0|98-101|live|drug
DDI-DrugBank.d625.s0|112-119|vaccines|group
DDI-DrugBank.d625.s0|175-188|Nalidixic acid|brand
DDI-DrugBank.d625.s1|157-176|received cyclosporin|drug
DDI-DrugBank.d752.s0|5-16|Interactions|brand
DDI-DrugBank.d752.s0|19-28|Inhibitors|group
DDI-DrugBank.d752.s0|40-47|Isozymes|brand
DDI-DrugBank.d752.s0|50-56|Caution|brand
DDI-DrugBank.d752.s0|74-82|midazolam|drug
DDI-DrugBank.d752.s0|234-245|antimycotics|group
DDI-DrugBank.d752.s0|257-266|inhibitors|group
DDI-DrugBank.d752.s0|277-283|channel|drug_n
DDI-DrugBank.d752.s0|302-322|macrolide antibiotics|group
DDI-DrugBank.d752.s1|14-25|erythromycin|drug
DDI-DrugBank.d752.s1|50-61|ketoconazole|drug
DDI-DrugBank.d752.s1|64-74|fluconazole|drug
DDI-DrugBank.d752.s1|80-91|itraconazole|drug
DDI-DrugBank.d752.s1|144-146|AUC|brand
DDI-DrugBank.d752.s1|171-179|midazolam|drug
DDI-DrugBank.d752.s2|112-120|midazolam|drug
DDI-DrugBank.d752.s3|53-62|inhibitors|group
DDI-DrugBank.d752.s3|64-72|ritonavir|drug
DDI-DrugBank.d752.s3|78-87|nelfinavir|drug
DDI-DrugBank.d752.s3|198-206|midazolam|drug
DDI-DrugBank.d752.s4|24-35|VERSED Syrup|brand
DDI-DrugBank.d752.s5|27-36|considered|drug
DDI-DrugBank.d752.s5|98-108|anticipated|group
DDI-DrugBank.d752.s6|19-26|Isozymes|brand
DDI-DrugBank.d752.s6|29-38|Cytochrome|brand
DDI-DrugBank.d752.s6|73-85|carbamazepine|drug
DDI-DrugBank.d752.s6|163-165|AUC|brand
DDI-DrugBank.d752.s6|175-183|midazolam|drug
DDI-DrugBank.d752.s7|51-63|phenobarbital|drug
DDI-DrugBank.d752.s8|38-49|VERSED Syrup|brand
DDI-DrugBank.d752.s8|135-144|considered|drug
DDI-DrugBank.d752.s9|102-110|sedatives|drug_n
DDI-DrugBank.d752.s10|4-11|sedative|drug
DDI-DrugBank.d752.s10|23-34|VERSED Syrup|brand
DDI-DrugBank.d752.s10|140-151|particularly|drug
DDI-DrugBank.d752.s10|153-161|narcotics|group
DDI-DrugBank.d752.s10|168-175|morphine|drug
DDI-DrugBank.d752.s10|178-187|meperidine|drug
DDI-DrugBank.d752.s10|214-221|ketamine|drug
DDI-DrugBank.d752.s10|232-236|oxide|drug
DDI-DrugBank.d752.s10|239-250|secobarbital|drug
DDI-DrugBank.d752.s11|26-37|VERSED Syrup|brand
DDI-DrugBank.d752.s12|72-79|atropine|drug
DDI-DrugBank.d752.s12|82-92|scopolamine|drug
DDI-DrugBank.d752.s12|111-118|diazepam|drug
DDI-DrugBank.d752.s12|121-131|hydroxyzine|drug
DDI-DrugBank.d752.s12|171-181|anesthetics|group
DDI-DrugBank.d607.s0|21-27|Leukine|drug
DDI-DrugBank.d607.s1|31-48|myeloproliferative|drug
DDI-DrugBank.d607.s1|61-67|Leukine|drug
DDI-DrugBank.d607.s1|90-104|corticosteroids|drug
DDI-DrugBank.d776.s0|64-71|DIFLUCAN|brand
DDI-DrugBank.d776.s0|91-104|agents/classes|group
DDI-DrugBank.d776.s1|45-52|DIFLUCAN|brand
DDI-DrugBank.d776.s1|72-85|agents/classes|group
DDI-DrugBank.d776.s2|46-63|Oral hypoglycemics|group
DDI-DrugBank.d776.s2|66-93|Coumarin-type anticoagulants|group
DDI-DrugBank.d776.s2|96-104|Phenytoin|brand
DDI-DrugBank.d776.s2|107-118|Cyclosporine|drug
DDI-DrugBank.d776.s2|121-128|Rifampin|brand
DDI-DrugBank.d776.s2|131-142|Theophylline|drug
DDI-DrugBank.d776.s2|145-155|Terfenadine|drug
DDI-DrugBank.d776.s2|158-166|Cisapride|drug
DDI-DrugBank.d776.s2|169-178|Astemizole|brand
DDI-DrugBank.d776.s2|181-189|Rifabutin|drug
DDI-DrugBank.d776.s2|192-201|Tacrolimus|brand
DDI-DrugBank.d776.s2|204-215|Short-acting|brand
DDI-DrugBank.d776.s2|217-231|benzodiazepines|group
DDI-DrugBank.d776.s2|235-252|Oral hypoglycemics|group
DDI-DrugBank.d776.s2|255-264|Clinically|brand
DDI-DrugBank.d776.s2|325-332|DIFLUCAN|brand
DDI-DrugBank.d776.s2|344-362|hypoglycemic agents|group
DDI-DrugBank.d776.s3|69-76|combined|drug
DDI-DrugBank.d776.s3|78-85|DIFLUCAN|brand
DDI-DrugBank.d776.s3|91-99|glyburide|drug
DDI-DrugBank.d776.s4|35-45|tolbutamide|drug
DDI-DrugBank.d776.s4|48-56|glyburide|drug
DDI-DrugBank.d776.s4|63-71|glipizide|drug
DDI-DrugBank.d776.s4|121-126|agents|group
DDI-DrugBank.d776.s5|5-12|DIFLUCAN|brand
DDI-DrugBank.d776.s5|56-67|sulfonylurea|drug
DDI-DrugBank.d776.s5|74-92|hypoglycemic agents|group
DDI-DrugBank.d776.s5|174-185|sulfonylurea|drug
DDI-DrugBank.d776.s6|0-27|Coumarin-type anticoagulants|group
DDI-DrugBank.d776.s6|30-40|Prothrombin|brand
DDI-DrugBank.d776.s6|98-105|DIFLUCAN|brand
DDI-DrugBank.d776.s6|111-138|coumarin-type anticoagulants|group
DDI-DrugBank.d776.s7|50-60|antifungals|group
DDI-DrugBank.d776.s7|242-252|fluconazole|drug
DDI-DrugBank.d776.s7|272-279|warfarin|drug
DDI-DrugBank.d776.s8|61-68|DIFLUCAN|brand
DDI-DrugBank.d776.s8|74-101|coumarin-type anticoagulants|group
DDI-DrugBank.d776.s9|42-53|PHARMACOLOGY|brand
DDI-DrugBank.d776.s9|61-80|Interaction Studies.|brand
DDI-DrugBank.d776.s10|11-18|DIFLUCAN|brand
DDI-DrugBank.d776.s11|69-76|DIFLUCAN|brand
DDI-DrugBank.d776.s12|42-53|PHARMACOLOGY|brand
DDI-DrugBank.d776.s12|61-80|Interaction Studies.|brand
DDI-DrugBank.d776.s13|0-11|Cyclosporine|drug
DDI-DrugBank.d776.s13|14-21|DIFLUCAN|brand
DDI-DrugBank.d776.s13|50-61|cyclosporine|drug
DDI-DrugBank.d776.s14|22-33|cyclosporine|drug
DDI-DrugBank.d776.s14|60-69|creatinine|drug
DDI-DrugBank.d776.s14|108-115|DIFLUCAN|brand
DDI-DrugBank.d776.s14|121-132|cyclosporine|drug
DDI-DrugBank.d776.s15|5-25|CLINICAL PHARMACOLOGY|brand
DDI-DrugBank.d776.s15|33-52|Interaction Studies.|brand
DDI-DrugBank.d776.s16|10-17|Rifampin|brand
DDI-DrugBank.d776.s16|72-79|DIFLUCAN|brand
DDI-DrugBank.d776.s17|37-49|consideration|drug
DDI-DrugBank.d776.s17|61-65|given|drug
DDI-DrugBank.d776.s17|93-100|DIFLUCAN|brand
DDI-DrugBank.d776.s18|0-11|Theophylline|drug
DDI-DrugBank.d776.s18|14-21|DIFLUCAN|brand
DDI-DrugBank.d776.s18|61-72|theophylline|drug
DDI-DrugBank.d776.s19|28-39|theophylline|drug
DDI-DrugBank.d776.s19|78-85|DIFLUCAN|brand
DDI-DrugBank.d776.s19|91-102|theophylline|drug
DDI-DrugBank.d776.s20|0-10|Terfenadine|drug
DDI-DrugBank.d776.s20|13-19|Because|brand
DDI-DrugBank.d776.s20|104-106|QTc|brand
DDI-DrugBank.d776.s20|145-155|antifungals|group
DDI-DrugBank.d776.s20|177-187|terfenadine|drug
DDI-DrugBank.d776.s21|36-46|fluconazole|drug
DDI-DrugBank.d776.s21|88-90|QTc|brand
DDI-DrugBank.d776.s22|51-61|fluconazole|drug
DDI-DrugBank.d776.s22|81-88|DIFLUCAN|brand
DDI-DrugBank.d776.s22|175-185|terfenadine|drug
DDI-DrugBank.d776.s23|4-11|combined|drug
DDI-DrugBank.d776.s23|20-30|fluconazole|drug
DDI-DrugBank.d776.s23|67-77|terfenadine|drug
DDI-DrugBank.d776.s24|24-34|fluconazole|drug
DDI-DrugBank.d776.s24|72-82|terfenadine|drug
DDI-DrugBank.d776.s25|0-8|Cisapride|drug
DDI-DrugBank.d776.s25|11-15|There|brand
DDI-DrugBank.d776.s25|103-113|fluconazole|drug
DDI-DrugBank.d776.s25|119-127|cisapride|drug
DDI-DrugBank.d776.s26|42-52|fluconazole|drug
DDI-DrugBank.d776.s26|76-84|cisapride|drug
DDI-DrugBank.d776.s26|143-151|cisapride|drug
DDI-DrugBank.d776.s26|187-189|QTc|brand
DDI-DrugBank.d776.s27|4-11|combined|drug
DDI-DrugBank.d776.s27|20-30|fluconazole|drug
DDI-DrugBank.d776.s27|37-45|cisapride|drug
DDI-DrugBank.d776.s28|12-14|The|brand
DDI-DrugBank.d776.s28|23-33|fluconazole|drug
DDI-DrugBank.d776.s29|18-27|definitive|drug
DDI-DrugBank.d776.s29|86-96|fluconazole|drug
DDI-DrugBank.d776.s31|0-8|Rifabutin|drug
DDI-DrugBank.d776.s31|11-15|There|brand
DDI-DrugBank.d776.s31|66-76|fluconazole|drug
DDI-DrugBank.d776.s31|82-90|rifabutin|drug
DDI-DrugBank.d776.s32|19-27|rifabutin|drug
DDI-DrugBank.d776.s32|33-43|fluconazole|drug
DDI-DrugBank.d776.s33|12-16|There|brand
DDI-DrugBank.d776.s33|74-84|fluconazole|drug
DDI-DrugBank.d776.s34|34-44|fluconazole|drug
DDI-DrugBank.d776.s35|13-27|Benzodiazepines|group
DDI-DrugBank.d776.s35|30-38|Following|brand
DDI-DrugBank.d776.s35|63-71|midazolam|drug
DDI-DrugBank.d776.s35|74-84|fluconazole|drug
DDI-DrugBank.d776.s35|98-108|substantial|group
DDI-DrugBank.d776.s35|123-131|midazolam|drug
DDI-DrugBank.d776.s36|15-23|midazolam|drug
DDI-DrugBank.d776.s36|88-98|fluconazole|drug
DDI-DrugBank.d776.s36|110-120|fluconazole|drug
DDI-DrugBank.d776.s37|16-30|benzodiazepines|group
DDI-DrugBank.d776.s37|122-132|fluconazole|drug
DDI-DrugBank.d776.s37|135-147|consideration|drug
DDI-DrugBank.d776.s37|159-163|given|drug
DDI-DrugBank.d776.s37|183-196|benzodiazepine|drug
DDI-DrugBank.d776.s38|0-10|Fluconazole|drug
DDI-DrugBank.d776.s38|63-87|levonorgestrel-containing|drug
DDI-DrugBank.d776.s38|94-107|contraceptives|group
DDI-DrugBank.d776.s38|168-181|levonorgestrel|drug
DDI-DrugBank.d776.s39|90-103|levonorgestrel|drug
DDI-DrugBank.d776.s40|98-111|levonorgestrel|drug
DDI-DrugBank.d776.s40|113-115|AUC|brand
DDI-DrugBank.d776.s40|129-139|fluconazole|drug
DDI-DrugBank.d776.s41|15-22|evidence|drug
DDI-DrugBank.d776.s41|29-39|fluconazole|drug
DDI-DrugBank.d776.s41|93-106|levonorgestrel|drug
DDI-DrugBank.d776.s41|121-128|evidence|drug
DDI-DrugBank.d776.s41|135-145|fluconazole|drug
DDI-DrugBank.d776.s41|188-201|levonorgestrel|drug
DDI-DrugBank.d776.s43|137-148|PHARMACOLOGY|brand
DDI-DrugBank.d659.s0|152-158|TRENTAL|brand
DDI-DrugBank.d659.s0|177-190|anticoagulants|group
DDI-DrugBank.d659.s0|216-225|inhibitors|group
DDI-DrugBank.d659.s1|12-19|Warfarin|drug
DDI-DrugBank.d659.s1|168-173|peptic|drug
DDI-DrugBank.d659.s2|30-36|TRENTAL|brand
DDI-DrugBank.d659.s2|42-64|theophylline-containing|drug
DDI-DrugBank.d659.s2|91-102|theophylline|drug
DDI-DrugBank.d659.s2|115-126|theophylline|drug
DDI-DrugBank.d659.s3|79-90|theophylline|drug
DDI-DrugBank.d659.s4|40-55|antihypertensive|group
DDI-DrugBank.d659.s4|64-67|beta|group
DDI-DrugBank.d659.s4|90-98|diuretics|group
DDI-DrugBank.d659.s4|101-119|antidiabetic agents|group
DDI-DrugBank.d659.s4|126-140|antiarrhythmics|group
DDI-DrugBank.d659.s5|83-89|TRENTAL|brand
DDI-DrugBank.d659.s6|9-16|systemic|group
DDI-DrugBank.d659.s6|94-109|antihypertensive|group
DDI-DrugBank.d659.s7|28-50|antihypertensive agents|group
DDI-DrugBank.d597.s0|4-13|inhibitors|group
DDI-DrugBank.d597.s0|15-21|Reports|brand
DDI-DrugBank.d597.s0|36-41|NSAIDs|brand
DDI-DrugBank.d597.s0|60-75|antihypertensive|group
DDI-DrugBank.d597.s0|87-108|angiotensin-converting|drug_n
DDI-DrugBank.d597.s0|123-132|inhibitors|group
DDI-DrugBank.d597.s1|27-45|given consideration|drug
DDI-DrugBank.d597.s1|66-71|NSAIDs|brand
DDI-DrugBank.d597.s1|92-105|ACE inhibitors|group
DDI-DrugBank.d597.s2|9-19|Concomitant|brand
DDI-DrugBank.d597.s2|56-58|TID|brand
DDI-DrugBank.d597.s2|106-108|AUC|brand
DDI-DrugBank.d597.s2|120-123|Cmax|brand
DDI-DrugBank.d597.s4|23-28|NSAIDs|brand
DDI-DrugBank.d597.s5|52-56|MOBIC|brand
DDI-DrugBank.d597.s5|93-94|GI|brand
DDI-DrugBank.d597.s5|150-154|MOBIC|brand
DDI-DrugBank.d597.s7|0-13|Cholestyramine|drug
DDI-DrugBank.d597.s7|16-27|Pretreatment|brand
DDI-DrugBank.d597.s7|48-61|cholestyramine|drug
DDI-DrugBank.d597.s8|91-93|AUC|brand
DDI-DrugBank.d597.s11|0-9|Cimetidine|drug
DDI-DrugBank.d597.s11|12-22|Concomitant|brand
DDI-DrugBank.d597.s11|49-58|cimetidine|drug
DDI-DrugBank.d597.s11|60-62|QID|brand
DDI-DrugBank.d597.s11|94-109|pharmacokinetics|group
DDI-DrugBank.d597.s12|0-6|Digoxin|drug
DDI-DrugBank.d597.s12|9-17|Meloxicam|brand
DDI-DrugBank.d597.s12|97-103|digoxin|drug
DDI-DrugBank.d597.s12|111-125|b-acetyldigoxin|drug
DDI-DrugBank.d597.s13|67-73|digoxin|drug
DDI-DrugBank.d597.s14|0-9|Furosemide|drug
DDI-DrugBank.d597.s14|12-19|Clinical|brand
DDI-DrugBank.d597.s14|86-91|NSAIDs|brand
DDI-DrugBank.d597.s14|108-118|natriuretic|drug
DDI-DrugBank.d597.s14|130-139|furosemide|drug
DDI-DrugBank.d597.s14|145-162|thiazide diuretics|group
DDI-DrugBank.d597.s16|13-29|furosemide agents|group
DDI-DrugBank.d597.s16|82-92|natriuretic|drug
DDI-DrugBank.d597.s17|0-9|Furosemide|drug
DDI-DrugBank.d597.s17|58-73|pharmacokinetics|group
DDI-DrugBank.d597.s18|46-55|furosemide|drug
DDI-DrugBank.d597.s18|61-65|MOBIC|brand
DDI-DrugBank.d597.s18|164-171|diuretic|group
DDI-DrugBank.d597.s19|9-10|In|brand
DDI-DrugBank.d597.s19|29-34|NSAIDs|brand
DDI-DrugBank.d597.s20|82-84|AUC|brand
DDI-DrugBank.d597.s20|172-174|BID|brand
DDI-DrugBank.d597.s20|197-198|QD|brand
DDI-DrugBank.d597.s21|85-89|MOBIC|brand
DDI-DrugBank.d597.s22|63-67|MOBIC|brand
DDI-DrugBank.d597.s23|123-138|pharmacokinetics|group
DDI-DrugBank.d597.s24|51-66|pharmacokinetics|group
DDI-DrugBank.d597.s26|0-7|Warfarin|drug
DDI-DrugBank.d597.s26|10-22|Anticoagulant|group
DDI-DrugBank.d597.s26|54-65|particularly|drug
DDI-DrugBank.d597.s26|118-122|MOBIC|brand
DDI-DrugBank.d597.s26|154-161|warfarin|drug
DDI-DrugBank.d597.s26|174-179|agents|group
DDI-DrugBank.d597.s27|31-43|anticoagulant|group
DDI-DrugBank.d597.s27|55-62|warfarin|drug
DDI-DrugBank.d597.s27|132-139|warfarin|drug
DDI-DrugBank.d597.s27|158-160|INR|brand
DDI-DrugBank.d597.s27|177-192|Normalized Ratio|brand
DDI-DrugBank.d597.s28|43-50|warfarin|drug
DDI-DrugBank.d597.s28|52-67|pharmacokinetics|group
DDI-DrugBank.d597.s28|85-97|anticoagulant|group
DDI-DrugBank.d597.s28|109-116|warfarin|drug
DDI-DrugBank.d597.s28|121-130|determined|drug
DDI-DrugBank.d597.s29|43-45|INR|brand
DDI-DrugBank.d597.s30|42-46|MOBIC|brand
DDI-DrugBank.d597.s30|53-60|warfarin|drug
DDI-DrugBank.d597.s30|80-87|warfarin|drug
DDI-DrugBank.d597.s30|115-117|INR|brand
DDI-DrugBank.d603.s0|37-46|ProAmatine|drug
DDI-DrugBank.d603.s0|60-69|glycosides|group
DDI-DrugBank.d603.s0|111-113|A.V|brand
DDI-DrugBank.d603.s2|32-47|alpha-adrenergic|group
DDI-DrugBank.d603.s2|66-78|phenylephrine|drug
DDI-DrugBank.d603.s2|81-95|pseudoephedrine|drug
DDI-DrugBank.d603.s2|98-106|ephedrine|drug
DDI-DrugBank.d603.s2|109-127|phenylpropanolamine|drug
DDI-DrugBank.d603.s2|132-148|dihydroergotamine|drug
DDI-DrugBank.d603.s2|200-209|ProAmatine|drug
DDI-DrugBank.d603.s2|215-223|Therefore|brand
DDI-DrugBank.d603.s2|254-263|ProAmatine|drug
DDI-DrugBank.d603.s2|303-308|agents|group
DDI-DrugBank.d603.s3|0-9|ProAmatine|drug
DDI-DrugBank.d603.s3|105-119|fludrocortisone|drug
DDI-DrugBank.d603.s4|18-23|supine|drug
DDI-DrugBank.d603.s4|138-152|fludrocortisone|drug
DDI-DrugBank.d603.s5|0-9|ProAmatine|drug
DDI-DrugBank.d603.s5|12-27|Alpha-adrenergic|group
DDI-DrugBank.d603.s5|38-43|agents|group
DDI-DrugBank.d603.s5|54-61|prazosin|drug
DDI-DrugBank.d603.s5|64-72|terazosin|drug
DDI-DrugBank.d603.s5|79-87|doxazosin|drug
DDI-DrugBank.d603.s5|120-129|ProAmatine|drug
DDI-DrugBank.d603.s5|132-140|Potential|brand
DDI-DrugBank.d603.s5|146-162|Drug Interactions|brand
DDI-DrugBank.d603.s5|165-166|It|brand
DDI-DrugBank.d603.s5|231-238|evidence|drug
DDI-DrugBank.d603.s5|274-288|desglymidodrine|drug
DDI-DrugBank.d603.s5|309-314|active|drug
DDI-DrugBank.d603.s5|426-435|cimetidine|drug
DDI-DrugBank.d603.s5|438-447|ranitidine|drug
DDI-DrugBank.d603.s5|450-461|procainamide|drug
DDI-DrugBank.d603.s5|477-486|flecainide|drug
DDI-DrugBank.d603.s5|493-501|quinidine|drug
DDI-DrugBank.d679.s0|12-19|evidence|drug
DDI-DrugBank.d679.s0|35-44|cimetidine|drug
DDI-DrugBank.d679.s0|55-65|mebendazole|drug
DDI-DrugBank.d679.s0|136-146|mebendazole|drug
DDI-DrugBank.d698.s0|17-26|Vitamin B2|group
DDI-DrugBank.d698.s0|43-49|Alcohol|brand
DDI-DrugBank.d698.s1|0-9|Probenecid|drug
DDI-DrugBank.d698.s2|67-76|probenecid|drug
DDI-DrugBank.d753.s0|29-31|CNS|brand
DDI-DrugBank.d753.s0|55-63|sedatives|drug_n
DDI-DrugBank.d753.s0|66-74|hypnotics|group
DDI-DrugBank.d753.s0|100-110|anesthetics|group
DDI-DrugBank.d753.s0|113-126|phenothiazines|group
DDI-DrugBank.d753.s0|144-168|tricyclic antidepressants|group
DDI-DrugBank.d753.s0|171-179|monoamine|drug
DDI-DrugBank.d753.s0|195-204|inhibitors|group
DDI-DrugBank.d753.s0|231-238|additive|drug
DDI-DrugBank.d753.s0|240-242|CNS|brand
DDI-DrugBank.d753.s1|10-17|combined|drug
DDI-DrugBank.d753.s1|68-73|agents|group
DDI-DrugBank.d753.s2|0-15|Anticholinergics|group
DDI-DrugBank.d753.s2|43-57|anticholinergic|group
DDI-DrugBank.d753.s2|210-218|paralytic|drug
DDI-DrugBank.d753.s3|30-38|incidence|drug
DDI-DrugBank.d753.s3|90-97|combined|drug
DDI-DrugBank.d753.s4|13-15|CNS|brand
DDI-DrugBank.d753.s4|143-152|cimetidine|drug
DDI-DrugBank.d587.s0|6-13|Celontin|brand
DDI-DrugBank.d587.s0|15-27|(methsuximide|drug
DDI-DrugBank.d587.s0|74-86|antiepileptic|group
DDI-DrugBank.d587.s0|167-178|methsuximide|drug
DDI-DrugBank.d587.s0|236-248|phenobarbital|drug
DDI-DrugBank.d622.s0|5-12|atropine|drug
DDI-DrugBank.d622.s0|189-196|atropine|drug
DDI-DrugBank.d622.s1|45-52|atropine|drug
DDI-DrugBank.d622.s2|6-8|The|brand
DDI-DrugBank.d622.s2|75-92|anticholinesterase|group
DDI-DrugBank.d622.s2|173-184|barbiturates|group
DDI-DrugBank.d622.s2|209-227|anticholinesterases|group
DDI-DrugBank.d622.s3|0-7|morphine|drug
DDI-DrugBank.d622.s3|10-21|theophylline|drug
DDI-DrugBank.d622.s3|24-36|aminophylline|drug
DDI-DrugBank.d622.s3|39-53|succinylcholine|drug
DDI-DrugBank.d622.s3|56-64|reserpine|drug
DDI-DrugBank.d622.s3|71-88|phenothiazine-type|drug
DDI-DrugBank.d622.s3|114-120|avoided|drug
DDI-DrugBank.d693.s0|37-43|digoxin|drug
DDI-DrugBank.d693.s0|75-80|agents|group
DDI-DrugBank.d693.s0|119-131|sulfasalazine|group
DDI-DrugBank.d693.s1|20-32|sulfasalazine|group
DDI-DrugBank.d693.s1|172-186|pharmacokinetic|drug
DDI-DrugBank.d693.s2|15-27|sulfasalazine|group
DDI-DrugBank.d693.s3|70-78|incidence|drug
DDI-DrugBank.d693.s3|156-164|incidence|drug
DDI-DrugBank.d693.s4|16-32|Test Interactions|brand
DDI-DrugBank.d693.s4|35-37|The|brand
DDI-DrugBank.d693.s4|51-63|sulfasalazine|group
DDI-DrugBank.d693.s6|35-48|sulphasalazine|drug
DDI-DrugBank.d693.s7|8-16|Jnl Rheum|brand
DDI-DrugBank.d584.s0|0-13|Anticoagulants|group
DDI-DrugBank.d584.s0|15-22|Anabolic|brand
DDI-DrugBank.d584.s0|66-79|anticoagulants|group
DDI-DrugBank.d584.s1|14-26|anticoagulant|group
DDI-DrugBank.d584.s2|24-36|anticoagulant|group
DDI-DrugBank.d584.s3|0-7|Warfarin|drug
DDI-DrugBank.d584.s3|31-41|oxandrolone|drug
DDI-DrugBank.d584.s3|44-48|given|drug
DDI-DrugBank.d584.s3|64-66|BID|brand
DDI-DrugBank.d584.s3|117-124|warfarin|drug
DDI-DrugBank.d584.s3|158-167|S-warfarin|drug
DDI-DrugBank.d584.s3|203-205|AUC|brand
DDI-DrugBank.d584.s3|257-266|R-warfarin|drug
DDI-DrugBank.d584.s3|282-284|AUC|brand
DDI-DrugBank.d584.s5|32-39|warfarin|drug
DDI-DrugBank.d584.s5|113-120|warfarin|drug
DDI-DrugBank.d584.s5|164-166|INR|brand
DDI-DrugBank.d584.s6|5-15|oxandrolone|drug
DDI-DrugBank.d584.s6|84-91|warfarin|drug
DDI-DrugBank.d584.s6|98-100|INR|brand
DDI-DrugBank.d584.s6|171-178|warfarin|drug
DDI-DrugBank.d584.s6|224-226|INR|brand
DDI-DrugBank.d584.s6|231-232|PT|brand
DDI-DrugBank.d584.s7|73-75|INR|brand
DDI-DrugBank.d584.s7|80-81|PT|brand
DDI-DrugBank.d584.s7|106-113|warfarin|drug
DDI-DrugBank.d584.s7|160-170|oxandrolone|drug
DDI-DrugBank.d584.s9|5-23|hypoglycemic agents|group
DDI-DrugBank.d584.s9|25-35|Oxandrolone|drug
DDI-DrugBank.d584.s9|72-90|hypoglycemic agents|group
DDI-DrugBank.d584.s10|20-26|ACTH In|brand
DDI-DrugBank.d584.s10|89-96|cortical|drug
DDI-DrugBank.d584.s10|110-113|ACTH|brand
DDI-DrugBank.d584.s11|34-41|Anabolic|brand
DDI-DrugBank.d584.s11|75-91|thyroxine-binding|drug
DDI-DrugBank.d584.s11|132-133|T4|brand
DDI-DrugBank.d584.s11|178-179|T3|brand
DDI-DrugBank.d584.s11|185-186|T4|brand
DDI-DrugBank.d584.s13|27-29|PBI|brand
DDI-DrugBank.d584.s13|35-52|radioactive iodine|drug
DDI-DrugBank.d700.s0|0-7|Antacids|group
DDI-DrugBank.d700.s0|10-19|Absorption|brand
DDI-DrugBank.d700.s0|41-48|Myfortic|drug
DDI-DrugBank.d700.s0|163-170|antacids|group
DDI-DrugBank.d700.s0|190-193|Cmax|brand
DDI-DrugBank.d700.s0|199-205|AUC(0-t|brand
DDI-DrugBank.d700.s0|219-221|MPA|brand
DDI-DrugBank.d700.s0|247-258|respectively|drug
DDI-DrugBank.d700.s0|271-278|Myfortic|drug
DDI-DrugBank.d700.s1|23-30|Myfortic|drug
DDI-DrugBank.d700.s1|36-43|antacids|group
DDI-DrugBank.d700.s2|0-11|Cyclosporine|drug
DDI-DrugBank.d700.s2|14-17|When|brand
DDI-DrugBank.d700.s2|64-75|cyclosporine|drug
DDI-DrugBank.d700.s2|78-80|USP|brand
DDI-DrugBank.d700.s2|93-108|pharmacokinetics|group
DDI-DrugBank.d700.s2|152-159|Myfortic|drug
DDI-DrugBank.d700.s3|0-20|Acyclovir/Ganciclovir|drug
DDI-DrugBank.d700.s3|41-48|Myfortic|drug
DDI-DrugBank.d700.s5|5-25|acyclovir/ganciclovir|drug
DDI-DrugBank.d700.s5|31-34|MPAG|brand
DDI-DrugBank.d700.s6|0-25|Azathioprine/Mycophenolate|drug
DDI-DrugBank.d700.s6|27-33|Mofetil|brand
DDI-DrugBank.d700.s6|36-40|Given|drug
DDI-DrugBank.d700.s6|47-58|azathioprine|drug
DDI-DrugBank.d700.s6|94-99|purine|drug
DDI-DrugBank.d700.s6|136-143|Myfortic|drug
DDI-DrugBank.d700.s6|184-195|azathioprine|drug
DDI-DrugBank.d700.s7|0-13|Cholestyramine|drug
DDI-DrugBank.d700.s7|19-23|Drugs|brand
DDI-DrugBank.d700.s7|30-38|Bind Bile|brand
DDI-DrugBank.d700.s7|40-44|Acids|group
DDI-DrugBank.d700.s7|47-51|These|brand
DDI-DrugBank.d700.s7|69-81|enterohepatic|drug
DDI-DrugBank.d700.s7|108-110|MPA|brand
DDI-DrugBank.d700.s8|29-36|Myfortic|drug
DDI-DrugBank.d700.s8|43-56|cholestyramine|drug
DDI-DrugBank.d700.s8|67-72|agents|group
DDI-DrugBank.d700.s8|98-110|enterohepatic|drug
DDI-DrugBank.d700.s8|154-158|acids|group
DDI-DrugBank.d700.s8|275-282|Myfortic|drug
DDI-DrugBank.d700.s9|5-18|Contraceptives|group
DDI-DrugBank.d700.s9|21-25|Given|drug
DDI-DrugBank.d700.s9|55-62|Myfortic|drug
DDI-DrugBank.d700.s9|73-86|contraceptives|group
DDI-DrugBank.d700.s10|48-62|levonorgesterol|drug
DDI-DrugBank.d700.s10|64-66|AUC|brand
DDI-DrugBank.d700.s11|39-52|contraceptives|group
DDI-DrugBank.d700.s11|80-87|Myfortic|drug
DDI-DrugBank.d700.s11|142-151|considered|drug
DDI-DrugBank.d700.s12|0-3|Live|drug
DDI-DrugBank.d700.s12|5-12|Vaccines|group
DDI-DrugBank.d700.s12|15-20|During|brand
DDI-DrugBank.d700.s12|37-44|Myfortic|drug
DDI-DrugBank.d700.s12|58-61|live|drug
DDI-DrugBank.d700.s12|74-81|vaccines|group
DDI-DrugBank.d700.s12|93-99|avoided|drug
DDI-DrugBank.d700.s12|162-170|effective|drug
DDI-DrugBank.d700.s15|62-69|Myfortic|drug
DDI-DrugBank.d700.s15|85-97|enterohepatic|drug
DDI-DrugBank.d700.s16|16-19|MPAG|brand
DDI-DrugBank.d700.s16|49-51|MPA|brand
DDI-MedLine.d231.s0|21-32|moxifloxacin|drug
DDI-MedLine.d231.s0|38-49|lomefloxacin|drug
DDI-MedLine.d231.s1|0-11|Moxifloxacin|drug
DDI-MedLine.d231.s1|17-28|lomefloxacin|drug
DDI-MedLine.d231.s1|34-60|fluoroquinolone antibiotics|group
DDI-MedLine.d231.s2|0-15|Fluoroquinolones|group
DDI-MedLine.d231.s2|68-73|active|drug
DDI-MedLine.d231.s3|6-17|moxifloxacin|drug
DDI-MedLine.d231.s3|23-34|lomefloxacin|drug
DDI-MedLine.d231.s3|36-51|fluoroquinolones|group
DDI-MedLine.d231.s3|120-131|erythromycin|drug
DDI-MedLine.d231.s3|143-150|minerals|drug
DDI-MedLine.d231.s4|40-45|acidic|drug
DDI-MedLine.d231.s5|99-106|examined|drug
DDI-MedLine.d231.s5|120-128|elucidate|drug
DDI-MedLine.d231.s6|16-27|moxifloxacin|drug
DDI-MedLine.d231.s6|33-44|lomefloxacin|drug
DDI-MedLine.d231.s6|150-162|Shimadzu HPLC|brand
DDI-MedLine.d231.s6|176-178|PDA|brand
DDI-MedLine.d231.s7|38-53|fluoroquinolones|group
DDI-MedLine.d231.s8|0-11|Moxifloxacin|drug
DDI-MedLine.d231.s8|17-28|Lomefloxacin|drug
DDI-MedLine.d231.s8|75-80|acidic|drug
DDI-MedLine.d231.s8|101-112|erythromycin|drug
DDI-MedLine.d231.s8|133-146|multi-minerals|drug
DDI-MedLine.d231.s9|37-52|fluoroquinolones|group
DDI-MedLine.d231.s10|24-44|effective therapeutic|drug
DDI-DrugBank.d696.s0|0-11|Methysergide|drug
DDI-DrugBank.d696.s0|51-58|narcotic|drug
DDI-DrugBank.d696.s1|36-41|agents|group
DDI-DrugBank.d696.s1|70-80|sumatriptan|drug
DDI-DrugBank.d696.s1|87-94|nicotine|drug
DDI-DrugBank.d727.s0|0-23|Zidovudine competitively|drug
DDI-DrugBank.d727.s0|71-79|stavudine|drug
DDI-DrugBank.d727.s1|18-27|zidovudine|drug
DDI-DrugBank.d727.s1|49-53|ZERIT|brand
DDI-DrugBank.d727.s1|65-71|avoided|drug
DDI-DrugBank.d727.s2|51-59|stavudine|drug
DDI-DrugBank.d727.s2|109-119|doxorubicin|drug
DDI-DrugBank.d727.s2|125-133|ribavirin|drug
DDI-DrugBank.d727.s4|30-38|stavudine|drug
DDI-DrugBank.d658.s0|78-91|anticoagulants|group
DDI-DrugBank.d658.s1|19-31|anticoagulant|group
DDI-DrugBank.d658.s2|16-32|Test Interactions|brand
DDI-DrugBank.d658.s2|35-45|Physiologic|brand
DDI-DrugBank.d658.s2|242-249|creatine|drug
DDI-MedLine.d209.s0|14-16|CYP|brand
DDI-MedLine.d209.s0|22-31|inhibitors|group
DDI-MedLine.d209.s2|6-16|extensively|drug
DDI-MedLine.d209.s2|39-44|active|drug
DDI-MedLine.d209.s2|135-137|CYP|brand
DDI-MedLine.d209.s3|46-48|CYP|brand
DDI-MedLine.d209.s3|54-63|inhibitors|group
DDI-MedLine.d209.s4|0-8|Selective|drug
DDI-MedLine.d209.s4|46-60|antidepressants|group
DDI-MedLine.d209.s4|80-82|CYP|brand
DDI-MedLine.d209.s5|0-9|Paroxetine|drug
DDI-MedLine.d209.s5|15-24|fluoxetine|drug
DDI-MedLine.d209.s6|4-18|epidemiological|drug
DDI-MedLine.d209.s6|92-111|SSRI antidepressants|group
DDI-MedLine.d209.s7|37-44|evidence|drug
DDI-MedLine.d209.s8|27-29|CYP|brand
DDI-MedLine.d209.s8|35-44|inhibitors|group
DDI-MedLine.d209.s8|122-132|statistical|drug
DDI-MedLine.d209.s9|44-46|CYP|brand
DDI-MedLine.d209.s9|52-61|inhibitors|group
DDI-MedLine.d209.s9|125-144|SSRI antidepressants|group
DDI-MedLine.d209.s9|154-163|paroxetine|drug
DDI-MedLine.d209.s9|169-178|fluoxetine|drug
DDI-MedLine.d209.s10|35-48|antidepressant|group
DDI-MedLine.d209.s10|68-82|antidepressants|group
DDI-MedLine.d209.s10|99-108|preventive|drug
DDI-MedLine.d209.s11|24-37|antidepressant|group
DDI-MedLine.d209.s11|42-51|considered|drug
DDI-MedLine.d200.s0|31-50|amlodipine/valsartan|drug
DDI-MedLine.d200.s0|82-93|hypertensive|drug
DDI-MedLine.d200.s1|35-54|amlodipine/valsartan|drug
DDI-MedLine.d200.s1|100-111|hypertensive|drug
DDI-MedLine.d200.s1|169-176|medicine|drug
DDI-MedLine.d200.s2|33-48|antihypertensive|group
DDI-MedLine.d200.s2|106-125|amlodipine/valsartan|drug
DDI-MedLine.d200.s3|14-29|antihypertensive|group
DDI-MedLine.d200.s4|78-84|UA767PC|brand
DDI-MedLine.d200.s5|11-12|BP|brand
DDI-MedLine.d200.s5|97-106|inefficacy|drug
DDI-MedLine.d200.s7|30-31|BP|brand
DDI-MedLine.d200.s7|56-75|amlodipine/valsartan|drug
DDI-MedLine.d200.s8|33-52|amlodipine/valsartan|drug
DDI-MedLine.d200.s8|141-142|BP|brand
DDI-MedLine.d200.s8|175-176|BP|brand
DDI-MedLine.d200.s8|209-220|respectively|drug
DDI-MedLine.d200.s8|247-262|antihypertensive|group
DDI-MedLine.d200.s8|301-312|respectively|drug
DDI-MedLine.d200.s8|340-349|inefficacy|drug
DDI-MedLine.d200.s8|377-388|respectively|drug
DDI-MedLine.d200.s10|75-94|amlodipine/valsartan|drug
DDI-MedLine.d200.s10|150-151|BP|brand
DDI-MedLine.d200.s10|192-207|antihypertensive|group
DDI-MedLine.d200.s10|242-251|inefficacy|drug
DDI-DrugBank.d572.s0|0-13|Cholestyramine|drug
DDI-DrugBank.d572.s0|16-26|Concomitant|brand
DDI-DrugBank.d572.s0|28-41|cholestyramine|drug
DDI-DrugBank.d572.s0|77-79|AUC|brand
DDI-DrugBank.d572.s1|16-20|LDL-C|brand
DDI-DrugBank.d572.s1|59-72|cholestyramine|drug
DDI-DrugBank.d572.s2|10-12|The|brand
DDI-DrugBank.d572.s2|25-37|effectiveness|drug
DDI-DrugBank.d572.s3|22-32|cholesterol|drug
DDI-DrugBank.d572.s4|52-62|cholesterol|drug
DDI-DrugBank.d572.s5|21-25|ZETIA|brand
DDI-DrugBank.d572.s6|13-14|In|brand
DDI-DrugBank.d572.s6|18-32|pharmacokinetic|drug
DDI-DrugBank.d572.s7|13-14|In|brand
DDI-DrugBank.d572.s7|18-32|pharmacokinetic|drug
DDI-DrugBank.d572.s8|18-27|inhibitors|group
DDI-DrugBank.d572.s8|30-31|No|brand
DDI-DrugBank.d572.s8|56-70|pharmacokinetic|drug
DDI-DrugBank.d572.s8|135-146|atorvastatin|drug
DDI-DrugBank.d572.s8|149-159|simvastatin|drug
DDI-DrugBank.d572.s8|162-172|pravastatin|drug
DDI-DrugBank.d572.s8|175-184|lovastatin|drug
DDI-DrugBank.d572.s8|190-200|fluvastatin|drug
DDI-DrugBank.d572.s9|0-11|Cyclosporine|drug
DDI-DrugBank.d572.s9|14-16|The|brand
DDI-DrugBank.d572.s9|132-143|cyclosporine|drug
DDI-DrugBank.d572.s10|37-48|cyclosporine|drug
DDI-DrugBank.d572.s11|16-26|Mutagenesis|brand
DDI-DrugBank.d572.s11|29-38|Impairment|brand
DDI-DrugBank.d572.s11|43-51|Fertility|brand
DDI-DrugBank.d572.s11|251-259|AUC0-24hr|brand
DDI-DrugBank.d572.s12|167-175|AUC0-24hr|brand
DDI-DrugBank.d572.s13|14-26|statistically|drug
DDI-DrugBank.d572.s13|59-68|incidences|drug
DDI-DrugBank.d572.s14|3-10|evidence|drug
DDI-DrugBank.d572.s14|95-104|Salmonella|brand
DDI-DrugBank.d572.s14|122-132|Escherichia|brand
DDI-DrugBank.d572.s15|3-10|evidence|drug
DDI-DrugBank.d572.s16|26-33|evidence|drug
DDI-DrugBank.d572.s17|80-87|evidence|drug
DDI-DrugBank.d572.s17|92-103|reproductive|drug
DDI-DrugBank.d572.s17|220-228|AUC0-24hr|brand
DDI-DrugBank.d572.s18|10-27|Pregnancy Category|brand
DDI-DrugBank.d572.s18|32-36|There|brand
DDI-DrugBank.d572.s20|128-135|evidence|drug
DDI-DrugBank.d572.s21|19-28|incidences|drug
DDI-DrugBank.d572.s21|234-242|AUC0-24hr|brand
DDI-DrugBank.d572.s22|48-56|incidence|drug
DDI-DrugBank.d572.s22|166-174|AUC0-24hr|brand
DDI-DrugBank.d572.s23|67-71|given|drug
DDI-DrugBank.d572.s24|35-39|given|drug
DDI-DrugBank.d572.s24|61-67|HMG-CoA|brand
DDI-DrugBank.d572.s24|79-97|inhibitors (statins|group
DDI-DrugBank.d572.s24|172-177|statin|drug
DDI-DrugBank.d572.s25|0-11|Reproductive|drug
DDI-DrugBank.d572.s26|4-10|HMG-CoA|brand
DDI-DrugBank.d572.s26|22-31|inhibitors|group
DDI-DrugBank.d572.s27|5-9|ZETIA|brand
DDI-DrugBank.d572.s27|35-41|HMG-CoA|brand
DDI-DrugBank.d572.s27|77-88|childbearing|drug
DDI-DrugBank.d572.s27|162-168|HMG-CoA|brand
DDI-DrugBank.d572.s28|10-17|Delivery|drug
DDI-DrugBank.d572.s28|19-21|The|brand
DDI-DrugBank.d572.s28|34-38|ZETIA|brand
DDI-DrugBank.d572.s28|53-60|delivery|drug
DDI-DrugBank.d572.s29|8-17|Mothers In|brand
DDI-DrugBank.d572.s31|11-15|ZETIA|brand
DDI-DrugBank.d572.s32|10-16|Use The|brand
DDI-DrugBank.d572.s32|18-33|pharmacokinetics|group
DDI-DrugBank.d572.s32|38-42|ZETIA|brand
DDI-DrugBank.d572.s33|26-30|ZETIA|brand
DDI-DrugBank.d572.s33|108-121|sitosterolemia|drug
DDI-DrugBank.d572.s33|168-171|HoFH|brand
DDI-DrugBank.d572.s34|15-19|ZETIA|brand
DDI-DrugBank.d572.s35|10-15|Use Of|brand
DDI-DrugBank.d572.s35|34-41|received|drug
DDI-DrugBank.d572.s35|43-47|ZETIA|brand
DDI-DrugBank.d572.s36|4-16|effectiveness|drug
DDI-DrugBank.d572.s36|32-36|ZETIA|brand
DDI-MedLine.d147.s0|15-25|dacarbazine|drug
DDI-MedLine.d147.s0|70-73|A375|brand
DDI-MedLine.d147.s1|67-77|dacarbazine|drug
DDI-MedLine.d147.s1|128-131|A375|brand
DDI-MedLine.d147.s1|147-150|line|drug
DDI-MedLine.d147.s2|14-17|DTIC|brand
DDI-MedLine.d147.s2|161-163|DNA|brand
DDI-MedLine.d147.s3|0-14|Pharmacokinetic|drug
DDI-MedLine.d147.s3|20-28|antitumor|group
DDI-MedLine.d147.s4|31-38|additive|drug
DDI-MedLine.d147.s5|55-57|DNA|brand
DDI-MedLine.d147.s6|55-62|cysteine|drug
DDI-MedLine.d147.s6|84-87|DTIC|brand
DDI-MedLine.d147.s7|133-141|effective|drug
DDI-MedLine.d147.s7|161-164|A375|brand
DDI-MedLine.d147.s8|11-21|dacarbazine|drug
DDI-MedLine.d147.s8|28-35|additive|drug
DDI-MedLine.d147.s8|79-82|A375|brand
DDI-MedLine.d214.s0|28-38|doxycycline|drug
DDI-MedLine.d214.s0|43-53|MPTP-evoked|drug_n
DDI-MedLine.d214.s0|78-84|C57BL/6|brand
DDI-MedLine.d214.s1|15-31|anti-parkinsonian|group
DDI-MedLine.d214.s1|48-79|[(2-adamantyl)hexamethylenimine]|drug
DDI-MedLine.d214.s2|7-16|antibiotic|group
DDI-MedLine.d214.s2|23-33|doxycycline|drug
DDI-MedLine.d214.s2|85-134|1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP|drug_n
DDI-MedLine.d214.s3|43-49|C57BL/6|brand
DDI-MedLine.d214.s4|31-34|MPTP|drug_n
DDI-MedLine.d214.s4|87-92|saline|drug
DDI-MedLine.d214.s5|37-47|doxycycline|drug
DDI-MedLine.d214.s6|12-19|obtained|drug
DDI-MedLine.d214.s6|106-113|combined|drug
DDI-MedLine.d214.s6|134-150|neurodegenerative|drug
DDI-DrugBank.d580.s0|58-75|ASMANEX TWISTHALER|brand
DDI-DrugBank.d580.s1|9-20|ketoconazole|drug
DDI-DrugBank.d580.s1|96-105|mometasone|drug
DDI-MedLine.d189.s0|11-24|CYP inhibitors|group
DDI-MedLine.d189.s0|72-76|liver|drug
DDI-MedLine.d189.s1|13-25|comprehensive|drug
DDI-MedLine.d189.s1|104-117|Sprague-Dawley|brand
DDI-MedLine.d189.s1|123-127|liver|drug
DDI-MedLine.d189.s1|207-216|inhibitors|group
DDI-MedLine.d189.s2|14-21|combines|group
DDI-MedLine.d189.s2|67-68|MS|brand
DDI-MedLine.d189.s2|150-157|critical|drug
DDI-MedLine.d189.s3|79-81|CYP|brand
DDI-MedLine.d189.s3|142-151|inhibitors|group
DDI-MedLine.d189.s4|45-49|liver|drug
DDI-MedLine.d189.s4|143-149|epoxide|drug
DDI-MedLine.d189.s5|19-23|liver|drug
DDI-MedLine.d189.s8|24-37|CYP inhibitors|group
DDI-MedLine.d189.s8|104-118|tranylcypromine|drug
DDI-MedLine.d189.s8|124-143|noticeably effective|drug
DDI-MedLine.d189.s8|167-170|CYPs|brand
DDI-MedLine.d189.s9|39-41|CYP|brand
DDI-MedLine.d189.s9|53-65|effectiveness|drug
DDI-MedLine.d189.s9|71-125|ABT>diethyldithiocarbamate~tranylcypromine>ketoconazole|drug
DDI-MedLine.d189.s10|0-10|Furafylline|drug
DDI-MedLine.d189.s10|16-29|sulfaphenazole|drug
DDI-MedLine.d189.s10|52-60|quinidine|drug
DDI-MedLine.d189.s11|31-35|liver|drug
DDI-MedLine.d189.s12|23-29|provide|drug
DDI-MedLine.d189.s12|80-82|CYP|brand
DDI-DrugBank.d605.s0|45-56|barbiturates|group
DDI-DrugBank.d605.s0|68-70|CNS|brand
